"# GtoPdb Version: 2024.2 - published: 2024-06-26"
"HGNC Symbol","HGNC ID","IUPHAR Name","IUPHAR ID","GtP URL"
"AAK1","19679","AP2 associated kinase 1","1921","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1921"
"AATK","21","apoptosis associated tyrosine kinase","1922","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1922"
"ABAT","23","4-aminobutyrate aminotransferase","2464","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2464"
"ABCA1","29","ABCA1","756","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=756"
"ABCA10","30","ABCA10","765","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=765"
"ABCA12","14637","ABCA12","766","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=766"
"ABCA13","14638","ABCA13","767","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=767"
"ABCA2","32","ABCA2","757","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=757"
"ABCA3","33","ABCA3","758","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=758"
"ABCA4","34","ABCA4","759","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=759"
"ABCA5","35","ABCA5","760","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=760"
"ABCA6","36","ABCA6","761","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=761"
"ABCA7","37","ABCA7","762","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=762"
"ABCA8","38","ABCA8","763","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=763"
"ABCA9","39","ABCA9","764","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=764"
"ABCB1","40","ABCB1","768","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=768"
"ABCB10","41","ABCB10","777","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=777"
"ABCB11","42","ABCB11","778","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=778"
"ABCB4","45","ABCB4","771","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=771"
"ABCB5","46","ABCB5","772","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=772"
"ABCB6","47","ABCB6","773","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=773"
"ABCB7","48","ABCB7","774","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=774"
"ABCB8","49","ABCB8","775","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=775"
"ABCB9","50","ABCB9","776","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=776"
"ABCC1","51","ABCC1","779","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=779"
"ABCC10","52","ABCC10","785","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=785"
"ABCC11","14639","ABCC11","786","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=786"
"ABCC12","14640","ABCC12","787","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=787"
"ABCC2","53","ABCC2","780","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=780"
"ABCC3","54","ABCC3","781","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=781"
"ABCC4","55","ABCC4","782","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=782"
"ABCC5","56","ABCC5","783","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=783"
"ABCC6","57","ABCC6","784","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=784"
"ABCC8","59","ATP-binding cassette, sub-family C (CFTR/MRP), member 8","2594","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2594"
"ABCC9","60","ABCC9","2746","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2746"
"ABCD1","61","ABCD1","788","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=788"
"ABCD2","66","ABCD2","789","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=789"
"ABCD3","67","ABCD3","790","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=790"
"ABCG1","73","ABCG1","791","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=791"
"ABCG2","74","ABCG2","792","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=792"
"ABCG4","13884","ABCG4","793","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=793"
"ABCG5","13886","ABCG5","794","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=794"
"ABCG8","13887","ABCG8","795","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=795"
"ABHD12","15868","&alpha;&beta;-Hydrolase 12","3070","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3070"
"ABHD2","18717","&alpha;&beta;-Hydrolase 2","3147","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3147"
"ABHD6","21398","&alpha;&beta;-Hydrolase 6","2919","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2919"
"ABL1","76","ABL proto-oncogene 1, non-receptor tyrosine kinase","1923","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1923"
"ABL2","77","ABL proto-oncogene 2, non-receptor tyrosine kinase","1924","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1924"
"ACACA","84","Acetyl-CoA carboxylase 1","1263","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1263"
"ACACB","85","Acetyl-CoA carboxylase 2","1264","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264"
"ACAT1","93","acetyl-CoA acetyltransferase 1","2435","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2435"
"ACAT2","94","acetyl-CoA acetyltransferase 2","2436","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2436"
"ACE","2707","Angiotensin-converting enzyme","1613","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1613"
"ACE2","13557","Angiotensin-converting enzyme 2","1614","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1614"
"ACER1","18356","alkaline ceramidase 1","2468","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2468"
"ACER2","23675","alkaline ceramidase 2","2469","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2469"
"ACER3","16066","alkaline ceramidase 3","2470","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2470"
"ACHE","108","acetylcholinesterase (Yt blood group)","2465","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2465"
"ACKR1","4035","ACKR1","316","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=316"
"ACKR2","1565","ACKR2","314","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=314"
"ACKR3","23692","ACKR3","80","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=80"
"ACKR4","1611","ACKR4","315","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=315"
"ACLY","115","ATP citrate lyase","3245","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3245"
"ACOD1","33904","aconitate decarboxylase 1","3018","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3018"
"ACR","126","acrosin","2327","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2327"
"ACSS2","15814","acyl-CoA synthetase short chain family member 2","3128","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3128"
"ACVR1","171","activin A receptor type 1","1785","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1785"
"ACVR1B","172","activin A receptor type 1B","1787","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1787"
"ACVR1C","18123","activin A receptor type 1C","1790","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1790"
"ACVR2A","173","activin A receptor type 2A","1791","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1791"
"ACVR2B","174","activin A receptor type 2B","1792","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1792"
"ACVRL1","175","activin A receptor type IL","1784","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1784"
"ADA","186","Adenosine deaminase","1230","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1230"
"ADAM10","188","ADAM10","1658","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1658"
"ADAM11","189","ADAM11","1659","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1659"
"ADAM12","190","ADAM12","1660","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1660"
"ADAM15","193","ADAM15","1661","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1661"
"ADAM17","195","ADAM17","1662","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1662"
"ADAM18","196","ADAM18","1663","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1663"
"ADAM19","197","ADAM19","1664","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1664"
"ADAM2","198","ADAM2","1651","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1651"
"ADAM20","199","ADAM20","1665","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1665"
"ADAM21","200","ADAM21","1666","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1666"
"ADAM22","201","ADAM22","1667","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1667"
"ADAM23","202","ADAM23","1668","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1668"
"ADAM28","206","ADAM28","1669","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1669"
"ADAM29","207","ADAM29","1670","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1670"
"ADAM30","208","ADAM30","1671","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1671"
"ADAM32","15479","ADAM32","1672","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1672"
"ADAM33","15478","ADAM33","1673","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1673"
"ADAM7","214","ADAM7","1655","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1655"
"ADAM8","215","ADAM8","1656","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1656"
"ADAM9","216","ADAM9","1657","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1657"
"ADAMTS1","217","ADAMTS1","1674","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1674"
"ADAMTS10","13201","ADAMTS10","1683","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1683"
"ADAMTS12","14605","ADAMTS12","1684","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1684"
"ADAMTS13","1366","ADAMTS13","1685","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1685"
"ADAMTS14","14899","ADAMTS14","1686","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1686"
"ADAMTS15","16305","ADAMTS15","1687","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1687"
"ADAMTS16","17108","ADAMTS16","1688","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1688"
"ADAMTS17","17109","ADAMTS17","1689","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1689"
"ADAMTS18","17110","ADAMTS18","1690","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1690"
"ADAMTS19","17111","ADAMTS19","1691","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1691"
"ADAMTS2","218","ADAMTS2","1675","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1675"
"ADAMTS20","17178","ADAMTS20","1692","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1692"
"ADAMTS3","219","ADAMTS3","1676","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1676"
"ADAMTS4","220","ADAMTS4","1677","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1677"
"ADAMTS5","221","ADAMTS5","1678","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1678"
"ADAMTS6","222","ADAMTS6","1679","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1679"
"ADAMTS7","223","ADAMTS7","1680","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1680"
"ADAMTS8","224","ADAMTS8","1681","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1681"
"ADAMTS9","13202","ADAMTS9","1682","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1682"
"ADCK1","19038","aarF domain containing kinase 1","1925","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1925"
"ADCK2","19039","aarF domain containing kinase 2","1926","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1926"
"ADCK5","21738","aarF domain containing kinase 5","1929","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1929"
"ADCY1","232","adenylyl cyclase 1","1278","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1278"
"ADCY10","21285","adenylyl cyclase 10","3068","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3068"
"ADCY2","233","adenylyl cyclase 2","1279","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1279"
"ADCY3","234","adenylyl cyclase 3","1280","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1280"
"ADCY4","235","adenylyl cyclase 4","1281","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1281"
"ADCY5","236","adenylyl cyclase 5","1282","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1282"
"ADCY6","237","adenylyl cyclase 6","1283","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1283"
"ADCY7","238","adenylyl cyclase 7","1284","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1284"
"ADCY8","239","adenylyl cyclase 8","1285","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1285"
"ADCY9","240","adenylyl cyclase 9","1286","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1286"
"ADCYAP1","241","PACAP-38","2258","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2258"
"ADCYAP1R1","242","PAC<sub>1</sub> receptor","370","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=370"
"ADGRA1","13838","ADGRA1","197","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=197"
"ADGRA2","17849","ADGRA2","198","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=198"
"ADGRA3","13839","ADGRA3","199","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=199"
"ADGRB1","943","ADGRB1","174","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=174"
"ADGRB2","944","ADGRB2","175","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=175"
"ADGRB3","945","ADGRB3","176","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=176"
"ADGRD1","19893","ADGRD1","202","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=202"
"ADGRD2","18651","ADGRD2","204","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=204"
"ADGRE1","3336","ADGRE1","182","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=182"
"ADGRE2","3337","ADGRE2","183","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=183"
"ADGRE3","23647","ADGRE3","184","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=184"
"ADGRE4P","19240","ADGRE4P","185","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=185"
"ADGRE5","1711","ADGRE5","177","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=177"
"ADGRF1","18990","ADGRF1","190","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=190"
"ADGRF2P","18991","ADGRF2","191","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=191"
"ADGRF3","18989","ADGRF3","193","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=193"
"ADGRF4","19011","ADGRF4","195","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=195"
"ADGRF5","19030","ADGRF5","196","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=196"
"ADGRG1","4512","ADGRG1","186","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=186"
"ADGRG2","4516","ADGRG2","187","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=187"
"ADGRG3","13728","ADGRG3","188","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=188"
"ADGRG4","18992","ADGRG4","192","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=192"
"ADGRG5","19010","ADGRG5","194","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=194"
"ADGRG6","13841","ADGRG6","200","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=200"
"ADGRG7","19241","ADGRG7","201","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=201"
"ADGRL1","20973","ADGRL1","206","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=206"
"ADGRL2","18582","ADGRL2","207","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=207"
"ADGRL3","20974","ADGRL3","208","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=208"
"ADGRL4","20822","ADGRL4","181","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=181"
"ADGRV1","17416","ADGRV1","189","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=189"
"ADIPOQ","13633","adiponectin","3726","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3726"
"ADIPOR1","24040","Adipo1 receptor","649","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=649"
"ADIPOR2","24041","Adipo2 receptor","650","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=650"
"ADK","257","Adenosine kinase","1231","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1231"
"ADM","259","adrenomedullin","683","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=683"
"ADM2","28898","adrenomedullin 2/intermedin","684","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=684"
"ADORA1","262","A<sub>1</sub> receptor","18","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18"
"ADORA2A","263","A<sub>2A</sub> receptor","19","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=19"
"ADORA2B","264","A<sub>2B</sub> receptor","20","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=20"
"ADORA3","268","A<sub>3</sub> receptor","21","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21"
"ADRA1A","277","&alpha;<sub>1A</sub>-adrenoceptor","22","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=22"
"ADRA1B","278","&alpha;<sub>1B</sub>-adrenoceptor","23","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=23"
"ADRA1D","280","&alpha;<sub>1D</sub>-adrenoceptor","24","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=24"
"ADRA2A","281","&alpha;<sub>2A</sub>-adrenoceptor","25","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=25"
"ADRA2B","282","&alpha;<sub>2B</sub>-adrenoceptor","26","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=26"
"ADRA2C","283","&alpha;<sub>2C</sub>-adrenoceptor","27","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=27"
"ADRB1","285","&beta;<sub>1</sub>-adrenoceptor","28","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=28"
"ADRB2","286","&beta;<sub>2</sub>-adrenoceptor","29","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=29"
"ADRB3","288","&beta;<sub>3</sub>-adrenoceptor","30","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=30"
"AEBP1","303","AE binding protein 1","1586","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1586"
"AGER","320","advanced glycosylation end-product specific receptor","2843","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2843"
"AGRN","329","agrin","5319","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5319"
"AGRP","330","agouti-related protein","1335","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1335"
"AGT","333","angiotensin I","583","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=583"
"AGTR1","336","AT<sub>1</sub> receptor","34","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34"
"AGTR2","338","AT<sub>2</sub> receptor","35","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=35"
"AHCY","343","S-Adenosylhomocysteine hydrolase","1233","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1233"
"AHR","348","Aryl hydrocarbon receptor","2951","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2951"
"AIM2","357","absent in melanoma 2","2923","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2923"
"AKR1B1","381","aldo-keto reductase family 1 member B","2768","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2768"
"AKR1C3","386","AKR1C3","1382","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1382"
"AKT1","391","AKT serine/threonine kinase 1","1479","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1479"
"AKT2","392","AKT serine/threonine kinase 2","1480","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1480"
"AKT3","393","AKT serine/threonine kinase 3","2286","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2286"
"ALDH2","404","aldehyde dehydrogenase 2 family member","2595","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2595"
"ALDH5A1","408","aldehyde dehydrogenase 5 family member A1","2466","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2466"
"ALDH9A1","412","aldehyde dehydrogenase 9 family member A1","2467","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2467"
"ALK","427","ALK receptor tyrosine kinase","1839","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1839"
"ALOX12","429","12S-LOX","1387","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1387"
"ALOX12B","430","12R-LOX","1386","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1386"
"ALOX15","433","15-LOX-1","1388","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1388"
"ALOX15B","434","15-LOX-2","1389","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1389"
"ALOX5","435","5-LOX","1385","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1385"
"ALOX5AP","436","5-LOX activating protein","5183","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5183"
"ALOXE3","13743","E-LOX","1390","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1390"
"ALPK1","20917","alpha kinase 1","1930","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1930"
"ALPK3","17574","alpha kinase 3","1931","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1931"
"AMBP","453","ulinastatin","10359","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10359"
"AMD1","457","S-Adenosylmethionine decarboxylase ","1269","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1269"
"AMH","464","M&uuml;llerian inhibiting substance","6686","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6686"
"AMHR2","465","anti-Mullerian hormone receptor type 2","1793","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1793"
"AMY2A","477","amylase alpha 2A","2596","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2596"
"ANGPT1","484","angiopoietin-1","4867","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4867"
"ANGPT2","485","angiopoietin-2","5316","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5316"
"ANGPT4","487","angiopoietin-4","4868","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4868"
"ANGPTL1","489","angiopoietin protein-like 1","5317","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5317"
"ANGPTL3","491","angiopoietin-like 3","8716","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8716"
"ANGPTL7","24078","angiopoietin-related protein 7","5321","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5321"
"ANKH","15492","ANKH inorganic pyrophosphate transport regulator","3046","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3046"
"ANKK1","21027","ankyrin repeat and kinase domain containing 1","1932","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1932"
"ANO1","21625","CaCC","708","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=708"
"ANPEP","500","Aminopeptidase N","1560","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1560"
"ANXA1","533","annexin I","1031","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1031"
"AOAH","548","acyloxyacyl hydrolase","2873","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2873"
"AOC3","550","amine oxidase copper containing 3","2767","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2767"
"AOPEP","1361","Aminopeptidase O","1561","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1561"
"AOX1","553","aldehyde oxidase 1","3186","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3186"
"APCS","584","amyloid P component, serum","2839","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2839"
"APEH","586","acylaminoacyl-peptide hydrolase","2328","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2328"
"APELA","48925","Elabela/Toddler-32","8524","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8524"
"APLN","16665","apelin-36","606","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=606"
"APLNR","339","apelin receptor","36","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=36"
"APP","620","amyloid &beta;","4865","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4865"
"AQP1","633","AQP1","688","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=688"
"AQP10","16029","AQP10","697","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=697"
"AQP11","19940","AQP11","3062","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3062"
"AQP2","634","AQP2","689","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=689"
"AQP3","636","AQP3","690","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=690"
"AQP4","637","AQP4","691","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=691"
"AQP5","638","AQP5","692","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=692"
"AQP6","639","AQP6","693","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=693"
"AQP7","640","AQP7","694","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=694"
"AQP8","642","AQP8","695","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=695"
"AQP9","643","AQP9","696","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=696"
"AR","644","Androgen receptor","628","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=628"
"ARAF","646","A-Raf proto-oncogene, serine/threonine kinase","1933","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1933"
"AREG","651","amphiregulin","4864","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4864"
"ARF1","652","ADP-ribosylation factor 1","5305","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5305"
"ARG1","663","Arginase I","1244","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1244"
"ARG2","664","Arginase II","1245","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1245"
"ARHGDIB","679","Rho GDP dissociation inhibitor beta","5174","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5174"
"ARTN","727","artemin","4871","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4871"
"ASAH1","735","N-acylsphingosine amidohydrolase 1","2491","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2491"
"ASAH2","18860","N-acylsphingosine amidohydrolase 2","2492","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2492"
"ASAH2B","23456","N-acylsphingosine amidohydrolase 2B","2493","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2493"
"ASH1L","19088","ASH1 like histone lysine methyltransferase","2648","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2648"
"ASIC1","100","ASIC1","684","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=684"
"ASIC2","99","ASIC2","685","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=685"
"ASIC3","101","ASIC3","686","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=686"
"ASIP","745","agouti","3609","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3609"
"ASPG","20123","asparaginase","2762","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2762"
"ATAD2","30123","ATPase family AAA domain containing 2","2719","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2719"
"ATAD2B","29230","ATPase family AAA domain containing 2B","2720","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2720"
"ATG4B","20790","autophagy related 4B cysteine peptidase","2329","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2329"
"ATM","795","ATM serine/threonine kinase","1934","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1934"
"ATP10A","13542","Probable phospholipid-transporting ATPase VA","862","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=862"
"ATP10B","13543","Probable phospholipid-transporting ATPase VB","863","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=863"
"ATP10D","13549","Probable phospholipid-transporting ATPase VD","864","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=864"
"ATP11A","13552","Probable phospholipid-transporting ATPase IH","865","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=865"
"ATP11B","13553","Probable phospholipid-transporting ATPase IF","866","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=866"
"ATP11C","13554","Phospholipid-transporting ATPase IG","867","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=867"
"ATP12A","13816","ATP12A","850","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=850"
"ATP13A1","24215","ATPase 13A1","3155","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3155"
"ATP13A2","30213","ATPase cation transporting 13A2","3156","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3156"
"ATP13A3","24113","ATPase 13A3","3157","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3157"
"ATP13A4","25422","ATPase 13A4","3158","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3158"
"ATP13A5","31789","ATPase 13A5","3159","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3159"
"ATP1A1","799","sodium/potassium-transporting ATPase subunit &alpha;-1","833","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=833"
"ATP1A2","800","sodium/potassium-transporting ATPase subunit &alpha;-2","834","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=834"
"ATP1A3","801","sodium/potassium-transporting ATPase subunit &alpha;-3","835","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=835"
"ATP1A4","14073","sodium/potassium-transporting ATPase subunit &alpha;-4","836","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=836"
"ATP1B1","804","sodium/potassium-transporting ATPase subunit &beta;-1","837","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=837"
"ATP1B2","805","sodium/potassium-transporting ATPase subunit &beta;-2","838","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=838"
"ATP1B3","806","sodium/potassium-transporting ATPase subunit &beta;-3","839","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=839"
"ATP2A1","811","SERCA1","840","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=840"
"ATP2A2","812","SERCA2","841","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=841"
"ATP2A3","813","SERCA3","842","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=842"
"ATP2B1","814","PMCA1","843","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=843"
"ATP2B2","815","PMCA2","844","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=844"
"ATP2B3","816","PMCA3","845","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=845"
"ATP2B4","817","PMCA4","846","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=846"
"ATP2C1","13211","SPCA1","847","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=847"
"ATP2C2","29103","SPCA2","848","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=848"
"ATP4A","819","ATP4A","849","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=849"
"ATP4B","820","ATP4B","851","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=851"
"ATP5F1A","823","F-type ATPase &alpha; subunit","796","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=796"
"ATP5F1B","830","F-type ATPase &beta; subunit","797","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=797"
"ATP5F1C","833","F-type ATPase &gamma; subunit","798","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=798"
"ATP5F1D","837","F-type ATPase &delta; subunit","799","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=799"
"ATP5F1E","838","F-type ATPase &epsilon; subunit","800","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=800"
"ATP5MC1","841","F-type ATPase C subunit","803","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5MC2","842","F-type ATPase C subunit","803","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5MC3","843","F-type ATPase C subunit","803","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5ME","846","F-type ATPase E subunit","805","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=805"
"ATP5MF","848","F-type ATPase F2 subunit","806","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=806"
"ATP5MGL","13213","F-type ATPase G2 subunit","808","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=808"
"ATP5PB","840","F-type ATPase B subunit","802","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=802"
"ATP5PD","845","F-type ATPase D subunit","804","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=804"
"ATP5PF","847","F-type ATPase F6 subunit","807","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=807"
"ATP6V0A1","865","V-type ATPase V<sub>0</sub> motor a1 subunit","823","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=823"
"ATP6V0A2","18481","V-type ATPase V<sub>0</sub> motor a2 subunit","824","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=824"
"ATP6V0A4","866","V-type ATPase V<sub>0</sub> motor a4 subunit","826","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=826"
"ATP6V0B","861","V-type ATPase V<sub>0</sub> motor b subunit","827","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=827"
"ATP6V0C","855","V-type ATPase V<sub>0</sub> motor c subunit","828","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=828"
"ATP6V0D1","13724","V-type ATPase V<sub>0</sub> motor d1 subunit","829","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=829"
"ATP6V0D2","18266","V-type ATPase V<sub>0</sub> motor d2 subunit","830","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=830"
"ATP6V0E1","863","V-type ATPase V<sub>0</sub> motor e1 subunit","831","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=831"
"ATP6V0E2","21723","V-type ATPase V<sub>0</sub> motor e2 subunit","832","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=832"
"ATP6V1A","851","V-type ATPase V<sub>1</sub> motor A subunit","810","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=810"
"ATP6V1B1","853","V-type ATPase V<sub>1</sub> motor B1 subunit","811","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=811"
"ATP6V1B2","854","V-type ATPase V<sub>1</sub> motor B2 subunit","812","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=812"
"ATP6V1C1","856","V-type ATPase V<sub>1</sub> motor C1 subunit","813","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=813"
"ATP6V1C2","18264","V-type ATPase V<sub>1</sub> motor C2 subunit","814","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=814"
"ATP6V1D","13527","V-type ATPase V<sub>1</sub> motor D subunit","815","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=815"
"ATP6V1E1","857","V-type ATPase V<sub>1</sub> motor E1 subunit","816","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=816"
"ATP6V1E2","18125","V-type ATPase V<sub>1</sub> motor E2 subunit","817","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=817"
"ATP6V1F","16832","V-type ATPase V<sub>1</sub> motor F subunit","818","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=818"
"ATP6V1G1","864","V-type ATPase V<sub>1</sub> motor G1 subunit","819","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=819"
"ATP6V1G2","862","V-type ATPase V<sub>1</sub> motor G2 subunit","820","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=820"
"ATP6V1G3","18265","V-type ATPase V<sub>1</sub> motor G3 subunit","821","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=821"
"ATP6V1H","18303","V-type ATPase V<sub>1</sub> motor H subunit","822","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=822"
"ATP7A","869","ATP7A","852","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=852"
"ATP7B","870","ATP7B","853","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=853"
"ATP8A1","13531","Phospholipid-transporting ATPase IA","854","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=854"
"ATP8A2","13533","Phospholipid-transporting ATPase IB","855","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=855"
"ATP8B1","3706","Phospholipid-transporting ATPase IC","856","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=856"
"ATP8B2","13534","Phospholipid-transporting ATPase ID","857","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=857"
"ATP8B3","13535","Phospholipid-transporting ATPase IK","858","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=858"
"ATP8B4","13536","Probable phospholipid-transporting ATPase IM","859","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=859"
"ATP9A","13540","Probable phospholipid-transporting ATPase IIA","860","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=860"
"ATP9B","13541","Probable phospholipid-transporting ATPase IIB","861","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=861"
"ATR","882","ATR serine/threonine kinase","1935","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1935"
"AURKA","11393","aurora kinase A","1936","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1936"
"AURKB","11390","aurora kinase B","1937","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1937"
"AURKC","11391","aurora kinase C","1938","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1938"
"AVP","894","vasopressin","2168","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2168"
"AVPR1A","895","V<sub>1A</sub> receptor","366","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=366"
"AVPR1B","896","V<sub>1B</sub> receptor","367","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=367"
"AVPR2","897","V<sub>2</sub> receptor","368","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=368"
"AXIN2","904","axin 2","3237","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3237"
"AXL","905","AXL receptor tyrosine kinase","1835","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1835"
"AZIN2","29957","L-Arginine decarboxylase ","1270","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1270"
"BACE1","933","beta-secretase 1","2330","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2330"
"BACE2","934","beta-secretase 2","2331","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2331"
"BAP1","950","BRCA1 associated protein 1","2332","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2332"
"BAZ1A","960","bromodomain adjacent to zinc finger domain 1A","2773","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2773"
"BAZ1B","961","bromodomain adjacent to zinc finger domain 1B","2774","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2774"
"BAZ2A","962","bromodomain adjacent to zinc finger domain 2A","2721","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2721"
"BAZ2B","963","bromodomain adjacent to zinc finger domain 2B","2722","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2722"
"BCAT1","976","branched chain amino acid transaminase 1","3210","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3210"
"BCAT2","977","branched chain amino acid transaminase 2","2893","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2893"
"BCHE","983","butyrylcholinesterase","2471","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2471"
"BCKDK","16902","branched chain keto acid dehydrogenase kinase","1939","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1939"
"BCL2","990","BCL2 apoptosis regulator","2844","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2844"
"BCL2L1","992","Bcl-2-like 1","2845","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2845"
"BCL2L2","995","Bcl-2-like 2","2846","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2846"
"BCL3","998","BCL3 transcription coactivator","3232","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3232"
"BCL6","1001","BCL6 transcription repressor","2957","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2957"
"BCR","1014","BCR activator of RhoGEF and GTPase","2755","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2755"
"BDKRB1","1029","B<sub>1</sub> receptor","41","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=41"
"BDKRB2","1030","B<sub>2</sub> receptor","42","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=42"
"BDNF","1033","BDNF","4872","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4872"
"BEST3","17105","bestrophin-3","5377","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5377"
"BID","1050","BH3 interacting-domain death agonist","5152","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5152"
"BIRC2","590","baculoviral IAP repeat containing 2","2791","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2791"
"BIRC3","591","baculoviral IAP repeat containing 3","2792","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2792"
"BIRC5","593","baculoviral IAP repeat containing 5","2795","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2795"
"BIRC6","13516","baculoviral IAP repeat containing 6","2796","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2796"
"BIRC7","13702","baculoviral IAP repeat containing 7","2794","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2794"
"BIRC8","14878","baculoviral IAP repeat containing 8","2797","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2797"
"BLK","1057","BLK proto-oncogene, Src family tyrosine kinase","1940","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1940"
"BLM","1058","BLM RecQ like helicase","3260","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3260"
"BMP1","1067","bone morphogenetic protein 1","2333","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2333"
"BMP10","20869","BMP-10","4875","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4875"
"BMP15","1068","BMP-15","4880","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4880"
"BMP2","1069","BMP-2","4881","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4881"
"BMP2K","18041","BMP2 inducible kinase","1941","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1941"
"BMP3","1070","BMP-3","4882","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4882"
"BMP4","1071","BMP-4","4883","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4883"
"BMP5","1072","BMP-5","4884","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4884"
"BMP6","1073","BMP-6","4885","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4885"
"BMP7","1074","BMP-7","4886","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4886"
"BMP8A","21650","BMP-8A","4887","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4887"
"BMP8B","1075","BMP-8B","4888","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4888"
"BMPR1A","1076","bone morphogenetic protein receptor type IA","1786","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1786"
"BMPR1B","1077","bone morphogenetic protein receptor type IB","1789","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1789"
"BMPR2","1078","bone morphogenetic protein receptor type 2","1794","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1794"
"BMX","1079","BMX non-receptor tyrosine kinase","1942","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1942"
"BPTF","3581","bromodomain PHD finger transcription factor","2723","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2723"
"BRAF","1097","B-Raf proto-oncogene, serine/threonine kinase","1943","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943"
"BRD1","1102","bromodomain containing 1","2724","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2724"
"BRD2","1103","bromodomain containing 2","1944","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1944"
"BRD3","1104","bromodomain containing 3","2725","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2725"
"BRD4","13575","bromodomain containing 4","1945","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1945"
"BRD7","14310","bromodomain containing 7","2726","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2726"
"BRD8","19874","bromodomain containing 8","2727","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2727"
"BRD9","25818","bromodomain containing 9","2728","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2728"
"BRDT","1105","bromodomain testis associated","2729","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2729"
"BRPF1","14255","bromodomain and PHD finger containing 1","2730","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2730"
"BRPF3","14256","bromodomain and PHD finger containing 3","2731","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2731"
"BRS3","1113","BB<sub>3</sub> receptor","40","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=40"
"BRSK1","18994","BR serine/threonine kinase 1","1946","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1946"
"BRSK2","11405","BR serine/threonine kinase 2","1947","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1947"
"BRWD1","12760","bromodomain and WD repeat domain containing 1","2732","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2732"
"BRWD3","17342","bromodomain and WD repeat domain containing 3","2775","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2775"
"BSG","1116","basigin (Ok blood group)","3127","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3127"
"BTC","1121","betacellulin","4873","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4873"
"BTK","1133","Bruton tyrosine kinase","1948","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1948"
"BTLA","21087","B and T lymphocyte attenuator","4891","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4891"
"BTN3A1","1138","butyrophilin subfamily 3 member A1","2948","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2948"
"BTNL3","1143","butyrophilin like 3","2944","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2944"
"BTNL8","26131","butyrophilin like 8","2947","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2947"
"BUB1","1148","BUB1 mitotic checkpoint serine/threonine kinase","1949","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1949"
"BUB1B","1149","BUB1 mitotic checkpoint serine/threonine kinase B","1950","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1950"
"C1R","1246","complement C1r","2334","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2334"
"C1S","1247","complement C1s","2335","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2335"
"C3","1318","complement C3","9414","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9414"
"C3AR1","1319","C3a receptor","31","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=31"
"C4A","1323","C4a","6547","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6547"
"C5","1331","C5a","573","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=573"
"C5AR1","1338","C5a<sub>1</sub> receptor","32","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=32"
"C5AR2","4527","C5a<sub>2</sub> receptor","33","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=33"
"CA1","1368","carbonic anhydrase 1","2597","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2597"
"CA12","1371","carbonic anhydrase 12","2747","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2747"
"CA13","14914","carbonic anhydrase 13","2748","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2748"
"CA14","1372","carbonic anhydrase 14","2598","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2598"
"CA2","1373","carbonic anhydrase 2","3092","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3092"
"CA4","1375","carbonic anhydrase 4","2599","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2599"
"CA5A","1377","carbonic anhydrase 5A","3093","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3093"
"CA7","1381","carbonic anhydrase 7","2749","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2749"
"CA9","1383","carbonic anhydrase 9","3055","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3055"
"CACNA1A","1388","Ca<sub>v</sub>2.1","532","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=532"
"CACNA1B","1389","Ca<sub>v</sub>2.2","533","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=533"
"CACNA1C","1390","Ca<sub>v</sub>1.2","529","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=529"
"CACNA1D","1391","Ca<sub>v</sub>1.3","530","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=530"
"CACNA1E","1392","Ca<sub>v</sub>2.3","534","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=534"
"CACNA1F","1393","Ca<sub>v</sub>1.4","531","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=531"
"CACNA1G","1394","Ca<sub>v</sub>3.1","535","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=535"
"CACNA1H","1395","Ca<sub>v</sub>3.2","536","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=536"
"CACNA1I","1396","Ca<sub>v</sub>3.3","537","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=537"
"CACNA1S","1397","Ca<sub>v</sub>1.1","528","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=528"
"CALCA","1437","&alpha;-CGRP","681","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=681"
"CALCB","1438","&beta;-CGRP","682","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=682"
"CALCR","1440","CT receptor","43","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=43"
"CALCRL","16709","calcitonin receptor-like receptor","47","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=47"
"CALM1","1442","calmodulin","2351","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CALM2","1445","calmodulin","2351","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CALM3","1449","calmodulin","2351","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CAMK1","1459","calcium/calmodulin dependent protein kinase I","1952","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1952"
"CAMK1D","19341","calcium/calmodulin dependent protein kinase ID","1953","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1953"
"CAMK1G","14585","calcium/calmodulin dependent protein kinase IG","1954","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1954"
"CAMK2A","1460","calcium/calmodulin-dependent protein kinase II alpha subunit","1555","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1555"
"CAMK2B","1461","calcium/calmodulin-dependent protein kinase II beta subunit","1556","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1556"
"CAMK2D","1462","calcium/calmodulin-dependent protein kinase II delta subunit","1558","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1558"
"CAMK2G","1463","calcium/calmodulin-dependent protein kinase II gamma subunit","1557","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1557"
"CAMK4","1464","calcium/calmodulin dependent protein kinase IV","1955","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1955"
"CAMKK1","1469","calcium/calmodulin dependent protein kinase kinase 1","1956","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1956"
"CAMKK2","1470","calcium/calmodulin dependent protein kinase kinase 2","1957","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1957"
"CAMKV","28788","CaM kinase like vesicle associated","1958","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1958"
"CAMP","1472","LL-37","5527","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5527"
"CAPN1","1476","calpain 1","2336","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2336"
"CAPN2","1479","calpain 2","2337","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2337"
"CARM1","23393","coactivator associated arginine methyltransferase 1","1255","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1255"
"CARTPT","24323","CART(55-102)","13185","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13185"
"CASK","1497","calcium/calmodulin dependent serine protein kinase","1959","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1959"
"CASP1","1499","Caspase 1","1617","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1617"
"CASP10","1500","Caspase 10","1626","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1626"
"CASP14","1502","Caspase 14","1627","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1627"
"CASP2","1503","Caspase 2","1618","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1618"
"CASP3","1504","Caspase 3","1619","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1619"
"CASP4","1505","Caspase 4","1620","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1620"
"CASP5","1506","Caspase 5","1621","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1621"
"CASP6","1507","Caspase 6","1622","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1622"
"CASP7","1508","Caspase 7","1623","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1623"
"CASP8","1509","Caspase 8","1624","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1624"
"CASP9","1511","Caspase 9","1625","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1625"
"CASR","1514","CaS receptor","54","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=54"
"CAT","1516","catalase","2979","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2979"
"CATSPER1","17116","CatSper1","388","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=388"
"CATSPER2","18810","CatSper2","389","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=389"
"CATSPER3","20819","CatSper3","390","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=390"
"CATSPER4","23220","CatSper4","391","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=391"
"CATSPERB","20500","CatSperBeta","2326","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2326"
"CBLB","1542","Cbl proto-oncogene B","3234","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3234"
"CBR1","1548","CBR1","1383","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1383"
"CBS","1550","Cystathionine &beta;-synthase","1443","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1443"
"CCK","1569","CCK-58","3552","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3552"
"CCKAR","1570","CCK<sub>1</sub> receptor","76","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=76"
"CCKBR","1571","CCK<sub>2</sub> receptor","77","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=77"
"CCL1","10609","CCL1","812","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=812"
"CCL11","10610","CCL11","769","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=769"
"CCL13","10611","CCL13","770","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=770"
"CCL14","10612","CCL14","753","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=753"
"CCL15","10613","CCL15","754","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=754"
"CCL16","10614","CCL16","1272","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1272"
"CCL17","10615","CCL17","797","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=797"
"CCL18","10616","CCL18","4382","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4382"
"CCL19","10617","CCL19","810","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=810"
"CCL2","10618","CCL2","771","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=771"
"CCL20","10619","CCL20","808","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=808"
"CCL21","10620","CCL21","811","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=811"
"CCL22","10621","CCL22","798","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=798"
"CCL23","10622","CCL23","755","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=755"
"CCL24","10623","CCL24","775","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=775"
"CCL25","10624","CCL25","817","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=817"
"CCL26","10625","CCL26","776","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=776"
"CCL27","10626","CCL27","3646","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3646"
"CCL28","17700","CCL28","3649","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3649"
"CCL3","10627","CCL3","756","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=756"
"CCL4","10630","CCL4","757","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=757"
"CCL5","10632","CCL5","758","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=758"
"CCL7","10634","CCL7","759","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=759"
"CCL8","10635","CCL8","772","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=772"
"CCN2","2500","connective tissue growth factor","8927","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8927"
"CCR1","1602","CCR1","58","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=58"
"CCR10","4474","CCR10","67","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=67"
"CCR2","1603","CCR2","59","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=59"
"CCR3","1604","CCR3","60","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=60"
"CCR4","1605","CCR4","61","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=61"
"CCR5","1606","CCR5","62","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=62"
"CCR6","1607","CCR6","63","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=63"
"CCR7","1608","CCR7","64","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=64"
"CCR8","1609","CCR8","65","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=65"
"CCR9","1610","CCR9","66","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=66"
"CCRL2","1612","CCRL2","78","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=78"
"CD14","1628","CD14 molecule","3126","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3126"
"CD19","1633","CD19","2764","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2764"
"CD1D","1637","CD1d molecule","2997","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2997"
"CD2","1639","CD2","2600","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2600"
"CD209","1641","CD209 molecule","2930","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2930"
"CD22","1643","CD22","2786","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2786"
"CD24","1645","CD24 molecule","3170","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3170"
"CD247","1677","T-cell surface glycoprotein CD3 zeta chain (CD247)","3142","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3142"
"CD27","11922","CD27","1876","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1876"
"CD274","17635","programmed cell death 1 ligand 1","9606","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9606"
"CD276","19137","B7-H3 (CD276)","2938","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2938"
"CD28","1653","CD28","2863","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2863"
"CD300A","19319","CD300a","2918","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2918"
"CD33","1659","CD33","2601","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2601"
"CD36","1663","CD36 molecule (CD36 blood group)","3104","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3104"
"CD37","1666","CD37 molecule","3010","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3010"
"CD38","1667","CD38","2766","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2766"
"CD3E","1674","CD3e","2742","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2742"
"CD4","1678","CD4","2995","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2995"
"CD40","11919","CD40","1874","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1874"
"CD40LG","11935","CD40 ligand","5077","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5077"
"CD47","1682","CD47","2943","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2943"
"CD52","1804","CD52","2602","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2602"
"CD55","2665","CD55 molecule (Cromer blood group)","3246","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3246"
"CD6","1691","CD6","2917","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2917"
"CD70","11937","CD70","5079","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5079"
"CD74","1697","CD74","2840","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2840"
"CD79B","1699","CD79B","2852","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2852"
"CD80","1700","CD80","2744","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2744"
"CD86","1705","CD86","2745","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2745"
"CDA","1712","cytidine deaminase","3133","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3133"
"CDC42BPA","1737","CDC42 binding protein kinase alpha","1507","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1507"
"CDC42BPB","1738","CDC42 binding protein kinase beta","1508","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1508"
"CDC42BPG","29829","CDC42 binding protein kinase gamma","1506","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1506"
"CDC7","1745","cell division cycle 7","1960","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1960"
"CDK1","1722","cyclin dependent kinase 1","1961","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1961"
"CDK10","1770","cyclin dependent kinase 10","1962","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1962"
"CDK11A","1730","cyclin dependent kinase 11A","1963","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1963"
"CDK11B","1729","cyclin dependent kinase 11B","1964","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1964"
"CDK12","24224","cyclin dependent kinase 12","1965","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1965"
"CDK13","1733","cyclin dependent kinase 13","1966","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1966"
"CDK14","8883","cyclin dependent kinase 14","1967","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1967"
"CDK15","14434","cyclin dependent kinase 15","1968","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1968"
"CDK16","8749","cyclin dependent kinase 16","1969","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1969"
"CDK17","8750","cyclin dependent kinase 17","1970","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1970"
"CDK18","8751","cyclin dependent kinase 18","1971","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1971"
"CDK19","19338","cyclin dependent kinase 19","1972","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1972"
"CDK2","1771","cyclin dependent kinase 2","1973","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1973"
"CDK20","21420","cyclin dependent kinase 20","1974","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1974"
"CDK3","1772","cyclin dependent kinase 3","1975","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1975"
"CDK4","1773","cyclin dependent kinase 4","1976","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1976"
"CDK5","1774","cyclin dependent kinase 5","1977","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1977"
"CDK6","1777","cyclin dependent kinase 6","1978","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1978"
"CDK7","1778","cyclin dependent kinase 7","1979","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1979"
"CDK8","1779","cyclin dependent kinase 8","1980","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1980"
"CDK9","1780","cyclin dependent kinase 9","1981","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1981"
"CDKL1","1781","cyclin dependent kinase like 1","1982","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1982"
"CDKL2","1782","cyclin dependent kinase like 2","1983","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1983"
"CDKL3","15483","cyclin-dependent kinase like 3","1984","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1984"
"CDKL4","19287","cyclin-dependent kinase like 4","1985","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1985"
"CDKL5","11411","cyclin-dependent kinase like 5","1986","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1986"
"CDNF","24913","cerebral dopamine neurotrophic factor","13048","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13048"
"CEACAM5","1817","CD66e (CEACAM5)","2836","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2836"
"CECR2","1840","CECR2 histone acetyl-lysine reader","2733","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2733"
"CEL","1848","carboxyl ester lipase","2872","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2872"
"CELA1","3308","chymotrypsin like elastase 1","2338","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2338"
"CELA2A","24609","chymotrypsin like elastase 2A","3201","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3201"
"CELSR1","1850","<i>CELSR1</i>","178","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=178"
"CELSR2","3231","<i>CELSR2</i>","179","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=179"
"CELSR3","3230","<i>CELSR3</i>","180","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=180"
"CERK","19256","ceramide kinase","2473","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2473"
"CERS1","14253","ceramide synthase 1","2474","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2474"
"CERS2","14076","ceramide synthase 2","2475","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2475"
"CERS3","23752","ceramide synthase 3","2476","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2476"
"CERS4","23747","ceramide synthase 4","2477","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2477"
"CERS5","23749","ceramide synthase 5","2478","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2478"
"CERS6","23826","ceramide synthase 6","2479","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2479"
"CES1","1863","carboxylesterase 1","2592","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2592"
"CETP","1869","cholesteryl ester transfer protein","3248","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3248"
"CFB","1037","complement factor B","2339","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2339"
"CFD","2771","complement factor D","2842","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2842"
"CFLAR","1876","FLICE-like inhibitory protein subunit p43","5188","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5188"
"CFTR","1884","CFTR","707","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=707"
"CGA","1885","glycoprotein hormone common alpha subunit","3731","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3731"
"CGAS","21367","Cyclic GMP-AMP synthase","3165","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3165"
"CGB3","1886","chorionic gonadotropin beta subunit","4396","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4396"
"CHAT","1912","choline O-acetyltransferase","2480","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2480"
"CHEK1","1925","checkpoint kinase 1","1987","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1987"
"CHEK2","16627","checkpoint kinase 2","1988","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1988"
"CHGA","1929","chromogranin A","5165","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5165"
"CHI3L1","1932","chitinase 3 like 1","2987","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2987"
"CHIA","17432","chitinase acidic","2982","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2982"
"CHIT1","1936","chitinase 1","3187","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3187"
"CHRM1","1950","M<sub>1</sub> receptor","13","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=13"
"CHRM2","1951","M<sub>2</sub> receptor","14","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14"
"CHRM3","1952","M<sub>3</sub> receptor","15","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15"
"CHRM4","1953","M<sub>4</sub> receptor","16","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16"
"CHRM5","1954","M<sub>5</sub> receptor","17","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=17"
"CHRNA1","1955","nicotinic acetylcholine receptor &alpha;1 subunit","462","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=462"
"CHRNA10","13800","nicotinic acetylcholine receptor &alpha;10 subunit","470","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=470"
"CHRNA2","1956","nicotinic acetylcholine receptor &alpha;2 subunit","463","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=463"
"CHRNA3","1957","nicotinic acetylcholine receptor &alpha;3 subunit","464","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=464"
"CHRNA4","1958","nicotinic acetylcholine receptor &alpha;4 subunit","465","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=465"
"CHRNA5","1959","nicotinic acetylcholine receptor &alpha;5 subunit","466","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=466"
"CHRNA6","15963","nicotinic acetylcholine receptor &alpha;6 subunit","467","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=467"
"CHRNA7","1960","nicotinic acetylcholine receptor &alpha;7 subunit","468","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468"
"CHRNA9","14079","nicotinic acetylcholine receptor &alpha;9 subunit","469","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=469"
"CHRNB1","1961","nicotinic acetylcholine receptor &beta;1 subunit","471","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=471"
"CHRNB2","1962","nicotinic acetylcholine receptor &beta;2 subunit","472","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=472"
"CHRNB3","1963","nicotinic acetylcholine receptor &beta;3 subunit","473","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=473"
"CHRNB4","1964","nicotinic acetylcholine receptor &beta;4 subunit","474","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=474"
"CHRND","1965","nicotinic acetylcholine receptor &delta; subunit","476","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=476"
"CHRNE","1966","nicotinic acetylcholine receptor &epsilon; subunit","477","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=477"
"CHRNG","1967","nicotinic acetylcholine receptor &gamma; subunit","475","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=475"
"CHUK","1974","component of inhibitor of nuclear factor kappa B kinase complex","1989","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1989"
"CIITA","7067","CIITA","1767","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1767"
"CILK1","21219","ciliogenesis associated kinase 1","2038","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2038"
"CIT","1985","citron rho-interacting serine/threonine kinase","1509","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1509"
"CLCF1","17412","cardiotrophin-like cytokine factor 1","4895","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4895"
"CLCN1","2019","ClC-1","698","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=698"
"CLCN2","2020","ClC-2","699","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=699"
"CLCN3","2021","ClC-3","702","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=702"
"CLCN4","2022","ClC-4","703","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=703"
"CLCN5","2023","ClC-5","704","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=704"
"CLCN6","2024","ClC-6","705","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=705"
"CLCN7","2025","ClC-7","706","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=706"
"CLCNKA","2026","ClC-Ka","700","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=700"
"CLCNKB","2027","ClC-Kb","701","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=701"
"CLDN18","2039","claudin 18","2903","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2903"
"CLEC12A","31713","C-type lectin domain family 12 member A","3081","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3081"
"CLEC4A","13257","C-type lectin domain family 4 member A","2931","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2931"
"CLEC4C","13258","C-type lectin domain family 4 member C","3135","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3135"
"CLEC4E","14555","C-type lectin domain family 4 member E","2929","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2929"
"CLEC6A","14556","C-type lectin domain family 6 member A","2928","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2928"
"CLEC7A","14558","C-type lectin domain family 7 member A","2927","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2927"
"CLK1","2068","CDC like kinase 1","1990","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1990"
"CLK2","2069","CDC like kinase 2","1991","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1991"
"CLK3","2071","CDC like kinase 3","1992","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1992"
"CLK4","13659","CDC like kinase 4","1993","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1993"
"CLOCK","2082","clock circadian regulator","2649","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2649"
"CLPP","2084","caseinolytic mitochondrial matrix peptidase proteolytic subunit","3273","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3273"
"CLU","2095","clusterin","3195","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3195"
"CLUL1","2096","CLUL1 (52-77)","10543","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10543"
"CMA1","2097","chymase 1","2340","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2340"
"CMKLR1","2121","chemerin receptor 1","79","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=79"
"CMKLR2","4463","chemerin receptor 2","82","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=82"
"CNDP1","20675","Carnosine dipeptidase 1 (metallopeptidase M20 family)","1603","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1603"
"CNDP2","24437","Carnosine dipeptidase 2","1604","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1604"
"CNGA1","2148","CNGA1","394","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=394"
"CNGA2","2149","CNGA2","395","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=395"
"CNGA3","2150","CNGA3","396","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=396"
"CNGA4","2152","CNGA4","397","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=397"
"CNGB1","2151","CNGB1","398","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=398"
"CNGB3","2153","CNGB3","399","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=399"
"CNR1","2159","CB<sub>1</sub> receptor","56","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=56"
"CNR2","2160","CB<sub>2</sub> receptor","57","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=57"
"CNTF","2169","ciliary neurotrophic factor","4897","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4897"
"CNTFR","2170","Ciliary neurotrophic factor receptor &alpha; subunit","1711","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1711"
"CNTN1","2171","contactin-1","6617","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6617"
"CNTN3","2173","contactin-3","6609","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6609"
"CNTN4","2174","contactin-4","6612","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6612"
"CNTN5","2175","contactin-5","6613","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6613"
"CNTN6","2176","contactin-6","6614","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6614"
"COL1A1","2197","COL1A1","4898","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4898"
"COL2A1","2200","COL2A1","4899","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4899"
"COL3A1","2201","COL3A1","4900","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4900"
"COL4A1","2202","COL4A1","4901","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4901"
"COMT","2228","Catechol-O-methyltransferase","2472","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2472"
"COPA","2230","xenin","1587","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1587"
"COQ8A","16812","coenzyme Q8A","1927","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1927"
"COQ8B","19041","coenzyme Q8B","1928","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1928"
"CORT","2257","CST-17","2008","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2008"
"CPA1","2296","Carboxypeptidase A1 (pancreatic)","1587","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1587"
"CPA2","2297","Carboxypeptidase A2 (pancreatic)","1588","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1588"
"CPA3","2298","Carboxypeptidase A3 (mast cell)","1589","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1589"
"CPA4","15740","Carboxypeptidase A4","1590","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1590"
"CPA5","15722","Carboxypeptidase A5","1591","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1591"
"CPA6","17245","Carboxypeptidase A6","1592","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1592"
"CPB1","2299","Carboxypeptidase B1 (tissue)","1593","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1593"
"CPB2","2300","Carboxypeptidase B2 (plasma)","1594","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1594"
"CPD","2301","Carboxypeptidase D","1582","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1582"
"CPE","2303","Carboxypeptidase E","1595","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1595"
"CPM","2311","Carboxypeptidase M","1596","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1596"
"CPN1","2312","Carboxypeptidase N, polypeptide 1","1597","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1597"
"CPN2","2313","Carboxypeptidase N, polypeptide 2","1598","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1598"
"CPO","21011","Carboxypeptidase O","1599","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1599"
"CPQ","16910","Carboxypeptidase Q","1610","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1610"
"CPT1A","2328","carnitine palmitoyltransferase 1A","3249","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3249"
"CPT1B","2329","carnitine palmitoyltransferase 1B","3250","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3250"
"CPT1C","18540","carnitine palmitoyltransferase 1C","3251","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3251"
"CPT2","2330","carnitine palmitoyltransferase 2","3252","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3252"
"CPVL","14399","Vitellogenic carboxypeptidase-like protein","1583","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1583"
"CPXM1","15771","Carboxypeptidase X (M14 family), member 1","1600","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1600"
"CPXM2","26977","Carboxypeptidase X (M14 family), member 2","1601","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1601"
"CPZ","2333","Carboxypeptidase Z","1602","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1602"
"CRABP1","2338","cellular retinoic acid binding protein 1","2529","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2529"
"CRABP2","2339","cellular retinoic acid binding protein 2","2530","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2530"
"CRBN","30185","cereblon","3086","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3086"
"CREBBP","2348","CREB binding protein","2734","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2734"
"CRH","2355","corticotrophin-releasing hormone","912","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=912"
"CRHR1","2357","CRF<sub>1</sub> receptor","212","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=212"
"CRHR2","2358","CRF<sub>2</sub> receptor","213","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=213"
"CRLF1","2364","cytokine receptor-like factor 1","4904","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4904"
"CRLF2","14281","Cytokine receptor-like factor 2","1704","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1704"
"CRY1","2384","cryptochrome circadian regulator 1","2876","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2876"
"CSF1","2432","M-CSF","4905","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4905"
"CSF1R","2433","colony stimulating factor 1 receptor","1806","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1806"
"CSF2","2434","GM-CSF","4942","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4942"
"CSF2RA","2435","GM-CSF receptor, &alpha; subunit","1707","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1707"
"CSF2RB","2436","Cytokine receptor common &beta; subunit","2306","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2306"
"CSF3","2438","G-CSF","4934","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4934"
"CSF3R","2439","Granulocyte colony-stimulating factor receptor","1719","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1719"
"CSH1","2440","choriomammotropin","4893","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4893"
"CSH2","2441","choriomammotropin","4893","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4893"
"CSHL1","2442","chorionic somatomammotropin hormone-like 1 ","4894","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4894"
"CSK","2444","C-terminal Src kinase","1994","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1994"
"CSNK1A1","2451","casein kinase 1 alpha 1","1995","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1995"
"CSNK1A1L","20289","casein kinase 1 alpha 1 like","1996","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1996"
"CSNK1D","2452","casein kinase 1 delta","1997","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1997"
"CSNK1E","2453","casein kinase 1 epsilon","1998","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1998"
"CSNK1G1","2454","casein kinase 1 gamma 1","1999","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1999"
"CSNK1G2","2455","casein kinase 1 gamma 2","2000","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2000"
"CSNK1G3","2456","casein kinase 1 gamma 3","2001","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2001"
"CSNK2A1","2457","casein kinase 2, alpha 1 polypeptide subunit","1549","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1549"
"CSNK2A2","2459","casein kinase 2, alpha prime polypeptide subunit","1550","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1550"
"CSNK2B","2460","casein kinase 2, beta polypeptide subunit","1551","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1551"
"CTF1","2499","cardiotrophin-1","4906","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4906"
"CTH","2501","Cystathionine &gamma;-lyase","1444","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1444"
"CTLA4","2505","cytotoxic T-lymphocyte-associated protein 4 (CD152)","2743","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2743"
"CTNNB1","2514","&beta;-catenin","5371","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5371"
"CTNS","2518","cystinosin, lysosomal cystine transporter","3163","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3163"
"CTPS1","2519","CTP synthase 1","3215","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3215"
"CTPS2","2520","CTP synthase 2","3216","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3216"
"CTRB1","2521","chymotrypsinogen B1","3272","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3272"
"CTRC","2523","chymotrypsin C","2341","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2341"
"CTRL","2524","chymotrypsin like","2342","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2342"
"CTSA","9251","Cathepsin A","1581","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1581"
"CTSB","2527","cathepsin B","2343","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2343"
"CTSC","2528","cathepsin C","2344","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2344"
"CTSD","2529","cathepsin D","2345","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2345"
"CTSE","2530","cathepsin E","2346","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2346"
"CTSF","2531","cathepsin F","2347","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2347"
"CTSG","2532","cathepsin G","2348","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2348"
"CTSH","2535","cathepsin H","2349","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2349"
"CTSK","2536","cathepsin K","2350","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2350"
"CTSL","2537","cathepsin L","2351","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2351"
"CTSS","2545","cathepsin S","2353","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2353"
"CTSV","2538","cathepsin V","2352","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2352"
"CTSZ","2547","cathepsin Z","2354","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2354"
"CX3CL1","10647","CX<sub>3</sub>CL1","856","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=856"
"CX3CR1","2558","CX<sub>3</sub>CR1","74","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=74"
"CXCL1","4602","CXCL1","819","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=819"
"CXCL10","10637","CXCL10","835","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=835"
"CXCL11","10638","CXCL11","836","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=836"
"CXCL12","10672","CXCL12&delta;","8531","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8531"
"CXCL13","10639","CXCL13","3645","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3645"
"CXCL14","10640","CXCL14","3680","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3680"
"CXCL16","16642","CXCL16","855","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=855"
"CXCL17","19232","CXCL17","6479","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6479"
"CXCL2","4603","CXCL2","827","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=827"
"CXCL3","4604","CXCL3","828","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=828"
"CXCL5","10642","CXCL5","829","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=829"
"CXCL6","10643","CXCL6","820","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=820"
"CXCL8","6025","CXCL8","821","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=821"
"CXCL9","7098","CXCL9","837","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=837"
"CXCR1","6026","CXCR1","68","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=68"
"CXCR2","6027","CXCR2","69","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=69"
"CXCR3","4540","CXCR3","70","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=70"
"CXCR4","2561","CXCR4","71","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71"
"CXCR5","1060","CXCR5","72","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=72"
"CXCR6","16647","CXCR6","73","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=73"
"CYBB","2578","cytochrome b-245 beta chain","3002","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3002"
"CYP11A1","2590","CYP11A1","1358","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1358"
"CYP11B1","2591","CYP11B1","1359","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1359"
"CYP11B2","2592","CYP11B2","1360","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1360"
"CYP17A1","2593","CYP17A1","1361","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1361"
"CYP19A1","2594","CYP19A1","1362","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1362"
"CYP1A1","2595","CYP1A1","1318","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1318"
"CYP1A2","2596","CYP1A2","1319","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1319"
"CYP1B1","2597","CYP1B1","1320","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1320"
"CYP20A1","20576","CYP20A1","1363","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1363"
"CYP21A2","2600","CYP21A2","1364","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1364"
"CYP24A1","2602","CYP24A1","1365","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1365"
"CYP26A1","2603","CYP26A1","1366","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1366"
"CYP26B1","20581","CYP26B1","1367","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1367"
"CYP26C1","20577","CYP26C1","1368","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1368"
"CYP27A1","2605","CYP27A1","1369","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1369"
"CYP27B1","2606","CYP27B1","1370","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1370"
"CYP27C1","33480","CYP27C1","1371","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1371"
"CYP2A13","2608","CYP2A13","1323","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1323"
"CYP2A6","2610","CYP2A6","1321","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1321"
"CYP2A7","2611","CYP2A7","1322","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1322"
"CYP2B6","2615","CYP2B6","1324","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1324"
"CYP2C18","2620","CYP2C18","1327","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1327"
"CYP2C19","2621","CYP2C19","1328","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1328"
"CYP2C8","2622","CYP2C8","1325","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1325"
"CYP2C9","2623","CYP2C9","1326","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1326"
"CYP2D6","2625","CYP2D6","1329","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1329"
"CYP2E1","2631","CYP2E1","1330","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1330"
"CYP2F1","2632","CYP2F1","1331","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1331"
"CYP2J2","2634","CYP2J2","1332","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1332"
"CYP2R1","20580","CYP2R1","1333","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1333"
"CYP2S1","15654","CYP2S1","1334","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1334"
"CYP2U1","20582","CYP2U1","1335","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1335"
"CYP2W1","20243","CYP2W1","1336","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1336"
"CYP39A1","17449","CYP39A1 ","1372","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1372"
"CYP3A4","2637","CYP3A4","1337","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1337"
"CYP3A43","17450","CYP3A43","1340","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1340"
"CYP3A5","2638","CYP3A5","1338","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1338"
"CYP3A7","2640","CYP3A7","1339","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1339"
"CYP46A1","2641","CYP46A1","1373","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1373"
"CYP4A11","2642","CYP4A11","1341","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1341"
"CYP4A22","20575","CYP4A22","1342","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1342"
"CYP4B1","2644","CYP4B1","1343","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1343"
"CYP4F11","13265","CYP4F11","1347","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1347"
"CYP4F12","18857","CYP4F12","1348","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1348"
"CYP4F2","2645","CYP4F2","1344","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1344"
"CYP4F22","26820","CYP4F22","1349","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1349"
"CYP4F3","2646","CYP4F3","1345","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1345"
"CYP4F8","2648","CYP4F8","1346","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1346"
"CYP4V2","23198","CYP4V2","1350","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1350"
"CYP4X1","20244","CYP4X1","1351","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1351"
"CYP4Z1","20583","CYP4Z1","1352","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1352"
"CYP51A1","2649","CYP51A1","1374","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1374"
"CYP7A1","2651","CYP7A1","1354","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1354"
"CYP7B1","2652","CYP7B1","1355","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1355"
"CYP8B1","2653","CYP8B1","1357","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1357"
"CYSLTR1","17451","CysLT<sub>1</sub> receptor","269","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=269"
"CYSLTR2","18274","CysLT<sub>2</sub> receptor","270","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=270"
"DAGLA","1165","diacylglycerol lipase &alpha;","1396","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1396"
"DAGLB","28923","diacylglycerol lipase &beta;","1397","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1397"
"DAPK1","2674","death associated protein kinase 1","2002","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2002"
"DAPK2","2675","death associated protein kinase 2","2003","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2003"
"DAPK3","2676","death associated protein kinase 3","2004","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2004"
"DBH","2689","Dopamine beta-hydroxylase (dopamine beta-monooxygenase)","2486","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2486"
"DCAF1","30911","DDB1 and CUL4 associated factor 1","3244","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3244"
"DCLK1","2700","doublecortin like kinase 1","2005","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2005"
"DCLK2","19002","doublecortin like kinase 2","2006","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2006"
"DCLK3","19005","doublecortin like kinase 3","2007","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2007"
"DDAH1","2715","<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 1","1247","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1247"
"DDAH2","2716","<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 2","1248","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1248"
"DDC","2719","L-Aromatic amino-acid decarboxylase ","1271","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1271"
"DDR1","2730","discoidin domain receptor tyrosine kinase 1","1843","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1843"
"DDR2","2731","discoidin domain receptor tyrosine kinase 2","1844","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1844"
"DEFB4A","2767","beta-defensin 4A","3648","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3648"
"DEFB4B","30193","beta-defensin 4A","3648","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3648"
"DEGS1","13709","delta 4-desaturase, sphingolipid 1","2484","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2484"
"DEGS2","20113","delta 4-desaturase, sphingolipid 2","2485","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2485"
"DGAT1","2843","diacylglycerol O-acyltransferase 1","2821","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2821"
"DGAT2","16940","diacylglycerol O-acyltransferase 2","3211","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3211"
"DGKA","2849","diacylglycerol kinase alpha","3256","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3256"
"DGKZ","2857","diacylglycerol kinase zeta","3257","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3257"
"DHFR","2861","dihydrofolate reductase","2603","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2603"
"DHODH","2867","dihydroorotate dehydrogenase (quinone)","2604","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2604"
"DHX58","29517","DExH-box helicase 58","2922","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2922"
"DIO1","2883","iodothyronine deiodinase 1","2481","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2481"
"DIO2","2884","iodothyronine deiodinase 2","2482","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2482"
"DIO3","2885","iodothyronine deiodinase 3","2483","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2483"
"DKK1","2891","Dickkopf 1","3701","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3701"
"DLL3","2909","delta like canonical Notch ligand 3","10560","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10560"
"DLL4","2910","delta like canonical Notch ligand 4","8452","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8452"
"DMPK","2933","DM1 protein kinase","1505","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1505"
"DNMT1","2976","DNA methyltransferase 1","2605","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2605"
"DNMT3A","2978","DNA (cytosine-5-)-methyltransferase 3&alpha;","2750","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2750"
"DNPEP","2981","Aminopeptidase A","1559","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1559"
"DOT1L","24948","DOT1 like histone lysine methyltransferase","2650","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2650"
"DPEP1","3002","Dipeptidase 1","1393","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1393"
"DPEP2","23028","Dipeptidase 2","1394","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1394"
"DPP3","3008","dipeptidyl peptidase 3","2355","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2355"
"DPP4","3009","dipeptidyl peptidase 4","1612","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1612"
"DPP7","14892","Dipeptidyl-peptidase 7","1605","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1605"
"DPP8","16490","dipeptidyl peptidase 8","2356","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2356"
"DPP9","18648","dipeptidyl peptidase 9","2357","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2357"
"DPYD","3012","dihydropyrimidine dehydrogenase","3102","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3102"
"DRD1","3020","D<sub>1</sub> receptor","214","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214"
"DRD2","3023","D<sub>2</sub> receptor","215","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=215"
"DRD3","3024","D<sub>3</sub> receptor","216","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=216"
"DRD4","3025","D<sub>4</sub> receptor","217","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217"
"DRD5","3026","D<sub>5</sub> receptor","218","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=218"
"DSTYK","29043","dual serine/threonine and tyrosine protein kinase","2008","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2008"
"DUOX1","3062","dual oxidase 1","3000","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3000"
"DUOX2","13273","dual oxidase 2","2999","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2999"
"DYRK1A","3091","dual specificity tyrosine phosphorylation regulated kinase 1A","2009","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2009"
"DYRK1B","3092","dual specificity tyrosine phosphorylation regulated kinase 1B","2010","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2010"
"DYRK2","3093","dual specificity tyrosine phosphorylation regulated kinase 2","2011","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2011"
"DYRK3","3094","dual specificity tyrosine phosphorylation regulated kinase 3","2012","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2012"
"DYRK4","3095","dual specificity tyrosine phosphorylation regulated kinase 4","2013","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2013"
"EBI3","3129","IL-27 subunit &beta;","6153","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6153"
"ECE1","3146","Endothelin-converting enzyme 1","1615","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1615"
"ECE2","13275","Endothelin-converting enzyme 2","1616","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1616"
"EDA","3157","ectodysplasin A1","6144","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6144"
"EDA2R","17756","ectodysplasin A2 isoform receptor","1896","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1896"
"EDAR","2895","ectodysplasin 1, anhidrotic receptor","2325","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2325"
"EDN1","3176","endothelin-1","989","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=989"
"EDN2","3177","endothelin-2","990","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=990"
"EDN3","3178","endothelin-3","1004","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1004"
"EDNRA","3179","ET<sub>A</sub> receptor","219","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219"
"EDNRB","3180","ET<sub>B</sub> receptor","220","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220"
"EED","3188","embryonic ectoderm development","2487","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2487"
"EEF2","3214","eukaryotic translation elongation factor 2","2756","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2756"
"EEF2K","24615","eukaryotic elongation factor 2 kinase","2014","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2014"
"EFNA1","3221","ephrin-A1","4908","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4908"
"EFNA2","3222","ephrin-A2","4909","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4909"
"EFNA3","3223","ephrin-A3","4910","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4910"
"EFNA4","3224","ephrin-A4","4911","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4911"
"EFNA5","3225","ephrin-A5","4912","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4912"
"EFNB1","3226","ephrin-B1","4913","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4913"
"EFNB2","3227","ephrin-B2","4914","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4914"
"EFNB3","3228","ephrin-B3","4915","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4915"
"EGF","3229","EGF","4916","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4916"
"EGFR","3236","epidermal growth factor receptor","1797","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1797"
"EGLN1","1232","egl-9 family hypoxia inducible factor 1","2833","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2833"
"EGLN2","14660","egl-9 family hypoxia inducible factor 2","2832","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2832"
"EGLN3","14661","egl-9 family hypoxia inducible factor 3","2834","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2834"
"EHMT1","24650","euchromatic histone lysine methyltransferase 1","2651","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2651"
"EHMT2","14129","euchromatic histone lysine methyltransferase 2","2652","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2652"
"EIF2AK1","24921","eukaryotic translation initiation factor 2 alpha kinase 1","2015","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2015"
"EIF2AK2","9437","eukaryotic translation initiation factor 2 alpha kinase 2","2016","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2016"
"EIF2AK3","3255","eukaryotic translation initiation factor 2 alpha kinase 3","2017","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2017"
"EIF2AK4","19687","eukaryotic translation initiation factor 2 alpha kinase 4","2018","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2018"
"ELANE","3309","elastase, neutrophil expressed","2358","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2358"
"ELP3","20696","elongator acetyltransferase complex subunit 3","2653","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2653"
"ENG","3349","endoglin (CD105)","2895","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2895"
"ENHO","24838","adropin","9573","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9573"
"ENPEP","3355","Glutamyl aminopeptidase","1568","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1568"
"ENPP2","3357","autotaxin","2901","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2901"
"ENTPD1","3363","ectonucleoside triphosphate diphosphohydrolase 1","2888","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2888"
"ENTPD2","3364","ectonucleoside triphosphate diphosphohydrolase 2","2889","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2889"
"EP300","3373","E1A binding protein p300","2735","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2735"
"EPAS1","3374","endothelial PAS domain protein 1","3148","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3148"
"EPB41","3377","erythrocyte membrane protein band 4.1","3151","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3151"
"EPGN","17470","epigen","4917","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4917"
"EPHA1","3385","EPH receptor A1","1821","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1821"
"EPHA10","19987","EPH receptor A10","1829","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1829"
"EPHA2","3386","EPH receptor A2","1822","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1822"
"EPHA3","3387","EPH receptor A3","1823","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1823"
"EPHA4","3388","EPH receptor A4","1824","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1824"
"EPHA5","3389","EPH receptor A5","1825","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1825"
"EPHA6","19296","EPH receptor A6","1826","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1826"
"EPHA7","3390","EPH receptor A7","1827","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1827"
"EPHA8","3391","EPH receptor A8","1828","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1828"
"EPHB1","3392","EPH receptor B1","1830","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1830"
"EPHB2","3393","EPH receptor B2","1831","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1831"
"EPHB3","3394","EPH receptor B3","1832","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1832"
"EPHB4","3395","EPH receptor B4","1833","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1833"
"EPHB6","3396","EPH receptor B6","1834","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1834"
"EPHX2","3402","epoxide hydrolase 2","2970","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2970"
"EPO","3415","erythropoietin","4921","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4921"
"EPOR","3416","Eythropoietin receptor","1718","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1718"
"ERAP1","18173","Endoplasmic reticulum aminopeptidase 1","1566","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1566"
"ERAP2","29499","Endoplasmic reticulum aminopeptidase 2","1567","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1567"
"ERBB2","3430","erb-b2 receptor tyrosine kinase 2","2019","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019"
"ERBB3","3431","erb-b2 receptor tyrosine kinase 3","1798","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1798"
"ERBB4","3432","erb-b2 receptor tyrosine kinase 4","1799","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1799"
"EREG","3443","epiregulin","4918","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4918"
"ERN1","3449","endoplasmic reticulum to nucleus signaling 1","2020","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2020"
"ERN2","16942","endoplasmic reticulum to nucleus signaling 2","2021","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2021"
"ERVW-1","13525","endogenous retrovirus group W member 1, envelope","3182","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3182"
"ESR1","3467","Estrogen receptor-&alpha;","620","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=620"
"ESR2","3468","Estrogen receptor-&beta;","621","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=621"
"ESRRA","3471","Estrogen-related receptor-&alpha;","622","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=622"
"ESRRB","3473","Estrogen-related receptor-&beta;","623","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=623"
"ESRRG","3474","Estrogen-related receptor-&gamma;","624","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=624"
"EZH1","3526","enhancer of zeste 1 polycomb repressive complex 2 subunit","2835","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2835"
"EZH2","3527","enhancer of zeste 2 polycomb repressive complex 2 subunit","2654","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2654"
"F10","3528","coagulation factor X","2359","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2359"
"F11","3529","coagulation factor XI","2360","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2360"
"F12","3530","coagulation factor XII","2361","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2361"
"F2","3535","coagulation factor II, thrombin","2362","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2362"
"F2R","3537","PAR1","347","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=347"
"F2RL1","3538","PAR2","348","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=348"
"F2RL2","3539","PAR3","349","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=349"
"F2RL3","3540","PAR4","350","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=350"
"F3","3541","coagulation factor III, tissue factor","3192","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3192"
"F5","3542","coagulation factor V","2606","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2606"
"F7","3544","coagulation factor VII","2363","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2363"
"F8","3546","coagulation factor VIII","2607","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2607"
"F9","3551","coagulation factor IX","2364","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2364"
"FAAH","3553","Fatty acid amide hydrolase","1400","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1400"
"FAAH2","26440","Fatty acid amide hydrolase-2","1401","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1401"
"FABP1","3555","fatty acid binding protein 1","2531","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2531"
"FABP12","34524","fatty acid binding protein 12","2584","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2584"
"FABP2","3556","fatty acid binding protein 2","2532","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2532"
"FABP3","3557","fatty acid binding protein 3","2533","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2533"
"FABP4","3559","fatty acid binding protein 4","2534","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2534"
"FABP5","3560","fatty acid binding protein 5","2535","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2535"
"FABP6","3561","fatty acid binding protein 6","2536","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2536"
"FABP7","3562","fatty acid binding protein 7","2537","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2537"
"FABP9","3563","fatty acid binding protein 9","2538","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2538"
"FAP","3590","fibroblast activation protein alpha","2365","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2365"
"FAS","11920","Fas","1875","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1875"
"FASLG","11936","Fas ligand","5078","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5078"
"FASN","3594","fatty acid synthase","2608","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2608"
"FBN1","3603","asprosin","9200","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9200"
"FBXO10","13589","F-box protein 10","2655","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2655"
"FBXO11","13590","F-box protein 11","1260","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1260"
"FBXO3","13582","F-box protein 3","3233","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3233"
"FCAR","3608","Fc fragment of IgA receptor","2991","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2991"
"FCER1A","3609","Fc fragment of IgE receptor Ia","2933","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2933"
"FCER1G","3611","Fc fragment of IgE receptor Ig","2934","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2934"
"FCER2","3612","Fc fragment of IgE receptor II","2935","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2935"
"FCGR2A","3616","Fc fragment of IgG receptor IIa","3190","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3190"
"FCGR3A","3619","Fc fragment of IgG receptor IIIa","3017","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3017"
"FCGRT","3621","Fc fragment of IgG receptor and transporter","2985","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2985"
"FCMR","14315","Fc fragment of IgM receptor","2992","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2992"
"FDFT1","3629","squalene synthase ","645","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=645"
"FDPS","3631","farnesyl diphosphate synthase","644","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=644"
"FER","3655","FER tyrosine kinase","2022","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2022"
"FES","3657","FES proto-oncogene, tyrosine kinase","2023","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2023"
"FFAR1","4498","FFA1 receptor","225","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=225"
"FFAR2","4501","FFA2 receptor","226","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=226"
"FFAR3","4499","FFA3 receptor","227","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=227"
"FFAR4","19061","FFA4 receptor","127","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=127"
"FGA","3661","fibrinogen alpha chain","6750","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6750"
"FGB","3662","fibrinogen beta chain","6751","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6751"
"FGF1","3665","FGF-1","4923","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4923"
"FGF10","3666","FGF-10","9641","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9641"
"FGF18","3674","FGF-18","10974","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10974"
"FGF19","3675","FGF-19","11545","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11545"
"FGF2","3676","FGF-2","4924","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4924"
"FGF21","3678","FGF-21","11721","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11721"
"FGF23","3680","FGF-23","9291","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9291"
"FGF3","3681","FGF-3","9629","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9629"
"FGF4","3682","FGF-4","4925","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4925"
"FGF5","3683","FGF-5","4926","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4926"
"FGF6","3684","FGF-6","4927","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4927"
"FGF7","3685","FGF-7","4928","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4928"
"FGF8","3686","FGF-8","4929","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4929"
"FGF9","3687","FGF-9","4930","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4930"
"FGFR1","3688","fibroblast growth factor receptor 1","1808","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1808"
"FGFR2","3689","fibroblast growth factor receptor 2","1809","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1809"
"FGFR3","3690","fibroblast growth factor receptor 3","1810","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1810"
"FGFR4","3691","fibroblast growth factor receptor 4","1811","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1811"
"FGG","3694","fibrinogen gamma chain","6752","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6752"
"FGR","3697","FGR proto-oncogene, Src family tyrosine kinase","2024","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2024"
"FKBP1A","3711","FKBP prolyl isomerase 1A","2609","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2609"
"FKBP4","3720","FKBP prolyl isomerase 4","3176","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3176"
"FKBP5","3721","FKBP prolyl isomerase 5","3175","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3175"
"FKBP8","3724","FKBP prolyl isomerase 8","3177","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3177"
"FKBPL","13949","FKBP prolyl isomerase like","3178","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3178"
"FLT1","3763","fms related receptor tyrosine kinase 1","1812","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1812"
"FLT3","3765","fms related receptor tyrosine kinase 3","1807","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1807"
"FLT3LG","3766","Fms-related tyrosine kinase 3 ligand","4932","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4932"
"FLT4","3767","fms related receptor tyrosine kinase 4","1814","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1814"
"FLVCR1","24682","Feline leukemia virus subgroup C cellular receptor family, member 1","1910","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1910"
"FLVCR2","20105","Feline leukemia virus subgroup C cellular receptor family, member 2","1911","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1911"
"FN1","3778","fibronectin","6754","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6754"
"FNTA","3782","farnesyltransferase, CAAX box, subunit alpha","2825","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2825"
"FNTB","3785","farnesyltransferase, CAAX box, subunit beta","2826","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2826"
"FOLH1","3788","Folate hydrolase (prostate-specific membrane antigen) 1","1606","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1606"
"FOLH1B","13636","Folate hydrolase 1B","1607","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1607"
"FOLR1","3791","folate receptor alpha","3212","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3212"
"FOXN1","12765","forkhead box N1","2958","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2958"
"FPR1","3826","FPR1","222","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=222"
"FPR2","3827","FPR2","223","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223"
"FPR3","3828","FPR3","224","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=224"
"FRK","3955","fyn related Src family tyrosine kinase","2025","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2025"
"FRZB","3959","sFRP-3","3693","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3693"
"FSHB","3964","FSH &beta; subunit","3733","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3733"
"FSHR","3969","FSH receptor","253","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=253"
"FST","3971","follistatin","4933","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4933"
"FURIN","8568","furin, paired basic amino acid cleaving enzyme","2366","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2366"
"FXYD1","4025","FXYD domain containing ion transport regulator 1","3152","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3152"
"FXYD2","4026","sodium/potassium-transporting ATPase subunit &gamma;","2610","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2610"
"FXYD3","4027","FXYD domain containing ion transport regulator 3","3153","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3153"
"FYN","4037","FYN proto-oncogene, Src family tyrosine kinase","2026","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2026"
"FZD1","4038","FZD<sub>1</sub>","229","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=229"
"FZD10","4039","FZD<sub>10</sub>","238","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=238"
"FZD2","4040","FZD<sub>2</sub>","230","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=230"
"FZD3","4041","FZD<sub>3</sub>","231","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=231"
"FZD4","4042","FZD<sub>4</sub>","232","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=232"
"FZD5","4043","FZD<sub>5</sub>","233","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=233"
"FZD6","4044","FZD<sub>6</sub>","234","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=234"
"FZD7","4045","FZD<sub>7</sub>","235","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=235"
"FZD8","4046","FZD<sub>8</sub>","236","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=236"
"FZD9","4047","FZD<sub>9</sub>","237","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=237"
"GAA","4065","alpha glucosidase","2611","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2611"
"GABBR1","4070","GABA<sub>B1</sub>","240","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=240"
"GABBR2","4507","GABA<sub>B2</sub>","241","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=241"
"GABRA1","4075","GABA<sub>A</sub> receptor &alpha;1 subunit","404","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=404"
"GABRA2","4076","GABA<sub>A</sub> receptor &alpha;2 subunit","405","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=405"
"GABRA3","4077","GABA<sub>A</sub> receptor &alpha;3 subunit","406","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=406"
"GABRA4","4078","GABA<sub>A</sub> receptor &alpha;4 subunit","407","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=407"
"GABRA5","4079","GABA<sub>A</sub> receptor &alpha;5 subunit","408","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=408"
"GABRA6","4080","GABA<sub>A</sub> receptor &alpha;6 subunit","409","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=409"
"GABRB1","4081","GABA<sub>A</sub> receptor &beta;1 subunit","410","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=410"
"GABRB2","4082","GABA<sub>A</sub> receptor &beta;2 subunit","411","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=411"
"GABRB3","4083","GABA<sub>A</sub> receptor &beta;3 subunit","412","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=412"
"GABRD","4084","GABA<sub>A</sub> receptor &delta; subunit","416","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=416"
"GABRE","4085","GABA<sub>A</sub> receptor &epsilon; subunit","417","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=417"
"GABRG1","4086","GABA<sub>A</sub> receptor &gamma;1 subunit","413","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=413"
"GABRG2","4087","GABA<sub>A</sub> receptor &gamma;2 subunit","414","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=414"
"GABRG3","4088","GABA<sub>A</sub> receptor &gamma;3 subunit","415","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=415"
"GABRP","4089","GABA<sub>A</sub> receptor &pi; subunit","419","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=419"
"GABRQ","14454","GABA<sub>A</sub> receptor &theta; subunit","418","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=418"
"GABRR1","4090","GABA<sub>A</sub> receptor &rho;1 subunit","420","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=420"
"GABRR2","4091","GABA<sub>A</sub> receptor &rho;2 subunit","421","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=421"
"GABRR3","17969","GABA<sub>A</sub> receptor &rho;3 subunit","422","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=422"
"GAD1","4092","Glutamic acid decarboxylase 1","1272","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1272"
"GAD2","4093","Glutamic acid decarboxylase 2","1273","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1273"
"GAK","4113","cyclin G associated kinase","2027","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2027"
"GAL","4114","galanin","3592","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3592"
"GALNS","4122","galactosamine (N-acetyl)-6-sulfatase","2765","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2765"
"GALP","24840","galanin-like peptide","3594","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3594"
"GALR1","4132","GAL<sub>1</sub> receptor","243","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=243"
"GALR2","4133","GAL<sub>2</sub> receptor","244","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=244"
"GALR3","4134","GAL<sub>3</sub> receptor","245","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=245"
"GART","4163","phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase","2612","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2612"
"GAS6","4168","growth arrest specific protein 6","4935","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4935"
"GAST","4164","desulfated gastrin-71","8410","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8410"
"GATM","4175","Arginine:glycine amidinotransferase","1246","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1246"
"GBA1","4177","glucosylceramidase beta","2978","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2978"
"GCG","4191","glucagon-like peptide 1","5194","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5194"
"GCGR","4192","glucagon receptor","251","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=251"
"GCK","4195","Glucokinase","2798","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2798"
"GCSH","4208","glycine cleavage system protein H","3098","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3098"
"GDF1","4214","growth/differentiation factor-1","4936","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4936"
"GDF10","4215","growth/differentiation factor-10","4937","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4937"
"GDF11","4216","growth/differentiation factor-11","4876","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4876"
"GDF15","30142","growth differentiation factor 15","9735","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9735"
"GDF2","4217","BMP-9","4889","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4889"
"GDF3","4218","growth/differentiation factor-3","4938","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4938"
"GDF5","4220","growth/differentiation factor-5","4879","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4879"
"GDF6","4221","growth/differentiation factor-6","4878","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4878"
"GDF7","4222","growth/differentiation factor-7","4877","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4877"
"GDF9","4224","growth/differentiation factor-9","4939","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4939"
"GDNF","4232","GDNF","4940","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4940"
"GFRA1","4243","GDNF family receptor &alpha;1","1743","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1743"
"GFRA2","4244","GDNF family receptor &alpha;2","1744","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1744"
"GFRA3","4245","GDNF family receptor &alpha;3","1745","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1745"
"GFRA4","13821","GDNF family receptor &alpha;4","1746","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1746"
"GFRAL","32789","GDNF family receptor alpha like","2977","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2977"
"GGCT","21705","&gamma;-Glutamyltransferase","1392","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1392"
"GGCX","4247","&gamma;-Glutamyl carboxylase","1268","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1268"
"GGH","4248","gamma-glutamyl hydrolase","2367","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2367"
"GGPS1","4249","geranylgeranyl diphosphate synthase","643","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=643"
"GH1","4261","growth hormone 1","4943","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4943"
"GH2","4262","growth hormone 2","4944","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4944"
"GHR","4263","Growth hormone receptor","1720","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1720"
"GHRH","4265","GHRH","2270","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2270"
"GHRHR","4266","GHRH receptor","247","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=247"
"GHRL","18129","ghrelin","1099","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1099"
"GHSR","4267","ghrelin receptor","246","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=246"
"GIP","4270","gastric inhibitory polypeptide","3542","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3542"
"GIPR","4271","GIP receptor","248","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=248"
"GJA1","4274","Cx43","728","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=728"
"GJA10","16995","Cx62","734","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=734"
"GJA3","4277","Cx46","730","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=730"
"GJA4","4278","Cx37","725","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=725"
"GJA5","4279","Cx40","726","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=726"
"GJA8","4281","Cx50","732","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=732"
"GJA9","19155","Cx59","733","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=733"
"GJB1","4283","Cx32","723","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=723"
"GJB2","4284","Cx26","716","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=716"
"GJB3","4285","Cx31","720","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=720"
"GJB4","4286","Cx30.3","719","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=719"
"GJB5","4287","Cx31.1","721","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=721"
"GJB6","4288","Cx30","717","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=717"
"GJB7","16690","Cx25","715","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=715"
"GJC1","4280","Cx45","729","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=729"
"GJC2","17494","Cx47","731","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=731"
"GJC3","17495","Cx30.2","718","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=718"
"GJD2","19154","Cx36","724","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=724"
"GJD3","19147","Cx31.9","722","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=722"
"GJD4","23296","Cx40.1","727","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=727"
"GJE1","33251","Cx23","714","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=714"
"GLP1R","4324","GLP-1 receptor","249","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=249"
"GLP2R","4325","GLP-2 receptor","250","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=250"
"GLRA1","4326","glycine receptor &alpha;1 subunit","423","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=423"
"GLRA2","4327","glycine receptor &alpha;2 subunit","424","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=424"
"GLRA3","4328","glycine receptor &alpha;3 subunit","425","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=425"
"GLRA4","31715","glycine receptor &alpha;4 subunit <i>(pseudogene in humans)</i>","426","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=426"
"GLRB","4329","glycine receptor &beta; subunit","427","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=427"
"GLS","4331","glutaminase","2891","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2891"
"GNAQ","4390","G protein subunit alpha q","2914","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2914"
"GNRH1","4419","GnRH I","1162","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1162"
"GNRH2","4420","GnRH II","1164","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1164"
"GNRHR","4421","GnRH<sub>1</sub> receptor","256","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=256"
"GNRHR2","16341","GnRH<sub>2</sub> receptor","257","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=257"
"GPBAR1","19680","GPBA receptor","37","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=37"
"GPC3","4451","glypican 3","2959","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2959"
"GPER1","4485","GPER","221","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=221"
"GPR101","14963","<i>GPR101</i>","125","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=125"
"GPR107","17830","<i>GPR107</i>","651","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=651"
"GPR119","19060","<i>GPR119</i>","126","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=126"
"GPR12","4466","<i>GPR12</i>","86","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=86"
"GPR132","17482","<i>GPR132</i>","128","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=128"
"GPR135","19991","<i>GPR135</i>","129","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=129"
"GPR137","24300","<i>GPR137</i>","652","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=652"
"GPR139","19995","<i>GPR139</i>","130","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=130"
"GPR141","19997","<i>GPR141</i>","131","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=131"
"GPR142","20088","<i>GPR142</i>","132","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=132"
"GPR143","20145","<i>GPR143</i>","203","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=203"
"GPR146","21718","<i>GPR146</i>","133","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=133"
"GPR148","23623","<i>GPR148</i>","134","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=134"
"GPR149","23627","<i>GPR149</i>","135","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=135"
"GPR15","4469","<i>GPR15</i>","87","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=87"
"GPR150","23628","<i>GPR150</i>","136","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=136"
"GPR151","23624","<i>GPR151</i>","137","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=137"
"GPR152","23622","<i>GPR152</i>","138","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=138"
"GPR153","23618","<i>GPR153</i>","139","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=139"
"GPR156","20844","<i>GPR156</i>","209","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=209"
"GPR157","23687","<i>GPR157</i>","205","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=205"
"GPR158","23689","<i>GPR158</i>","210","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=210"
"GPR15LG","31428","GPR15L","10567","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10567"
"GPR160","23693","<i>GPR160</i>","140","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=140"
"GPR161","23694","<i>GPR161</i>","141","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=141"
"GPR162","16693","<i>GPR162</i>","142","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=142"
"GPR17","4471","<i>GPR17</i>","88","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=88"
"GPR171","30057","<i>GPR171</i>","143","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=143"
"GPR173","18186","<i>GPR173</i>","144","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=144"
"GPR174","30245","<i>GPR174</i>","145","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=145"
"GPR176","32370","<i>GPR176</i>","637","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=637"
"GPR179","31371","<i>GPR179</i>","211","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=211"
"GPR18","4472","<i>GPR18</i>","89","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=89"
"GPR182","13708","<i>GPR182</i>","146","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=146"
"GPR183","3128","<i>GPR183</i>","81","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=81"
"GPR19","4473","<i>GPR19</i>","90","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=90"
"GPR20","4475","<i>GPR20</i>","91","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=91"
"GPR21","4476","<i>GPR21</i>","92","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=92"
"GPR22","4477","<i>GPR22</i>","93","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=93"
"GPR25","4480","<i>GPR25</i>","95","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=95"
"GPR26","4481","<i>GPR26</i>","96","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=96"
"GPR27","4482","<i>GPR27</i>","97","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=97"
"GPR3","4484","<i>GPR3</i>","83","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=83"
"GPR31","4486","<i>GPR31</i>","98","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=98"
"GPR32","4487","<i>GPR32</i>","99","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=99"
"GPR33","4489","<i>GPR33</i>","100","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=100"
"GPR34","4490","<i>GPR34</i>","101","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=101"
"GPR35","4492","<i>GPR35</i>","102","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=102"
"GPR37","4494","<i>GPR37</i>","103","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=103"
"GPR37L1","14923","<i>GPR37L1</i>","104","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=104"
"GPR39","4496","<i>GPR39</i>","105","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=105"
"GPR4","4497","<i>GPR4</i>","84","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=84"
"GPR42","4500","<i>GPR42</i>","228","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=228"
"GPR45","4503","<i>GPR45</i>","106","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=106"
"GPR50","4506","<i>GPR50</i>","107","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=107"
"GPR52","4508","<i>GPR52</i>","108","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=108"
"GPR55","4511","<i>GPR55</i>","109","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=109"
"GPR6","4515","<i>GPR6</i>","85","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=85"
"GPR61","13300","<i>GPR61</i>","110","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=110"
"GPR62","13301","<i>GPR62</i>","111","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=111"
"GPR63","13302","<i>GPR63</i>","112","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=112"
"GPR65","4517","<i>GPR65</i>","113","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=113"
"GPR68","4519","<i>GPR68</i>","114","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=114"
"GPR75","4526","<i>GPR75</i>","115","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=115"
"GPR78","4528","<i>GPR78</i>","116","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=116"
"GPR79","4529","<i>GPR79</i>","117","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=117"
"GPR82","4533","<i>GPR82</i>","118","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=118"
"GPR83","4523","<i>GPR83</i>","119","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=119"
"GPR84","4535","<i>GPR84</i>","120","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=120"
"GPR85","4536","<i>GPR85</i>","121","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=121"
"GPR87","4538","<i>GPR87</i>","122","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=122"
"GPR88","4539","<i>GPR88</i>","123","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=123"
"GPRC5A","9836","<i>GPRC5A</i>","258","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=258"
"GPRC5B","13308","<i>GPRC5B</i>","259","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=259"
"GPRC5C","13309","<i>GPRC5C</i>","260","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=260"
"GPRC5D","13310","<i>GPRC5D</i>","261","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=261"
"GPRC6A","18510","GPRC6 receptor","55","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=55"
"GPX4","4556","glutathione peroxidase 4","3239","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3239"
"GREM1","2001","gremlin 1","11768","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11768"
"GRIA1","4571","GluA1","444","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=444"
"GRIA2","4572","GluA2","445","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=445"
"GRIA3","4573","GluA3","446","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=446"
"GRIA4","4574","GluA4","447","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=447"
"GRID1","4575","GluD1","448","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=448"
"GRID2","4576","GluD2","449","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=449"
"GRIK1","4579","GluK1","450","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=450"
"GRIK2","4580","GluK2","451","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=451"
"GRIK3","4581","GluK3","452","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=452"
"GRIK4","4582","GluK4","453","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=453"
"GRIK5","4583","GluK5","454","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=454"
"GRIN1","4584","GluN1","455","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=455"
"GRIN2A","4585","GluN2A","456","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456"
"GRIN2B","4586","GluN2B","457","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=457"
"GRIN2C","4587","GluN2C","458","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=458"
"GRIN2D","4588","GluN2D","459","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=459"
"GRIN3A","16767","GluN3A","460","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=460"
"GRIN3B","16768","GluN3B","461","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=461"
"GRK1","10013","G protein-coupled receptor kinase 1","1465","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1465"
"GRK2","289","beta adrenergic receptor kinase 1","1466","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1466"
"GRK3","290","beta adrenergic receptor kinase 2","1467","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1467"
"GRK4","4543","G protein-coupled receptor kinase 4","1468","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1468"
"GRK5","4544","G protein-coupled receptor kinase 5","1469","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1469"
"GRK6","4545","G protein-coupled receptor kinase 6","1470","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1470"
"GRK7","17031","G protein-coupled receptor kinase 7","1471","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1471"
"GRM1","4593","mGlu<sub>1</sub> receptor","289","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289"
"GRM2","4594","mGlu<sub>2</sub> receptor","290","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=290"
"GRM3","4595","mGlu<sub>3</sub> receptor","291","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=291"
"GRM4","4596","mGlu<sub>4</sub> receptor","292","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=292"
"GRM5","4597","mGlu<sub>5</sub> receptor","293","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293"
"GRM6","4598","mGlu<sub>6</sub> receptor","294","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=294"
"GRM7","4599","mGlu<sub>7</sub> receptor","295","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295"
"GRM8","4600","mGlu<sub>8</sub> receptor","296","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=296"
"GRP","4605","gastrin-releasing peptide","612","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=612"
"GRPR","4609","BB<sub>2</sub> receptor","39","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=39"
"GSDMD","25697","gasdermin D","3278","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3278"
"GSK3A","4616","glycogen synthase kinase 3 alpha","2029","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2029"
"GSK3B","4617","glycogen synthase kinase 3 beta","2030","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2030"
"GSR","4623","glutathione-disulfide reductase","2613","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2613"
"GSTO1","13312","glutathione S-transferase omega 1","3110","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3110"
"GTF3C4","4667","general transcription factor IIIC subunit 4","2656","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2656"
"GUCA1A","4678","guanylyl cyclase-activating protein 1","9164","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9164"
"GUCA1B","4679","guanylyl cyclase-activating protein 2","9165","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9165"
"GUCA2A","4682","guanylin","4945","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4945"
"GUCA2B","4683","uroguanylin","5084","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5084"
"GUCY1A1","4685","Guanylyl cyclase &alpha;<sub>1</sub> subunit","1288","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1288"
"GUCY1A2","4684","Guanylyl cyclase &alpha;<sub>2</sub> subunit","1289","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1289"
"GUCY1B1","4687","Guanylyl cyclase &beta;<sub>1</sub> subunit","1290","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1290"
"GUCY1B2","4686","Guanylyl cyclase &beta;<sub>2</sub> subunit","1291","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1291"
"GUCY2C","4688","Guanylyl cyclase-C","1750","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1750"
"GUCY2D","4689","Guanylyl cyclase-E","2031","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2031"
"GUCY2F","4691","Guanylyl cyclase-F","2899","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2899"
"GUCY2GP","31863","Guanylyl cyclase-G","2900","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2900"
"GZMA","4708","granzyme A","2368","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2368"
"GZMB","4709","granzyme B","2369","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2369"
"GZMK","4711","granzyme K","2370","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2370"
"HAMP","15598","hepcidin-25","5378","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5378"
"HASPIN","19682","histone H3 associated protein kinase","2028","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2028"
"HAT1","4821","histone acetyltransferase 1","2657","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2657"
"HAVCR2","18437","TIM3 (CD366)","2940","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2940"
"HBB","4827","&beta;-haemoglobin","5370","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5370"
"HBEGF","3059","HB-EGF","4948","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4948"
"HCAR1","4532","HCA<sub>1</sub> receptor","311","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=311"
"HCAR2","24827","HCA<sub>2</sub> receptor","312","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=312"
"HCAR3","16824","HCA<sub>3</sub> receptor","313","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=313"
"HCK","4840","HCK proto-oncogene, Src family tyrosine kinase","2032","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2032"
"HCN1","4845","HCN1","400","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=400"
"HCN2","4846","HCN2","401","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401"
"HCN3","19183","HCN3","402","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=402"
"HCN4","16882","HCN4","403","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=403"
"HCRT","4847","orexin-A","1697","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1697"
"HCRTR1","4848","OX<sub>1</sub> receptor","321","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=321"
"HCRTR2","4849","OX<sub>2</sub> receptor","322","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=322"
"HDAC1","4852","histone deacetylase 1","2658","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2658"
"HDAC10","18128","histone deacetylase 10","2614","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2614"
"HDAC11","19086","histone deacetylase 11","2615","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2615"
"HDAC2","4853","histone deacetylase 2","2616","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2616"
"HDAC3","4854","histone deacetylase 3","2617","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2617"
"HDAC4","14063","histone deacetylase 4","2659","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2659"
"HDAC5","14068","histone deacetylase 5","2660","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2660"
"HDAC6","14064","histone deacetylase 6","2618","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2618"
"HDAC7","14067","histone deacetylase 7","2661","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2661"
"HDAC8","13315","histone deacetylase 8","2619","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2619"
"HDAC9","14065","histone deacetylase 9","2620","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2620"
"HDC","4855","Histidine decarboxylase","1274","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1274"
"HEBP1","17176","F2L","3935","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3935"
"HGF","4893","hepatocyte growth factor alpha chain","4950","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4950"
"HIPK1","19006","homeodomain interacting protein kinase 1","2033","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2033"
"HIPK2","14402","homeodomain interacting protein kinase 2","2034","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2034"
"HIPK3","4915","homeodomain interacting protein kinase 3","2035","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2035"
"HIPK4","19007","homeodomain interacting protein kinase 4","2036","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2036"
"HMGB1","4983","high mobility group box 1","3279","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3279"
"HMGCR","5006","hydroxymethylglutaryl-CoA reductase","639","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=639"
"HMGCS1","5007","hydroxymethylglutaryl-CoA synthase 1","638","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=638"
"HMGCS2","5008","hydroxymethylglutaryl-CoA synthase 2","2432","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2432"
"HMOX1","5013","Haem oxygenase 1","1441","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1441"
"HMOX2","5014","Haem oxygenase 2","1442","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1442"
"HNF4A","5024","Hepatocyte nuclear factor-4-&alpha;","608","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=608"
"HNF4G","5026","Hepatocyte nuclear factor-4-&gamma;","609","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=609"
"HPD","5147","4-hydroxyphenylpyruvate dioxygenase","2621","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2621"
"HPGD","5154","HPGD","1384","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1384"
"HPGDS","17890","H-PGDS","1381","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1381"
"HPSE","5164","heparanase","2996","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2996"
"HRAS","5173","HRAS","2822","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2822"
"HRH1","5182","H<sub>1</sub> receptor","262","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=262"
"HRH2","5183","H<sub>2</sub> receptor","263","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=263"
"HRH3","5184","H<sub>3</sub> receptor","264","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=264"
"HRH4","17383","H<sub>4</sub> receptor","265","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=265"
"HSD11B1","5208","hydroxysteroid 11-beta dehydrogenase 1","2763","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2763"
"HSD11B2","5209","hydroxysteroid 11-beta dehydrogenase 2","3143","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3143"
"HSD17B13","18685","hydroxysteroid 17-beta dehydrogenase 13","3222","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3222"
"HSD17B2","5211","hydroxysteroid 17-beta dehydrogenase 2","3094","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3094"
"HSD3B2","5218","hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2","2622","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2622"
"HSP90AA1","5253","heat shock protein 90 alpha family class A member 1","2905","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2905"
"HSP90AB1","5258","heat shock protein 90 alpha family class B member 1","2907","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2907"
"HSP90B1","12028","heat shock protein 90 beta family member 1","2904","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2904"
"HSPA1A","5232","heat shock protein family A (Hsp70) member 1A","2539","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2539"
"HSPA1B","5233","heat shock protein family A (Hsp70) member 1B","2540","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2540"
"HSPA1L","5234","heat shock protein family A (Hsp70) member 1 like","2989","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2989"
"HSPA2","5235","heat shock protein family A (Hsp70) member 2","2541","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2541"
"HSPA5","5238","heat shock protein family A (Hsp70) member 5","3193","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3193"
"HSPA6","5239","heat shock protein family A (Hsp70) member 6","2542","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2542"
"HSPA8","5241","heat shock protein family A (Hsp70) member 8","2543","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2543"
"HSPD1","5261","hsp60","4953","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4953"
"HTR1A","5286","5-HT<sub>1A</sub> receptor","1","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1"
"HTR1B","5287","5-HT<sub>1B</sub> receptor","2","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2"
"HTR1D","5289","5-HT<sub>1D</sub> receptor","3","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3"
"HTR1E","5291","5-ht<sub>1e</sub> receptor","4","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=4"
"HTR1F","5292","5-HT<sub>1F</sub> receptor","5","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=5"
"HTR2A","5293","5-HT<sub>2A</sub> receptor","6","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6"
"HTR2B","5294","5-HT<sub>2B</sub> receptor","7","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=7"
"HTR2C","5295","5-HT<sub>2C</sub> receptor","8","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=8"
"HTR3A","5297","5-HT<sub>3</sub>A","373","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=373"
"HTR3B","5298","5-HT<sub>3</sub>B","374","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=374"
"HTR3C","24003","5-HT<sub>3</sub>C","375","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=375"
"HTR3D","24004","5-HT<sub>3</sub>D","376","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=376"
"HTR3E","24005","5-HT<sub>3</sub>E","377","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=377"
"HTR4","5299","5-HT<sub>4</sub> receptor","9","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=9"
"HTR5A","5300","5-HT<sub>5A</sub> receptor","10","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=10"
"HTR5BP","16291","5-ht<sub>5b</sub> receptor","648","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=648"
"HTR6","5301","5-HT<sub>6</sub> receptor","11","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11"
"HTR7","5302","5-HT<sub>7</sub> receptor","12","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12"
"HTRA1","9476","HtrA serine peptidase 1","3194","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3194"
"HTT","4851","huntingtin","5199","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5199"
"HUNK","13326","hormonally up-regulated Neu-associated kinase","2037","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2037"
"HVCN1","28240","H<sub>v</sub>1","746","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=746"
"IAPP","5329","amylin","687","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=687"
"ICAM1","5344","ICAM-1","6757","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6757"
"ICAM2","5345","ICAM-2","6756","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6756"
"ICOS","5351","ICOS (CD278)","2939","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2939"
"ICOSLG","17087","ICOS ligand","9593","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9593"
"IDE","5381","insulin degrading enzyme","2371","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2371"
"IDH1","5382","isocitrate dehydrogenase (NADP(+)) 1","2884","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2884"
"IDH2","5383","isocitrate dehydrogenase (NADP(+)) 2","2885","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2885"
"IDI1","5387","isopentenyl-diphosphate &Delta;-isomerase 1","646","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=646"
"IDI2","23487","isopentenyl-diphosphate &Delta;-isomerase 2","647","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=647"
"IDO1","6059","indoleamine 2,3-dioxygenase 1","2829","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2829"
"IDO2","27269","indoleamine 2,3-dioxygenase 2","3019","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3019"
"IFI16","5395","interferon gamma inducible protein 16","2924","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2924"
"IFIH1","18873","interferon induced with helicase C domain 1","2921","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2921"
"IFNA1","5417","IFN-&alpha;1/13","4955","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4955"
"IFNA10","5418","IFN-&alpha;10","4956","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4956"
"IFNA13","5419","IFN-&alpha;1/13","4955","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4955"
"IFNA14","5420","IFN-&alpha;14","4957","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4957"
"IFNA16","5421","IFN-&alpha;16","4958","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4958"
"IFNA17","5422","IFN-&alpha;17","4959","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4959"
"IFNA2","5423","IFN-&alpha;2","4960","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4960"
"IFNA21","5424","IFN-&alpha;21","4961","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4961"
"IFNA4","5425","IFN-&alpha;4","4962","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4962"
"IFNA5","5426","IFN-&alpha;5","4963","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4963"
"IFNA6","5427","IFN-&alpha;6","4964","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4964"
"IFNA7","5428","IFN-&alpha;7","4965","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4965"
"IFNA8","5429","IFN-&alpha;8","4966","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4966"
"IFNAR1","5432","interferon &alpha;/&beta;  receptor 1","1723","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1723"
"IFNAR2","5433","Interferon &alpha;/&beta; receptor 2","1724","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1724"
"IFNB1","5434","IFN-&beta;","4967","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4967"
"IFNG","5438","IFN-&gamma;","4968","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4968"
"IFNGR1","5439","Interferon &gamma; receptor 1","1725","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1725"
"IFNGR2","5440","Interferon &gamma; receptor 2","1726","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1726"
"IFNK","21714","IFN-&kappa;","4969","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4969"
"IFNL1","18363","IFN-&lambda;1","4993","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4993"
"IFNL2","18364","IFN-&lambda;2","4991","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4991"
"IFNL3","18365","IFN-&lambda;3","4992","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4992"
"IFNLR1","18584","Interferon-&lambda; receptor subunit 1","1733","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1733"
"IFNW1","5448","IFN-&omega;","4970","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4970"
"IGF1","5464","insulin-like growth factor 1","4971","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4971"
"IGF1R","5465","Insulin-like growth factor I receptor","1801","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1801"
"IGF2","5466","insulin-like growth factor 2","4972","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4972"
"IGHE","5522","immunoglobulin heavy constant epsilon","2741","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2741"
"IKBKB","5960","inhibitor of nuclear factor kappa B kinase subunit beta","2039","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2039"
"IKBKE","14552","inhibitor of nuclear factor kappa B kinase subunit epsilon","2040","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2040"
"IL10","5962","IL-10","4975","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4975"
"IL10RA","5964","Interleukin 10 receptor, &alpha; subunit","1727","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1727"
"IL10RB","5965","Interleukin 10 receptor, &beta; subunit","1728","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1728"
"IL11","5966","IL-11","4976","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4976"
"IL11RA","5967","Interleukin-11 receptor, &alpha; subunit","1709","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1709"
"IL12A","5969","IL-12A","5001","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5001"
"IL12B","5970","IL-12B","5002","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5002"
"IL12RB1","5971","Interleukin-12 receptor, &beta;1 subunit","1715","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1715"
"IL12RB2","5972","Interleukin-12 receptor, &beta;2 subunit","1716","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1716"
"IL13","5973","IL-13","4980","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4980"
"IL13RA1","5974","Interleukin-13 receptor subunit &alpha;1","1700","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1700"
"IL13RA2","5975","Interleukin 13 receptor, &alpha;2","1701","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1701"
"IL15","5977","IL-15","4981","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4981"
"IL15RA","5978","Interleukin-15 receptor subunit &alpha;","1702","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1702"
"IL17A","5981","IL-17A","4982","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4982"
"IL17B","5982","IL-17B","5877","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5877"
"IL17C","5983","IL-17C","5875","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5875"
"IL17F","16404","IL-17F","5873","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5873"
"IL17RA","5985","Interleukin 17 receptor A","1738","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1738"
"IL17RB","18015","Interleukin 17 receptor B","1739","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1739"
"IL17RC","18358","interleukin 17 receptor C","1740","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1740"
"IL17RD","17616","Interleukin-17 receptor D","1741","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1741"
"IL17RE","18439","Interleukin 17 receptor E","1742","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1742"
"IL18","5986","IL-18","4983","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4983"
"IL18R1","5988","Interleukin-18 receptor 1","1737","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1737"
"IL18RAP","5989","IL-18 receptor accessory protein","2320","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2320"
"IL19","5990","IL-19","4984","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4984"
"IL1A","5991","IL-1&alpha;","4973","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4973"
"IL1B","5992","IL-1&beta;","4974","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4974"
"IL1R1","5993","Interleukin 1 receptor, type I","1734","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1734"
"IL1R2","5994","Interleukin 1 receptor, type II","2319","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2319"
"IL1RAP","5995","IL-1 receptor accessory protein","1897","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1897"
"IL1RL1","5998","Interleukin-1 receptor-like 1","1735","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1735"
"IL1RL2","5999","Interleukin-1 receptor-like 2","1736","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1736"
"IL1RN","6000","IL-1 receptor antagonist","5878","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5878"
"IL2","6001","IL-2","4985","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4985"
"IL20","6002","IL-20","4986","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4986"
"IL20RA","6003","Interleukin 20 receptor, &alpha; subunit","1729","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1729"
"IL20RB","6004","Interleukin 20 receptor, &beta; subunit","1730","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1730"
"IL21","6005","IL-21","4987","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4987"
"IL21R","6006","Interleukin 21 receptor","1703","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1703"
"IL22","14900","IL-22","4988","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4988"
"IL22RA1","13700","Interleukin 22 receptor, &alpha;1 subunit","1731","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1731"
"IL22RA2","14901","Interleukin-22 receptor &alpha;2","1732","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1732"
"IL23A","15488","IL-23A","4989","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4989"
"IL23R","19100","Interleukin 23 receptor","1717","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1717"
"IL24","11346","IL-24","4990","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4990"
"IL25","13765","IL-25","5876","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5876"
"IL27","19157","IL-27 subunit &alpha;","6152","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6152"
"IL27RA","17290","Interleukin 27 receptor, alpha","2318","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2318"
"IL2RA","6008","Interleukin-2 receptor subunit &alpha;","1695","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1695"
"IL2RB","6009","Interleukin-2 receptor subunit &beta;","1696","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1696"
"IL2RG","6010","Interleukin-2 receptor subunit &gamma;","2303","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2303"
"IL3","6011","IL-3","4994","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4994"
"IL31","19372","IL-31","4995","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4995"
"IL31RA","18969","Interleukin-31 receptor, &alpha; subunit","1710","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1710"
"IL33","16028","IL-33","5880","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5880"
"IL34","28529","IL-34","8975","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8975"
"IL36A","15562","IL-36&alpha;","5881","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5881"
"IL36B","15564","IL-36&beta;","5882","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5882"
"IL36G","15741","IL-36&gamma;","5883","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5883"
"IL36RN","15561","IL-36 receptor antagonist","5879","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5879"
"IL37","15563","IL-37","6149","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6149"
"IL3RA","6012","Interleukin 3 receptor, &alpha; subunit","1705","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1705"
"IL4","6014","IL-4","4996","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4996"
"IL4R","6015","Interleukin-4 receptor subunit &alpha;","1697","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1697"
"IL5","6016","IL-5","4997","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4997"
"IL5RA","6017","Interleukin 5 receptor, &alpha; subunit","1706","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1706"
"IL6","6018","IL-6","4998","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4998"
"IL6R","6019","Interleukin-6 receptor, &alpha; subunit","1708","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1708"
"IL6ST","6021","Interleukin-6 receptor, &beta; subunit","2317","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2317"
"IL7","6023","IL-7","4999","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4999"
"IL7R","6024","Interleukin-7 receptor subunit &alpha;","1698","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1698"
"IL9","6029","IL-9","5000","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5000"
"IL9R","6030","Interleukin 9 receptor","1699","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1699"
"ILDR2","18131","immunoglobulin like domain containing receptor 2","2986","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2986"
"ILK","6040","integrin linked kinase","2041","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2041"
"IMPA1","6050","IMPase 1","1463","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1463"
"IMPA2","6051","IMPase 2","1464","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1464"
"IMPDH1","6052","inosine monophosphate dehydrogenase 1","2624","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2624"
"IMPDH2","6053","inosine monophosphate dehydrogenase 2","2625","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2625"
"INHA","6065","inhibin &alpha;","5005","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5005"
"INHBA","6066","inhibin &beta;A","5006","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5006"
"INHBB","6067","inhibin &beta;B","5007","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5007"
"INHBC","6068","inhibin &beta;C","5008","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5008"
"INHBE","24029","inhibin &beta;E","5009","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5009"
"INPP1","6071","INPP1","1450","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1450"
"INPP4A","6074","INPP4A","1451","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1451"
"INPP4B","6075","INPP4B","1452","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1452"
"INPP5A","6076","INPP5A","1453","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1453"
"INPP5B","6077","INPP5B","1454","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1454"
"INPP5D","6079","INPP5D","1455","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1455"
"INPP5E","21474","INPP5E","1456","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1456"
"INPP5J","8956","INPP5J","1457","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1457"
"INPP5K","33882","INPP5K","1458","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1458"
"INPPL1","6080","INPPL1","1459","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1459"
"INS","6081","proinsulin C-peptide","6145","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6145"
"INSL3","6086","INSL3 (B chain)","3749","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3749"
"INSL5","6088","INSL5 (B chain)","3751","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3751"
"INSR","6091","Insulin receptor","1800","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1800"
"INSRR","6093","Insulin receptor-related receptor","1802","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1802"
"IRAK1","6112","interleukin 1 receptor associated kinase 1","2042","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2042"
"IRAK2","6113","interleukin 1 receptor associated kinase 2","2043","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2043"
"IRAK3","17020","interleukin 1 receptor associated kinase 3","2044","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2044"
"IRAK4","17967","interleukin 1 receptor associated kinase 4","2045","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2045"
"ITGA1","6134","integrin, alpha 1 subunit","2437","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2437"
"ITGA10","6135","integrin, alpha 10 subunit","2438","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2438"
"ITGA11","6136","integrin, alpha 11 subunit","2439","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2439"
"ITGA2","6137","integrin, alpha 2 subunit (CD49B, alpha 2 subunit of VLA-2 receptor)","2440","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2440"
"ITGA2B","6138","integrin, alpha IIb subunit (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)","2441","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2441"
"ITGA3","6139","integrin, alpha 3 subunit (antigen CD49C, alpha 3 subunit of VLA-3 receptor)","2442","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2442"
"ITGA4","6140","integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)","2443","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2443"
"ITGA5","6141","integrin, alpha 5 subunit (fibronectin receptor, alpha polypeptide)","2444","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2444"
"ITGA6","6142","integrin, alpha 6 subunit","2445","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2445"
"ITGA7","6143","integrin, alpha 7 subunit","2446","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2446"
"ITGA8","6144","integrin, alpha 8 subunit","2447","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2447"
"ITGA9","6145","integrin, alpha 9 subunit","2448","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2448"
"ITGAD","6146","integrin, alpha D subunit","2449","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2449"
"ITGAE","6147","integrin, alpha E subunit (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)","2450","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2450"
"ITGAL","6148","integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)","2451","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2451"
"ITGAM","6149","integrin, alpha M subunit (complement component 3 receptor 3 subunit)","2452","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2452"
"ITGAV","6150","integrin, alpha V subunit","2453","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2453"
"ITGAX","6152","integrin, alpha X subunit (complement component 3 receptor 4 subunit)","2454","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2454"
"ITGB1","6153","integrin, beta 1 subunit (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)","2455","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2455"
"ITGB2","6155","integrin, beta 2 subunit (complement component 3 receptor 3 and 4 subunit)","2456","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2456"
"ITGB3","6156","integrin, beta 3 subunit (platelet glycoprotein IIIa, antigen CD61)","2457","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2457"
"ITGB4","6158","integrin, beta 4 subunit","2458","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2458"
"ITGB5","6160","integrin, beta 5 subunit","2459","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2459"
"ITGB6","6161","integrin, beta 6 subunit","2460","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2460"
"ITGB7","6162","integrin, beta 7 subunit","2461","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2461"
"ITGB8","6163","integrin, beta 8 subunit","2462","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2462"
"ITK","6171","IL2 inducible T cell kinase","2046","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2046"
"ITPKA","6178","IP<sub>3</sub> kinase A","1447","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1447"
"ITPKB","6179","IP<sub>3</sub> kinase B","1448","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1448"
"ITPKC","14897","IP<sub>3</sub> kinase C","1449","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1449"
"ITPR1","6180","IP<sub>3</sub>R1","743","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=743"
"ITPR2","6181","IP<sub>3</sub>R2","744","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=744"
"ITPR3","6182","IP<sub>3</sub>R3","745","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=745"
"IYD","21071","iodotyrosine deiodinase","2488","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2488"
"JAG2","6189","Jagged2","13352","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13352"
"JAK1","6190","Janus kinase 1","2047","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2047"
"JAK2","6192","Janus kinase 2","2048","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2048"
"JAK3","6193","Janus kinase 3","2049","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2049"
"JMJD1C","12313","jumonji domain containing 1C","2663","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2663"
"JMJD6","19355","jumonji domain containing 6, arginine demethylase and lysine hydroxylase","2892","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2892"
"KALRN","4814","kalirin RhoGEF kinase","2050","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2050"
"KAT2A","4201","lysine acetyltransferase 2A","2736","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2736"
"KAT2B","8638","lysine acetyltransferase 2B","2737","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2737"
"KAT5","5275","lysine acetyltransferase 5","2664","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2664"
"KAT6A","13013","lysine acetyltransferase 6A","2665","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2665"
"KAT6B","17582","lysine acetyltransferase 6B","2666","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2666"
"KAT7","17016","lysine acetyltransferase 7","2667","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2667"
"KAT8","17933","lysine acetyltransferase 8","2668","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2668"
"KATNA1","6216","katanin catalytic subunit A1","2912","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2912"
"KCNA1","6218","K<SUB>v</SUB>1.1","538","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=538"
"KCNA10","6219","K<SUB>v</SUB>1.8","545","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=545"
"KCNA2","6220","K<SUB>v</SUB>1.2","539","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=539"
"KCNA3","6221","K<SUB>v</SUB>1.3","540","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=540"
"KCNA4","6222","K<SUB>v</SUB>1.4","541","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=541"
"KCNA5","6224","K<SUB>v</SUB>1.5","542","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=542"
"KCNA6","6225","K<SUB>v</SUB>1.6","543","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=543"
"KCNA7","6226","K<SUB>v</SUB>1.7","544","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=544"
"KCNB1","6231","K<SUB>v</SUB>2.1","546","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=546"
"KCNB2","6232","K<SUB>v</SUB>2.2","547","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=547"
"KCNC1","6233","K<SUB>v</SUB>3.1","548","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=548"
"KCNC2","6234","K<SUB>v</SUB>3.2","549","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=549"
"KCNC3","6235","K<SUB>v</SUB>3.3","550","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=550"
"KCNC4","6236","K<SUB>v</SUB>3.4","551","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=551"
"KCND1","6237","K<SUB>v</SUB>4.1","552","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=552"
"KCND2","6238","K<SUB>v</SUB>4.2","553","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=553"
"KCND3","6239","K<SUB>v</SUB>4.3","554","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=554"
"KCNF1","6246","K<SUB>v</SUB>5.1","555","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=555"
"KCNG1","6248","K<SUB>v</SUB>6.1","556","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=556"
"KCNG2","6249","K<SUB>v</SUB>6.2","557","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=557"
"KCNG3","18306","K<SUB>v</SUB>6.3","558","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=558"
"KCNG4","19697","K<SUB>v</SUB>6.4","559","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=559"
"KCNH1","6250","K<SUB>v</SUB>10.1","570","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=570"
"KCNH2","6251","K<SUB>v</SUB>11.1","572","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=572"
"KCNH3","6252","K<SUB>v</SUB>12.2","576","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=576"
"KCNH4","6253","K<SUB>v</SUB>12.3","577","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=577"
"KCNH5","6254","K<SUB>v</SUB>10.2","571","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=571"
"KCNH6","18862","K<SUB>v</SUB>11.2","573","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=573"
"KCNH7","18863","K<SUB>v</SUB>11.3","574","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=574"
"KCNH8","18864","K<SUB>v</SUB>12.1","575","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=575"
"KCNJ1","6255","K<sub>ir</sub>1.1","429","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=429"
"KCNJ10","6256","K<sub>ir</sub>4.1","438","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=438"
"KCNJ11","6257","K<sub>ir</sub>6.2","442","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=442"
"KCNJ12","6258","K<sub>ir</sub>2.2","431","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=431"
"KCNJ13","6259","K<sub>ir</sub>7.1","443","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=443"
"KCNJ14","6260","K<sub>ir</sub>2.4","433","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=433"
"KCNJ15","6261","K<sub>ir</sub>4.2","439","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=439"
"KCNJ16","6262","K<sub>ir</sub>5.1","440","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=440"
"KCNJ2","6263","K<sub>ir</sub>2.1","430","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=430"
"KCNJ3","6264","K<sub>ir</sub>3.1","434","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=434"
"KCNJ4","6265","K<sub>ir</sub>2.3","432","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=432"
"KCNJ5","6266","K<sub>ir</sub>3.4","437","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=437"
"KCNJ6","6267","K<sub>ir</sub>3.2","435","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=435"
"KCNJ8","6269","K<sub>ir</sub>6.1","441","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=441"
"KCNJ9","6270","K<sub>ir</sub>3.3","436","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=436"
"KCNK1","6272","K<sub>2P</sub>1.1","513","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=513"
"KCNK10","6273","K<sub>2P</sub>10.1","521","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=521"
"KCNK12","6274","K<sub>2P</sub>12.1","522","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=522"
"KCNK13","6275","K<sub>2P</sub>13.1","523","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=523"
"KCNK15","13814","K<sub>2P</sub>15.1","524","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=524"
"KCNK16","14464","K<sub>2P</sub>16.1","525","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=525"
"KCNK17","14465","K<sub>2P</sub>17.1","526","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=526"
"KCNK18","19439","K<sub>2P</sub>18.1","527","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=527"
"KCNK2","6277","K<sub>2P</sub>2.1","514","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=514"
"KCNK3","6278","K<sub>2P</sub>3.1","515","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=515"
"KCNK4","6279","K<sub>2P</sub>4.1","516","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=516"
"KCNK5","6280","K<sub>2P</sub>5.1","517","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=517"
"KCNK6","6281","K<sub>2P</sub>6.1","518","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=518"
"KCNK7","6282","K<sub>2P</sub>7.1","519","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=519"
"KCNK9","6283","K<sub>2P</sub>9.1","520","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=520"
"KCNMA1","6284","K<sub>Ca</sub>1.1","380","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=380"
"KCNN1","6290","K<sub>Ca</sub>2.1","381","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=381"
"KCNN2","6291","K<sub>Ca</sub>2.2","382","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=382"
"KCNN3","6292","K<sub>Ca</sub>2.3","383","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=383"
"KCNN4","6293","K<sub>Ca</sub>3.1","384","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=384"
"KCNQ1","6294","K<SUB>v</SUB>7.1","560","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=560"
"KCNQ2","6296","K<SUB>v</SUB>7.2","561","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=561"
"KCNQ3","6297","K<SUB>v</SUB>7.3","562","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=562"
"KCNQ4","6298","K<SUB>v</SUB>7.4","563","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=563"
"KCNQ5","6299","K<SUB>v</SUB>7.5","564","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=564"
"KCNS1","6300","K<SUB>v</SUB>9.1","567","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=567"
"KCNS2","6301","K<SUB>v</SUB>9.2","568","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=568"
"KCNS3","6302","K<SUB>v</SUB>9.3","569","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=569"
"KCNT1","18865","K<sub>Na</sub>1.1","385","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=385"
"KCNT2","18866","K<sub>Na</sub>1.2","386","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=386"
"KCNU1","18867","K<sub>Ca</sub>5.1","387","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=387"
"KCNV1","18861","K<SUB>v</SUB>8.1","565","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=565"
"KCNV2","19698","K<SUB>v</SUB>8.2","566","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=566"
"KCTD12","14678","KCTD12","1918","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1918"
"KCTD16","29244","KCTD16","1920","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1920"
"KCTD8","22394","KCTD8","1917","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1917"
"KDM1A","29079","lysine demethylase 1A","2669","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2669"
"KDM1B","21577","lysine demethylase 1B","2670","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2670"
"KDM2A","13606","lysine demethylase 2A","2671","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2671"
"KDM2B","13610","lysine demethylase 2B","2672","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2672"
"KDM3A","20815","lysine demethylase 3A","2673","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2673"
"KDM3B","1337","lysine demethylase 3B","2674","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2674"
"KDM4A","22978","lysine demethylase 4A","2675","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2675"
"KDM4B","29136","lysine demethylase 4B","2676","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2676"
"KDM4C","17071","lysine demethylase 4C","2677","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2677"
"KDM4D","25498","lysine demethylase 4D","2678","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2678"
"KDM4E","37098","lysine demethylase 4E","2679","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2679"
"KDM5A","9886","lysine demethylase 5A","2680","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2680"
"KDM5B","18039","lysine demethylase 5B","2681","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2681"
"KDM5C","11114","lysine demethylase 5C","2682","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2682"
"KDM5D","11115","lysine demethylase 5D","2683","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2683"
"KDM6A","12637","lysine demethylase 6A","2684","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2684"
"KDM6B","29012","lysine demethylase 6B","2685","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2685"
"KDM7A","22224","lysine demethylase 7A","2686","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2686"
"KDM8","25840","lysine demethylase 8","2687","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2687"
"KDR","6307","kinase insert domain receptor","1813","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813"
"KDSR","4021","3-ketodihydrosphingosine reductase","2463","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2463"
"KEAP1","23177","kelch like ECH-associated protein 1","2757","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2757"
"KHK","6315","ketohexokinase","3236","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3236"
"KIF11","6388","kinesin-5","2788","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2788"
"KIR3DL2","6339","KIR3DL2 (CD158K)","3067","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3067"
"KISS1","6341","kisspeptin-54","1288","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1288"
"KISS1R","4510","kisspeptin receptor","266","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=266"
"KIT","6342","KIT proto-oncogene, receptor tyrosine kinase","1805","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1805"
"KITLG","6343","stem cell factor","5055","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5055"
"KL","6344","klotho","3146","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3146"
"KLHDC2","20231","kelch domain containing 2","3262","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3262"
"KLK1","6357","kallikrein 1","2865","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2865"
"KLK14","6362","kallikrein related peptidase 14","2866","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2866"
"KLK2","6363","kallikrein related peptidase 2","2372","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2372"
"KLK3","6364","kallikrein related peptidase 3","2373","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2373"
"KLK4","6365","kallikrein related peptidase 4","2374","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2374"
"KLK5","6366","kallikrein related peptidase 5","2375","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2375"
"KLK6","6367","kallikrein related peptidase 6","2376","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2376"
"KLK7","6368","kallikrein related peptidase 7","2377","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2377"
"KLK8","6369","kallikrein related peptidase 8","2378","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2378"
"KLKB1","6371","kallikrein B1","2379","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2379"
"KLRC1","6374","killer cell lectin like receptor C1 (CD159a)","2849","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2849"
"KLRC2","6375","killer cell lectin like receptor C2 (CD159c)","3172","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3172"
"KMO","6381","kynurenine 3-monooxygenase","2886","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2886"
"KMT2A","7132","lysine methyltransferase 2A","2688","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2688"
"KMT2B","15840","lysine methyltransferase 2B","2689","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2689"
"KMT2C","13726","lysine methyltransferase 2C","2690","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2690"
"KMT2D","7133","lysine methyltransferase 2D","2691","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2691"
"KMT2E","18541","lysine methyltransferase 2E (inactive)","2692","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2692"
"KMT5A","29489","lysine methyltransferase 5A","2704","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2704"
"KMT5B","24283","lysine methyltransferase 5B","2717","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2717"
"KMT5C","28405","lysine methyltransferase 5C","2718","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2718"
"KNG1","6383","T-kinin","639","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=639"
"KRAS","6407","KRAS","2824","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2824"
"KREMEN1","17550","kremen 1","3702","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3702"
"KREMEN2","18797","kremen 2","3703","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3703"
"KSR1","6465","kinase suppressor of ras 1","2051","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2051"
"KSR2","18610","kinase suppressor of ras 2","2052","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2052"
"KYAT1","1564","L-Cysteine:2-oxoglutarate aminotransferase","1445","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1445"
"L3MBTL3","23035","L3MBTL histone methyl-lysine binding protein 3","2830","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2830"
"LAG3","6476","LAG3 (CD223)","2932","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2932"
"LAIR1","6477","leukocyte associated immunoglobulin like receptor 1 (CD305)","2974","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2974"
"LANCL2","6509","LanC like 2","3082","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3082"
"LAP3","18449","Leucine aminopeptidase 3","1569","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1569"
"LATS1","6514","large tumor suppressor kinase 1","1515","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1515"
"LATS2","6515","large tumor suppressor kinase 2","1516","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1516"
"LCK","6524","LCK proto-oncogene, Src family tyrosine kinase","2053","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2053"
"LEAP2","29571","liver enriched antimicrobial peptide 2","9734","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9734"
"LEP","6553","leptin","5015","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5015"
"LEPR","6554","Leptin receptor","1712","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1712"
"LETM1","6556","leucine zipper and EF-hand containing transmembrane protein 1","3025","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3025"
"LETM2","14648","leucine zipper and EF-hand containing transmembrane protein 2","3026","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3026"
"LETMD1","24241","LETM1 domain containing 1","3027","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3027"
"LGALS1","6561","galectin-1","6603","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6603"
"LGALS3","6563","galectin-3","6619","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6619"
"LGALS3BP","6564","galectin-3 binding protein","6615","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6615"
"LGALS9","6570","galectin 9","9594","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9594"
"LGMN","9472","legumain","2380","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2380"
"LGR4","13299","<i>LGR4</i>","147","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=147"
"LGR5","4504","<i>LGR5</i>","148","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=148"
"LGR6","19719","<i>LGR6</i>","149","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=149"
"LHB","6584","LH &beta; subunit","3732","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3732"
"LHCGR","6585","LH receptor","254","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=254"
"LIF","6596","LIF","5016","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5016"
"LIFR","6597","Leukemia inhibitory factor receptor","1713","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1713"
"LILRA4","15503","leukocyte immunoglobulin like receptor A4 (CD85g)","2896","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2896"
"LILRB1","6605","leukocyte immunoglobulin like receptor B1 (CD85j)","2973","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2973"
"LIMK1","6613","LIM domain kinase 1","2054","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2054"
"LIMK2","6614","LIM domain kinase 2","2055","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2055"
"LINGO1","21205","leucine rich repeat and Ig domain containing 1","2882","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2882"
"LIPE","6621","lipase E, hormone sensitive type","2593","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2593"
"LIPF","6622","lipase, gastric","2626","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2626"
"LIPG","6623","lipase G, endothelial type","2591","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2591"
"LMTK2","17880","lemur tyrosine kinase 2","2056","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2056"
"LMTK3","19295","lemur tyrosine kinase 3","2057","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2057"
"LNPEP","6656","Leucyl-cysteinyl aminopeptidase","1570","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1570"
"LONP1","9479","lon peptidase 1, mitochondrial","3180","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3180"
"LOX","6664","lysyl oxidase","3097","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3097"
"LOXL2","6666","lysyl oxidase like 2","2853","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2853"
"LPAR1","3166","LPA<sub>1</sub> receptor","272","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=272"
"LPAR2","3168","LPA<sub>2</sub> receptor","273","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=273"
"LPAR3","14298","LPA<sub>3</sub> receptor","274","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=274"
"LPAR4","4478","LPA<sub>4</sub> receptor","94","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=94"
"LPAR5","13307","LPA<sub>5</sub> receptor","124","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=124"
"LPAR6","15520","LPA<sub>6</sub> receptor","163","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=163"
"LPIN1","13345","Lipin1","1435","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1435"
"LPIN2","14450","Lipin2","1436","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1436"
"LPIN3","14451","Lipin3","1437","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1437"
"LRP4","6696","low-density lipoprotein receptor-related protein 4","5320","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5320"
"LRRC32","4161","leucine rich repeat containing 32","2913","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2913"
"LRRC4B","25042","netrin-G3 ligand","6607","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6607"
"LRRK1","18608","leucine rich repeat kinase 1","2058","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2058"
"LRRK2","18618","leucine rich repeat kinase 2","2059","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2059"
"LSS","6708","lanosterol synthase","2434","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2434"
"LTA","6709","lymphotoxin-&alpha;","5064","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5064"
"LTA4H","6710","Leukotriene A<sub>4</sub> hydrolase","1395","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1395"
"LTB","6711","lymphotoxin-&beta;","5075","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5075"
"LTB4R","6713","BLT<sub>1</sub> receptor","267","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=267"
"LTB4R2","19260","BLT<sub>2</sub> receptor","268","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=268"
"LTBR","6718","lymphotoxin &beta; receptor","1872","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1872"
"LTC4S","6719","Leukotriene C4 synthase","1391","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1391"
"LTK","6721","leukocyte receptor tyrosine kinase","1838","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1838"
"LVRN","26904","Aminopeptidase Q","1562","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1562"
"LY96","17156","lymphocyte antigen 96","2890","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2890"
"LYN","6735","LYN proto-oncogene, Src family tyrosine kinase","2060","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2060"
"LYPLA1","6737","lysophospholipase 1","3290","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3290"
"LYPLA2","6738","lysophospholipase 2","3291","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3291"
"MADCAM1","6765","mucosal addressin cell adhesion molecule 1","9339","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9339"
"MAGEA3","6801","MAGE family member A3","3185","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3185"
"MAGT1","28880","magnesium transporter 1","3039","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3039"
"MAK","6816","male germ cell associated kinase","2061","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2061"
"MALT1","6819","MALT1 paracaspase","2983","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2983"
"MANSC1","25505","MANSC (415-431)","10539","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10539"
"MAOA","6833","Monoamine oxidase A","2489","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2489"
"MAOB","6834","Monoamine oxidase B","2490","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2490"
"MAP2K1","6840","mitogen-activated protein kinase kinase 1","2062","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2062"
"MAP2K2","6842","mitogen-activated protein kinase kinase 2","2063","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2063"
"MAP2K3","6843","mitogen-activated protein kinase kinase 3","2064","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2064"
"MAP2K4","6844","mitogen-activated protein kinase kinase 4","2065","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2065"
"MAP2K5","6845","mitogen-activated protein kinase kinase 5","2066","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2066"
"MAP2K6","6846","mitogen-activated protein kinase kinase 6","2067","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2067"
"MAP2K7","6847","mitogen-activated protein kinase kinase 7","2068","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2068"
"MAP3K1","6848","mitogen-activated protein kinase kinase kinase 1","2069","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2069"
"MAP3K10","6849","mitogen-activated protein kinase kinase kinase 10","2070","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2070"
"MAP3K11","6850","mitogen-activated protein kinase kinase kinase 11","2071","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2071"
"MAP3K12","6851","mitogen-activated protein kinase kinase kinase 12","2072","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2072"
"MAP3K13","6852","mitogen-activated protein kinase kinase kinase 13","2073","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2073"
"MAP3K14","6853","mitogen-activated protein kinase kinase kinase 14","2074","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2074"
"MAP3K15","31689","mitogen-activated protein kinase kinase kinase 15","2075","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2075"
"MAP3K19","26249","mitogen-activated protein kinase kinase kinase 19","2076","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2076"
"MAP3K2","6854","mitogen-activated protein kinase kinase kinase 2","2077","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2077"
"MAP3K20","17797","ZAK sterile alpha motif and leucine zipper containing kinase AZK","2289","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2289"
"MAP3K3","6855","mitogen-activated protein kinase kinase kinase 3","2078","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2078"
"MAP3K4","6856","mitogen-activated protein kinase kinase kinase 4","2079","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2079"
"MAP3K5","6857","mitogen-activated protein kinase kinase kinase 5","2080","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2080"
"MAP3K6","6858","mitogen-activated protein kinase kinase kinase 6","2081","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2081"
"MAP3K7","6859","mitogen-activated protein kinase kinase kinase 7","2082","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2082"
"MAP3K8","6860","mitogen-activated protein kinase kinase kinase 8","2083","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2083"
"MAP3K9","6861","mitogen-activated protein kinase kinase kinase 9","2084","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2084"
"MAP4K1","6863","mitogen-activated protein kinase kinase kinase kinase 1","2085","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2085"
"MAP4K2","6864","mitogen-activated protein kinase kinase kinase kinase 2","2086","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2086"
"MAP4K3","6865","mitogen-activated protein kinase kinase kinase kinase 3","2087","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2087"
"MAP4K4","6866","mitogen-activated protein kinase kinase kinase kinase 4","2088","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2088"
"MAP4K5","6867","mitogen-activated protein kinase kinase kinase kinase 5","2089","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2089"
"MAPK1","6871","mitogen-activated protein kinase 1","1495","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1495"
"MAPK10","6872","mitogen-activated protein kinase 10","1498","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1498"
"MAPK11","6873","mitogen-activated protein kinase 11","1500","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1500"
"MAPK12","6874","mitogen-activated protein kinase 12","1501","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1501"
"MAPK13","6875","mitogen-activated protein kinase 13","1502","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1502"
"MAPK14","6876","mitogen-activated protein kinase 14","1499","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1499"
"MAPK15","24667","mitogen-activated protein kinase 15","2090","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2090"
"MAPK3","6877","mitogen-activated protein kinase 3","1494","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1494"
"MAPK4","6878","mitogen-activated protein kinase 4","2091","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2091"
"MAPK6","6879","mitogen-activated protein kinase 6","2092","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2092"
"MAPK7","6880","mitogen-activated protein kinase 7","2093","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2093"
"MAPK8","6881","mitogen-activated protein kinase 8","1496","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1496"
"MAPK9","6886","mitogen-activated protein kinase 9","1497","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1497"
"MAPKAPK2","6887","MAPK activated protein kinase 2","2094","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2094"
"MAPKAPK3","6888","MAPK activated protein kinase 3","2095","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2095"
"MAPKAPK5","6889","MAPK activated protein kinase 5","2096","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2096"
"MAPT","6893","microtubule associated protein tau","9275","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9275"
"MARK1","6896","microtubule affinity regulating kinase 1","2097","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2097"
"MARK2","3332","microtubule affinity regulating kinase 2","2098","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2098"
"MARK3","6897","microtubule affinity regulating kinase 3","2099","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2099"
"MARK4","13538","microtubule affinity regulating kinase 4","2100","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2100"
"MAS1","6899","<i>MAS1</i>","150","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=150"
"MAS1L","13961","<i>MAS1L</i>","151","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=151"
"MAST1","19034","Microtubule associated serine/threonine kinase 1","1510","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1510"
"MAST2","19035","Microtubule associated serine/threonine kinase 2","1511","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1511"
"MAST3","19036","Microtubule associated serine/threonine kinase 3","1512","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1512"
"MAST4","19037","Microtubule associated serine/threonine kinase 4","1513","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1513"
"MASTL","19042","Microtubule associated serine/threonine kinase-like","1514","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1514"
"MATK","6906","megakaryocyte-associated tyrosine kinase","2101","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2101"
"MBTPS1","15456","membrane bound transcription factor peptidase, site 1","2381","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2381"
"MC1R","6929","MC<sub>1</sub> receptor","282","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=282"
"MC2R","6930","MC<sub>2</sub> receptor","283","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=283"
"MC3R","6931","MC<sub>3</sub> receptor","284","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=284"
"MC4R","6932","MC<sub>4</sub> receptor","285","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=285"
"MC5R","6933","MC<sub>5</sub> receptor","286","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=286"
"MCAM","6934","melanoma cell adhesion molecule","2988","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2988"
"MCHR1","4479","MCH<sub>1</sub> receptor","280","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=280"
"MCHR2","20867","MCH<sub>2</sub> receptor","281","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=281"
"MCL1","6943","MCL1 apoptosis regulator, BCL2 family member","2847","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2847"
"MCOLN1","13356","TRPML1","501","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=501"
"MCOLN2","13357","TRPML2","502","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=502"
"MCOLN3","13358","TRPML3","503","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=503"
"MDM2","6973","MDM2 proto-oncogene","3136","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3136"
"MELK","16870","maternal embryonic leucine zipper kinase","2102","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2102"
"MERTK","7027","MER proto-oncogene, tyrosine kinase","1837","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1837"
"MET","7029","MET proto-oncogene, receptor tyrosine kinase","1815","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1815"
"METAP1","15789","Methionyl aminopeptidase 1","1572","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1572"
"METAP1D","32583","Methionyl aminopeptidase type 1D (mitochondrial)","1574","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1574"
"METAP2","16672","Methionyl aminopeptidase 2","1573","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1573"
"METTL3","17563","methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit","3181","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3181"
"MFN1","18262","mitofusin 1","3130","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3130"
"MFN2","16877","mitofusin 2","3131","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3131"
"MFSD2A","25897","MFSD2 lysolipid transporter A, lysophospholipid","3041","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3041"
"MFSD2B","37207","MFSD2 lysolipid transporter B, sphingolipid","3042","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3042"
"MFSD4A","25433","major facilitator superfamily domain containing 4A","3043","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3043"
"MFSD4B","21053","major facilitator superfamily domain containing 4B","3044","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3044"
"MFSD5","28156","major facilitator superfamily domain containing 5","3045","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3045"
"MGAM","7043","maltase-glucoamylase","2627","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2627"
"MGLL","17038","monoacylglycerol lipase","1399","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1399"
"MIF","7097","macrophage migration inhibitory factor","9981","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9981"
"MINK1","17565","misshapen like kinase 1","2103","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2103"
"MIP","7103","AQP0","687","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=687"
"MKNK1","7110","MAPK interacting serine/threonine kinase 1","2104","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2104"
"MKNK2","7111","MAPK interacting serine/threonine kinase 2","2105","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2105"
"MLKL","26617","mixed lineage kinase domain like pseudokinase","2106","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2106"
"MLLT1","7134","MLLT1 super elongation complex subunit","3183","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3183"
"MLN","7141","motilin-associated peptide","5376","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5376"
"MLNR","4495","motilin receptor","297","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=297"
"MLYCD","7150","Malonyl-CoA decarboxylase","1275","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1275"
"MME","7154","Neutral endopeptidase","1611","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1611"
"MMP1","7155","MMP1","1628","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1628"
"MMP10","7156","MMP10","1634","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1634"
"MMP11","7157","MMP11","1635","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1635"
"MMP12","7158","MMP12","1636","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1636"
"MMP13","7159","matrix metalloproteinase 13","6656","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6656"
"MMP14","7160","MMP14","1638","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1638"
"MMP15","7161","MMP15","1639","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1639"
"MMP16","7162","MMP16","1640","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1640"
"MMP17","7163","MMP17","1641","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1641"
"MMP19","7165","MMP19","1642","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1642"
"MMP2","7166","MMP2","1629","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1629"
"MMP20","7167","MMP20","1643","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1643"
"MMP21","14357","MMP21","1644","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1644"
"MMP23B","7171","MMP23","1645","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1645"
"MMP24","7172","MMP24","1646","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1646"
"MMP25","14246","MMP25","1647","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1647"
"MMP26","14249","MMP26","1648","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1648"
"MMP27","14250","MMP27","1649","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1649"
"MMP28","14366","MMP28","1650","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1650"
"MMP3","7173","MMP3","1630","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1630"
"MMP7","7174","MMP7","1631","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1631"
"MMP8","7175","MMP8","1632","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1632"
"MMP9","7176","MMP9","1633","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1633"
"MNDA","7183","myeloid cell nuclear differentiation antigen","2926","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2926"
"MOGAT2","23248","monoacylglycerol O-acyltransferase 2","2881","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2881"
"MOK","9833","MOK protein kinase","2107","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2107"
"MOS","7199","MOS proto-oncogene, serine/threonine kinase","2108","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2108"
"MPC1","21606","mitochondrial pyruvate carrier 1","3022","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3022"
"MPC1L","44205","mitochondrial pyruvate carrier 1 like","3024","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3024"
"MPC2","24515","mitochondrial pyruvate carrier 2","3023","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3023"
"MPDU1","7207","mannose-P-dolichol utilization defect 1","3164","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3164"
"MPL","7217","Thrombopoietin receptor","1722","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1722"
"MPO","7218","myeloperoxidase","2789","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2789"
"MPST","7223","3-Mercaptopyruvate sulfurtransferase","1446","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1446"
"MRGPRD","29626","<i>MRGPRD</i>","152","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=152"
"MRGPRE","30694","<i>MRGPRE</i>","153","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=153"
"MRGPRF","24828","<i>MRGPRF</i>","154","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=154"
"MRGPRG","24829","<i>MRGPRG</i>","155","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=155"
"MRGPRX1","17962","<i>MRGPRX1</i>","156","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=156"
"MRGPRX2","17983","<i>MRGPRX2</i>","157","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=157"
"MRGPRX3","17980","<i>MRGPRX3</i>","158","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=158"
"MRGPRX4","17617","<i>MRGPRX4</i>","159","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=159"
"MS4A1","7315","CD20 (membrane-spanning 4-domains, subfamily A, member 1)","2628","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2628"
"MS4A2","7316","membrane spanning 4-domains A2","2936","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2936"
"MSMB","7372","MSMB (91-114)","10541","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10541"
"MST1","7380","macrophage stimulating protein 1","5023","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5023"
"MST1R","7381","macrophage stimulating 1 receptor","1816","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1816"
"MSTN","4223","myostatin","5025","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5025"
"MT-ATP6","7414","F-type ATPase A subunit","801","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=801"
"MT-ATP8","7415","F-type ATPase 8 subunit","809","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=809"
"MTCH1","17586","mitochondrial carrier 1","2554","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2554"
"MTCH2","17587","mitochondrial carrier 2","2555","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2555"
"MTNR1A","7463","MT<sub>1</sub> receptor","287","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=287"
"MTNR1B","7464","MT<sub>2</sub> receptor","288","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=288"
"MTOR","3942","mechanistic target of rapamycin kinase","2109","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2109"
"MTR","7468","5-methyltetrahydrofolate-homocysteine methyltransferase","3099","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3099"
"MT-RNR2","7471","humanin","1047","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1047"
"MUSK","7525","muscle associated receptor tyrosine kinase","1847","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1847"
"MVD","7529","diphosphomevalonate decarboxylase","642","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=642"
"MVK","7530","mevalonate kinase","640","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=640"
"MYBPC3","7551","myosin binding protein C3","2880","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2880"
"MYLK","7590","myosin light chain kinase","1552","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1552"
"MYLK2","16243","myosin light chain kinase 2","1553","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1553"
"MYLK3","29826","myosin light chain kinase 3","2110","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2110"
"MYLK4","27972","myosin light chain kinase family member 4","2111","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2111"
"MYO3A","7601","myosin IIIA","2112","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2112"
"MYO3B","15576","myosin IIIB","2113","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2113"
"NAAA","736","<i>N</i>-Acylethanolamine acid amidase","1402","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1402"
"NAALAD2","14526","N-Acetylated &alpha;-linked acidic dipeptidase 2","1609","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1609"
"NAALADL1","23536","N-Acetylated &alpha;-linked acidic dipeptidase-like 1","1608","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1608"
"NAIP","7634","NLR family apoptosis inhibitory protein","2793","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2793"
"NALCN","19082","Na<sub>vi</sub>2.1","750","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=750"
"NAPEPLD","21683","<i>N</i>-Acylphosphatidylethanolamine-phospholipase D","1398","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1398"
"NAT8L","26742","N-acetyltransferase 8 like","3144","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3144"
"NCAM1","7656","neural cell adhesion molecule 1 (CD56)","2769","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2769"
"NCAN","2465","chondroitin sulphate proteoglycan 3","6616","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6616"
"NCOA1","7668","nuclear receptor coactivator 1","2693","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2693"
"NCOA2","7669","nuclear receptor coactivator 2","2694","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2694"
"NCOA3","7670","nuclear receptor coactivator 3","2695","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2695"
"NCR3","19077","Natural cytotoxicity triggering receptor 3 (CD337)","3141","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3141"
"NCR3LG1","42400","Natural cytotoxicity triggering receptor 3 ligand 1","11142","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11142"
"NDP","7678","norrin","1063","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1063"
"NECTIN4","19688","nectin cell adhesion molecule 4","3112","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3112"
"NEK1","7744","NIMA related kinase 1","2114","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2114"
"NEK10","18592","NIMA related kinase 10","2115","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2115"
"NEK11","18593","NIMA related kinase 11","2116","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2116"
"NEK2","7745","NIMA related kinase 2","2117","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2117"
"NEK3","7746","NIMA related kinase 3","2118","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2118"
"NEK4","11399","NIMA related kinase 4","2119","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2119"
"NEK5","7748","NIMA related kinase 5","2120","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2120"
"NEK6","7749","NIMA related kinase 6","2121","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2121"
"NEK7","13386","NIMA related kinase 7","2122","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2122"
"NEK8","13387","NIMA related kinase 8","2123","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2123"
"NEK9","18591","NIMA related kinase 9","2124","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2124"
"NEU1","7758","neuraminidase 1","3214","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3214"
"NEU2","7759","neuraminidase 2","3258","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3258"
"NFE2L2","7782","nuclear factor, erythroid 2 like 2","3057","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3057"
"NFKB1","7794","nuclear factor kappa B subunit 1","3281","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3281"
"NFKB2","7795","nuclear factor kappa B subunit 2","3282","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3282"
"NFKBIZ","29805","NFKB inhibitor zeta","3008","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3008"
"NGF","7808","NGF","5026","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5026"
"NGFR","7809","nerve growth factor receptor","1888","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1888"
"NIM1K","28646","serine/threonine-protein kinase NIM1","2291","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2291"
"NIPA1","17043","NIPA magnesium transporter 1","3033","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3033"
"NIPA2","17044","NIPA magnesium transporter 2","3034","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3034"
"NIPAL1","27194","NIPA like domain containing 1","3035","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3035"
"NIPAL2","25854","NIPA like domain containing 2","3036","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3036"
"NIPAL3","25233","NIPA like domain containing 3","3037","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3037"
"NIPAL4","28018","NIPA like domain containing 4","3038","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3038"
"NLGN1","14291","neuroligin 1","12818","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12818"
"NLK","29858","nemo like kinase","2125","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2125"
"NLRC3","29889","NLRC3","1764","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1764"
"NLRC4","16412","NLRC4","1782","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1782"
"NLRC5","29933","NLRC5","1765","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1765"
"NLRP1","14374","NLRP1","1768","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1768"
"NLRP10","21464","NLRP10","1777","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1777"
"NLRP11","22945","NLRP11","1778","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1778"
"NLRP12","22938","NLRP12","1779","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1779"
"NLRP13","22937","NLRP13","1780","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1780"
"NLRP14","22939","NLRP14","1781","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1781"
"NLRP2","22948","NLRP2","1769","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1769"
"NLRP3","16400","NLRP3","1770","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1770"
"NLRP4","22943","NLRP4","1771","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1771"
"NLRP5","21269","NLRP5","1772","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1772"
"NLRP6","22944","NLRP6","1773","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1773"
"NLRP7","22947","NLRP7","1774","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1774"
"NLRP8","22940","NLRP8","1775","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1775"
"NLRP9","22941","NLRP9","1776","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1776"
"NLRX1","29890","NLRX1","1766","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1766"
"NMB","7842","neuromedin B","613","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=613"
"NMBR","7843","BB<sub>1</sub> receptor","38","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=38"
"NMS","32203","neuromedin S-33","1468","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1468"
"NMU","7859","neuromedin U-25","1470","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1470"
"NMUR1","4518","NMU1 receptor","298","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=298"
"NMUR2","16454","NMU2 receptor","299","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=299"
"NNMT","7861","nicotinamide N-methyltransferase","3205","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3205"
"NOD1","16390","nucleotide binding oligomerization domain containing 1","1762","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1762"
"NOD2","5331","nucleotide binding oligomerization domain containing 2","1763","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1763"
"NOG","7866","Noggin","10975","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10975"
"NOS1","7872","Neuronal NOS","1251","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1251"
"NOS2","7873","Inducible NOS","1250","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1250"
"NOS3","7876","Endothelial NOS","1249","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1249"
"NOTCH1","7881","notch receptor 1","2861","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2861"
"NOTCH2","7882","notch receptor 2","2859","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2859"
"NOTCH3","7883","notch receptor 3","2860","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2860"
"NOTCH4","7884","notch receptor 4","2862","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2862"
"NOX1","7889","NADPH oxidase 1","3001","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3001"
"NOX3","7890","NADPH oxidase 3","3003","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3003"
"NOX4","7891","NADPH oxidase 4","3004","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3004"
"NOX5","14874","NADPH oxidase 5","3005","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3005"
"NPB","30099","neuropeptide B-29","1502","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1502"
"NPBWR1","4522","NPBW1 receptor","303","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=303"
"NPBWR2","4530","NPBW2 receptor","304","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=304"
"NPC1","7897","NPC intracellular cholesterol transporter 1","3051","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3051"
"NPC1L1","7898","NPC1 like intracellular cholesterol transporter 1","2629","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2629"
"NPEPL1","16244","Aminopeptidase-like 1","1563","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1563"
"NPEPPS","7900","Puromycin-sensitive aminopeptidase","1575","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1575"
"NPFF","7901","neuropeptide AF","3735","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3735"
"NPFFR1","17425","NPFF1 receptor","300","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=300"
"NPFFR2","4525","NPFF2 receptor","301","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=301"
"NPPA","7939","atrial natriuretic peptide","4869","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4869"
"NPPB","7940","brain natriuretic peptide","4890","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4890"
"NPPC","7941","C-type natriuretic peptide","4896","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4896"
"NPR1","7943","Guanylyl cyclase-A","1747","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1747"
"NPR2","7944","Guanylyl cyclase-B","1748","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1748"
"NPR3","7945","natriuretic peptide receptor 3","1749","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1749"
"NPS","33940","neuropeptide S","1490","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1490"
"NPSR1","23631","NPS receptor","302","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=302"
"NPTN","17867","neuroplastin","3149","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3149"
"NPVF","13782","RFRP-1","5340","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5340"
"NPW","30509","neuropeptide W-30","1496","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1496"
"NPY","7955","neuropeptide Y","1504","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1504"
"NPY1R","7956","Y<sub>1</sub> receptor","305","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=305"
"NPY2R","7957","Y<sub>2</sub> receptor","306","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=306"
"NPY4R","9329","Y<sub>4</sub> receptor","307","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=307"
"NPY5R","7958","Y<sub>5</sub> receptor","308","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=308"
"NPY6R","7959","y<sub>6</sub> receptor","683","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=683"
"NR0B1","7960","DAX1","635","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=635"
"NR0B2","7961","SHP","636","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=636"
"NR1D1","7962","Rev-Erb-&alpha;","596","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=596"
"NR1D2","7963","Rev-Erb-&beta;","597","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=597"
"NR1H2","7965","Liver X receptor-&beta;","601","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=601"
"NR1H3","7966","Liver X receptor-&alpha;","602","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=602"
"NR1H4","7967","Farnesoid X receptor","603","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=603"
"NR1H5P","32673","Farnesoid X receptor-&beta;","604","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=604"
"NR1I2","7968","Pregnane X receptor","606","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=606"
"NR1I3","7969","Constitutive androstane receptor","607","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=607"
"NR2C1","7971","Testicular receptor 2","613","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=613"
"NR2C2","7972","Testicular receptor 4","614","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=614"
"NR2E1","7973","TLX","615","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=615"
"NR2E3","7974","PNR","616","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=616"
"NR2F1","7975","COUP-TF1","617","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=617"
"NR2F2","7976","COUP-TF2","618","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=618"
"NR2F6","7977","V-erbA-related gene","619","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=619"
"NR3C1","7978","Glucocorticoid receptor","625","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=625"
"NR3C2","7979","Mineralocorticoid receptor","626","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=626"
"NR4A1","7980","Nerve Growth factor IB","629","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=629"
"NR4A2","7981","Nuclear receptor related 1","630","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=630"
"NR4A3","7982","Neuron-derived orphan receptor 1","631","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=631"
"NR5A1","7983","Steroidogenic factor 1","632","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=632"
"NR5A2","7984","Liver receptor homolog-1","633","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=633"
"NR6A1","7985","Germ cell nuclear factor","634","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=634"
"NRAS","7989","NRAS","2823","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2823"
"NRBP1","7993","nuclear receptor binding protein 1","2126","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2126"
"NRBP2","19339","nuclear receptor binding protein 2","2127","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2127"
"NRG1","7997","neuregulin-1","5027","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5027"
"NRG2","7998","neuregulin-2","5029","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5029"
"NRG3","7999","neuregulin-3","5030","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5030"
"NRG4","29862","neuregulin-4","5031","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5031"
"NRK","25391","Nik related kinase","2128","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2128"
"NRP1","8004","neuropilin 1","2998","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2998"
"NRTN","8007","neurturin","5032","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5032"
"NSD1","14234","nuclear receptor binding SET domain protein 1","2696","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2696"
"NSD2","12766","nuclear receptor binding SET domain protein 2","3220","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3220"
"NSMAF","8017","neutral sphingomyelinase activation associated factor","2495","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2495"
"NT5C","17144","5'(3')-nucleotidase","1238","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1238"
"NT5C1A","17819","5'-nucleotidase IA","1234","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1234"
"NT5C1B","17818","5'-nucleotidase IB","1235","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1235"
"NT5C2","8022","5'-nucleotidase II","1236","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1236"
"NT5C3A","17820","5'-nucleotidase III","1237","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1237"
"NT5E","8021","Ecto-5'-Nucleotidase","1232","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1232"
"NT5M","15769","Mitochondrial 5'-nucleotidase","1239","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1239"
"NTF3","8023","neurotrophin-3","5033","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5033"
"NTF4","8024","neurotrophin-4","5034","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5034"
"NTN1","8029","netrin 1","12847","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12847"
"NTRK1","8031","neurotrophic receptor tyrosine kinase 1","1817","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1817"
"NTRK2","8032","neurotrophic receptor tyrosine kinase 2","1818","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1818"
"NTRK3","8033","neurotrophic receptor tyrosine kinase 3","1819","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1819"
"NTS","8038","large neurotensin","1577","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1577"
"NTSR1","8039","NTS<sub>1</sub> receptor","309","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=309"
"NTSR2","8040","NTS<sub>2</sub> receptor","310","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=310"
"NUAK1","14311","NUAK family kinase 1","2129","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2129"
"NUAK2","29558","NUAK family, SNF1-like kinase, 2","2130","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2130"
"NUCB1","8043","nucleobindin 1","2871","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2871"
"NUDT7","8054","nudix hydrolase 7","3085","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3085"
"OBSCN","15719","obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF","2131","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2131"
"OCRL","8108","OCRL","1460","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1460"
"ODC1","8109","Ornithine decarboxylase","1276","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1276"
"OGA","7056","O-GlcNAcase","3101","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3101"
"OGG1","8125","8-oxoguanine DNA glycosylase","3060","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3060"
"OPN1LW","9936","<i>OPN1LW</i>","2961","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2961"
"OPN1MW","4206","<i>OPN1MW</i>","2962","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2962"
"OPN1SW","1012","<i>OPN1SW</i>","2960","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2960"
"OPN3","14007","<i>OPN3</i>","160","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=160"
"OPN4","14449","<i>OPN4</i>","2758","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2758"
"OPN5","19992","<i>OPN5</i>","161","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=161"
"OPRD1","8153","&delta; receptor","317","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=317"
"OPRK1","8154","&kappa; receptor","318","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318"
"OPRL1","8155","NOP receptor","320","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=320"
"OPRM1","8156","&mu; receptor","319","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=319"
"OR51E1","15194","<i>OR51E1</i>","653","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=653"
"ORAI1","25896","Orai1","2964","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2964"
"ORAI2","21667","Orai2","2965","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2965"
"ORAI3","28185","Orai3","2966","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2966"
"OSM","8506","oncostatin M","5035","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5035"
"OSMR","8507","Oncostatin M-specific receptor, &beta; subunit","1714","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1714"
"OSTN","29961","osteocrin","5036","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5036"
"OTUB1","23077","OTU deubiquitinase, ubiquitin aldehyde binding 1","3208","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3208"
"OTULIN","25118","otulin","2910","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2910"
"OXER1","24884","OXE receptor","271","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=271"
"OXGR1","4531","oxoglutarate receptor","162","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=162"
"OXSR1","8508","oxidative stress responsive kinase 1","2132","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2132"
"OXT","8528","oxytocin","2174","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2174"
"OXTR","8529","OT receptor","369","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=369"
"P2RX1","8533","P2X1","478","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=478"
"P2RX2","15459","P2X2","479","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=479"
"P2RX3","8534","P2X3","480","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=480"
"P2RX4","8535","P2X4","481","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=481"
"P2RX5","8536","P2X5","482","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=482"
"P2RX6","8538","P2X6","483","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=483"
"P2RX7","8537","P2X7","484","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=484"
"P2RY1","8539","P2Y<sub>1</sub> receptor","323","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=323"
"P2RY10","19906","<i>P2RY10</i>","165","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=165"
"P2RY11","8540","P2Y<sub>11</sub> receptor","327","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=327"
"P2RY12","18124","P2Y<sub>12</sub> receptor","328","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=328"
"P2RY13","4537","P2Y<sub>13</sub> receptor","329","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=329"
"P2RY14","16442","P2Y<sub>14</sub> receptor","330","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=330"
"P2RY2","8541","P2Y<sub>2</sub> receptor","324","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=324"
"P2RY4","8542","P2Y<sub>4</sub> receptor","325","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=325"
"P2RY6","8543","P2Y<sub>6</sub> receptor","326","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=326"
"P2RY8","15524","<i>P2RY8</i>","164","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=164"
"PADI1","18367","peptidyl arginine deiminase 1","2894","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2894"
"PADI3","18337","peptidyl arginine deiminase 3","2878","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2878"
"PADI4","18368","peptidyl arginine deiminase 4","2877","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2877"
"PAFAH2","8579","platelet activating factor acetylhydrolase 2","2508","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2508"
"PAH","8582","L-Phenylalanine hydroxylase ","1240","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1240"
"PAK1","8590","p21 (RAC1) activated kinase 1","2133","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2133"
"PAK2","8591","p21 (RAC1) activated kinase 2","2134","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2134"
"PAK3","8592","p21 (RAC1) activated kinase 3","2135","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2135"
"PAK4","16059","p21 (RAC1) activated kinase 4","2136","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2136"
"PAK5","15916","p21 (RAC1) activated kinase 5","2138","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2138"
"PAK6","16061","p21 (RAC1) activated kinase 6","2137","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2137"
"PANX1","8599","Px1","735","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=735"
"PANX2","8600","Px2","736","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=736"
"PANX3","20573","Px3","737","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=737"
"PARP1","270","poly(ADP-ribose) polymerase 1","2771","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771"
"PARP10","25895","poly(ADP-ribose) polymerase family member 10","3267","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3267"
"PARP11","1186","poly(ADP-ribose) polymerase family member 11","3268","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3268"
"PARP14","29232","poly(ADP-ribose) polymerase family member 14","3269","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3269"
"PARP15","26876","poly(ADP-ribose) polymerase family member 15","3270","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3270"
"PARP2","272","poly(ADP-ribose) polymerase 2","2772","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2772"
"PARP3","273","poly (ADP-ribose) polymerase 3","2864","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2864"
"PASK","17270","PAS domain containing serine/threonine kinase","2139","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2139"
"PBK","18282","PDZ binding kinase","2140","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2140"
"PBRM1","30064","polybromo 1","2738","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2738"
"PC","8636","Pyruvate carboxylase","1262","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1262"
"PCCA","8653","Propionyl-CoA carboxylase &alpha; subunit","1266","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1266"
"PCCB","8654","Propionyl-CoA carboxylase &beta; subunit","1267","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1267"
"PCSK1","8743","proprotein convertase subtilisin/kexin type 1","2382","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2382"
"PCSK2","8744","proprotein convertase subtilisin/kexin type 2","2383","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2383"
"PCSK4","8746","proprotein convertase subtilisin/kexin type 4","2384","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2384"
"PCSK5","8747","proprotein convertase subtilisin/kexin type 5","2385","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2385"
"PCSK6","8569","proprotein convertase subtilisin/kexin type 6","2386","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2386"
"PCSK7","8748","proprotein convertase subtilisin/kexin type 7","2387","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2387"
"PCSK9","20001","proprotein convertase subtilisin/kexin type 9","2388","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2388"
"PDCD1","8760","programmed cell death 1 (CD279)","2760","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2760"
"PDE10A","8772","phosphodiesterase 10A","1310","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1310"
"PDE11A","8773","phosphodiesterase 11A","1311","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1311"
"PDE12","25386","phosphodiesterase 12","3207","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3207"
"PDE1A","8774","phosphodiesterase 1A","1294","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1294"
"PDE1B","8775","phosphodiesterase 1B","1295","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1295"
"PDE1C","8776","phosphodiesterase 1C","1296","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1296"
"PDE2A","8777","phosphodiesterase 2A","1297","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1297"
"PDE3A","8778","phosphodiesterase 3A","1298","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1298"
"PDE3B","8779","phosphodiesterase 3B","1299","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1299"
"PDE4A","8780","phosphodiesterase 4A","1300","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1300"
"PDE4B","8781","phosphodiesterase 4B","1301","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1301"
"PDE4C","8782","phosphodiesterase 4C","1302","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1302"
"PDE4D","8783","phosphodiesterase 4D","1303","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1303"
"PDE5A","8784","phosphodiesterase 5A","1304","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1304"
"PDE6A","8785","phosphodiesterase 6A","1312","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1312"
"PDE6B","8786","phosphodiesterase 6B","1313","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1313"
"PDE6C","8787","phosphodiesterase 6C","1314","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1314"
"PDE6D","8788","phosphodiesterase 6D","1315","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1315"
"PDE6G","8789","phosphodiesterase 6G","1316","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1316"
"PDE6H","8790","phosphodiesterase 6H","1317","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1317"
"PDE7A","8791","phosphodiesterase 7A","1305","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1305"
"PDE7B","8792","phosphodiesterase 7B","1306","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1306"
"PDE8A","8793","phosphodiesterase 8A","1307","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1307"
"PDE8B","8794","phosphodiesterase 8B","1308","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1308"
"PDE9A","8795","phosphodiesterase 9A","1309","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1309"
"PDGFA","8799","PDGFA","5042","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5042"
"PDGFB","8800","PDGFB","5043","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5043"
"PDGFC","8801","VEGFE","5089","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5089"
"PDGFD","30620","PDGFD","5323","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5323"
"PDGFRA","8803","platelet derived growth factor receptor alpha","1803","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1803"
"PDGFRB","8804","platelet derived growth factor receptor beta","1804","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804"
"PDIK1L","18981","PDLIM1 interacting kinase 1 like","2141","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2141"
"PDK1","8809","pyruvate dehydrogenase kinase 1","2915","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2915"
"PDK2","8810","pyruvate dehydrogenase kinase 2","2142","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2142"
"PDK3","8811","pyruvate dehydrogenase kinase 3","2143","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2143"
"PDK4","8812","pyruvate dehydrogenase kinase 4","2144","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2144"
"PDPK1","8816","3-phosphoinositide dependent protein kinase 1","1519","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1519"
"PDYN","8820","big dynorphin","3669","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3669"
"PDZD11","28034","PDZ domain containing 11","3150","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3150"
"PENK","8831","bovine adrenal medulla peptide 8-22","4058","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4058"
"PEPD","8840","peptidase D","2389","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2389"
"PF4","8861","CXCL4","3685","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3685"
"PFKFB3","8874","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3","2937","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2937"
"PGA5","8887","pepsinogen A5","2390","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2390"
"PGC","8890","progastricsin","2391","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2391"
"PGF","8893","placental growth factor","5314","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5314"
"PGR","8910","Progesterone receptor","627","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=627"
"PHF2","8920","PHD finger protein 2","2697","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2697"
"PHF8","20672","PHD finger protein 8","2698","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2698"
"PHIP","15673","pleckstrin homology domain interacting protein","2776","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2776"
"PHKG1","8930","phosphorylase kinase catalytic subunit gamma 1","2145","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2145"
"PHKG2","8931","phosphorylase kinase catalytic subunit gamma 2","2147","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2147"
"PI3","8947","elafin","12035","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12035"
"PI4K2A","30031","phosphatidylinositol 4-kinase type 2 alpha","2498","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2498"
"PI4K2B","18215","phosphatidylinositol 4-kinase type 2 beta","2499","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2499"
"PI4KA","8983","phosphatidylinositol 4-kinase alpha","2148","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2148"
"PI4KB","8984","phosphatidylinositol 4-kinase beta","2149","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2149"
"PIEZO1","28993","Piezo1","2945","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2945"
"PIEZO2","26270","Piezo2","2946","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2946"
"PIK3C2A","8971","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha","2150","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2150"
"PIK3C2B","8972","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta","2151","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2151"
"PIK3C2G","8973","phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma","2288","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2288"
"PIK3C3","8974","phosphatidylinositol 3-kinase catalytic subunit type 3","2152","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2152"
"PIK3CA","8975","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","2153","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2153"
"PIK3CB","8976","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","2154","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2154"
"PIK3CD","8977","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","2155","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2155"
"PIK3CG","8978","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","2156","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2156"
"PIK3R1","8979","phosphoinositide-3-kinase regulatory subunit 1","2503","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2503"
"PIK3R2","8980","phosphoinositide-3-kinase regulatory subunit 2","2504","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2504"
"PIK3R3","8981","phosphoinositide-3-kinase regulatory subunit 3","2505","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2505"
"PIK3R4","8982","phosphoinositide-3-kinase regulatory subunit 4","2157","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2157"
"PIK3R5","30035","phosphoinositide-3-kinase regulatory subunit 5","2506","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2506"
"PIK3R6","27101","phosphoinositide-3-kinase regulatory subunit 6","2507","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2507"
"PIKFYVE","23785","phosphoinositide kinase, FYVE-type zinc finger containing","2857","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2857"
"PIM1","8986","Pim-1 proto-oncogene, serine/threonine kinase","2158","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2158"
"PIM2","8987","Pim-2 proto-oncogene, serine/threonine kinase","2159","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2159"
"PIM3","19310","Pim-3 proto-oncogene, serine/threonine kinase","2160","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2160"
"PIN1","8988","peptidylprolyl cis/trans isomerase, NIMA-interacting 1","3171","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3171"
"PINK1","14581","PTEN induced kinase 1","2161","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2161"
"PIP4K2A","8997","phosphatidylinositol-5-phosphate 4-kinase type 2 alpha","2858","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2858"
"PIP4K2B","8998","phosphatidylinositol-5-phosphate 4-kinase type 2 beta","2162","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2162"
"PIP4K2C","23786","phosphatidylinositol-5-phosphate 4-kinase type 2 gamma","2163","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2163"
"PIP5K1A","8994","phosphatidylinositol-4-phosphate 5-kinase type 1 alpha","2164","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2164"
"PIP5K1B","8995","phosphatidylinositol-4-phosphate 5-kinase type 1 beta","2500","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2500"
"PIP5K1C","8996","phosphatidylinositol-4-phosphate 5-kinase type 1 gamma","2165","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2165"
"PISD","8999","Phosphatidylserine decarboxylase ","1277","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1277"
"PKD2","9009","TRPP1","504","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=504"
"PKD2L1","9011","TRPP2","505","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=505"
"PKD2L2","9012","TRPP3","506","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=506"
"PKDCC","25123","protein kinase domain containing, cytoplasmic","2166","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2166"
"PKLR","9020","pyruvate kinase L/R","3007","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3007"
"PKM","9021","pyruvate kinase M1/2","3006","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3006"
"PKMYT1","29650","protein kinase, membrane associated tyrosine/threonine 1","2167","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2167"
"PKN1","9405","protein kinase N1","1520","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1520"
"PKN2","9406","protein kinase N2","1521","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1521"
"PKN3","17999","protein kinase N3","1522","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1522"
"PLA2G10","9029","sPLA<sub>2</sub>-10","1422","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1422"
"PLA2G12A","18554","sPLA<sub>2</sub>-12A","1423","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1423"
"PLA2G1B","9030","sPLA<sub>2</sub>-1B","1416","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1416"
"PLA2G2A","9031","sPLA<sub>2</sub>-2A","1417","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1417"
"PLA2G2D","9033","sPLA<sub>2</sub>-2D","1418","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1418"
"PLA2G2E","13414","sPLA<sub>2</sub>-2E","1419","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1419"
"PLA2G2F","30040","sPLA<sub>2</sub>-2F","1420","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1420"
"PLA2G3","17934","sPLA<sub>2</sub>-3","1421","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1421"
"PLA2G4A","9035","cPLA<sub>2</sub>-4A","1424","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1424"
"PLA2G4B","9036","cPLA<sub>2</sub>-4B","1425","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1425"
"PLA2G4C","9037","cPLA<sub>2</sub>-4C","1426","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1426"
"PLA2G4D","30038","cPLA<sub>2</sub>-4D","1427","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1427"
"PLA2G4E","24791","cPLA<sub>2</sub>-4E","1428","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1428"
"PLA2G4F","27396","cPLA<sub>2</sub>-4F","1429","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1429"
"PLA2G5","9038","PLA<sub>2</sub>-G5","1430","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1430"
"PLA2G6","9039","iPLA<sub>2</sub>-G6","1431","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1431"
"PLA2G7","9040","PLA<sub>2</sub>-G7","1432","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1432"
"PLAT","9051","plasminogen activator, tissue type","2392","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2392"
"PLAU","9052","plasminogen activator, urokinase","2393","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2393"
"PLCB1","15917","PLC&beta;1","1403","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1403"
"PLCB2","9055","PLC&beta;2","1404","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1404"
"PLCB3","9056","PLC&beta;3","1405","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1405"
"PLCB4","9059","PLC&beta;4","1406","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1406"
"PLCD1","9060","PLC&delta;1","1409","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1409"
"PLCD3","9061","PLC&delta;3","1410","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1410"
"PLCD4","9062","PLC&delta;4","1411","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1411"
"PLCE1","17175","PLC&epsilon;1","1412","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1412"
"PLCG1","9065","PLC&gamma;1","1407","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1407"
"PLCG2","9066","PLC&gamma;2","1408","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1408"
"PLCH1","29185","PLC&eta;1","1414","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1414"
"PLCH2","29037","PLC&eta;2","1415","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1415"
"PLCZ1","19218","PLC&zeta;1","1413","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1413"
"PLD1","9067","PLD1","1433","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1433"
"PLD2","9068","PLD2","1434","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1434"
"PLG","9071","plasminogen","2394","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2394"
"PLK1","9077","polo like kinase 1","2168","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2168"
"PLK2","19699","polo like kinase 2","2169","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2169"
"PLK3","2154","polo like kinase 3","2170","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2170"
"PLK4","11397","polo like kinase 4","2171","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2171"
"PLPP1","9228","PPA2A","1438","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1438"
"PLPP2","9230","PPA3A","1440","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1440"
"PLPP3","9229","PPA2B","1439","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1439"
"PLSCR1","9092","phospholipid scramblase 1","3238","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3238"
"PMCH","9109","melanin-concentrating hormone","1298","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1298"
"PMP2","9117","peripheral myelin protein 2","2544","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2544"
"PMVK","9141","phosphomevalonate kinase","641","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=641"
"PNCK","13415","pregnancy up-regulated nonubiquitous CaM kinase","2172","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2172"
"PNLIP","9155","pancreatic lipase","2590","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2590"
"PNMT","9160","Phenylethanolamine N-methyltransferase","2496","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2496"
"PNOC","9163","nociceptin/orphanin FQ","1681","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1681"
"PNP","7892","purine nucleoside phosphorylase","2841","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2841"
"PNPLA2","30802","patatin like phospholipase domain containing 2","3253","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3253"
"POLB","9174","DNA polymerase beta","3231","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3231"
"POLQ","9186","DNA polymerase theta","3230","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3230"
"POMC","9201","ACTH","3633","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3633"
"PON1","9204","paraoxonase 1","3052","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3052"
"PON2","9205","paraoxonase 2","3053","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3053"
"PON3","9206","paraoxonase 3","3054","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3054"
"PORCN","17652","porcupine O-acyltransferase","3145","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3145"
"PPARA","9232","Peroxisome proliferator-activated receptor-&alpha;","593","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=593"
"PPARD","9235","Peroxisome proliferator-activated receptor-&beta;/&delta;","594","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=594"
"PPARG","9236","Peroxisome proliferator-activated receptor-&gamma;","595","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=595"
"PPAT","9238","phosphoribosyl pyrophosphate amidotransferase","2761","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2761"
"PPBP","9240","CXCL7","830","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=830"
"PPIA","9253","peptidylprolyl isomerase A","2751","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2751"
"PPID","9257","peptidylprolyl isomerase D","3179","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3179"
"PPM1D","9277","protein phosphatase, Mg2+/Mn2+ dependent 1D","3134","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3134"
"PPME1","30178","protein phosphatase methylesterase 1","2875","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2875"
"PPP1CA","9281","protein phosphatase 1 catalytic subunit alpha","3264","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3264"
"PPP2CA","9299","protein phosphatase 2 catalytic subunit alpha","3263","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3263"
"PPT1","9325","palmitoyl-protein thioesterase 1","3199","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3199"
"PPY","9327","pancreatic polypeptide","1512","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1512"
"PRCP","9344","Prolylcarboxypeptidase","1584","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1584"
"PRDM2","9347","PR/SET domain 2","2699","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2699"
"PREP","9358","prolyl endopeptidase","2395","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2395"
"PREPL","30228","prolyl endopeptidase like","2870","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2870"
"PRF1","9360","perforin 1","3100","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3100"
"PRKAA1","9376","protein kinase AMP-activated catalytic subunit alpha 1","1541","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1541"
"PRKAA2","9377","protein kinase AMP-activated catalytic subunit alpha 2","1542","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1542"
"PRKAB1","9378","protein kinase AMP-activated non-catalytic subunit beta 1","1543","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1543"
"PRKAB2","9379","protein kinase AMP-activated non-catalytic subunit beta 2","1544","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1544"
"PRKACA","9380","protein kinase, cAMP-dependent, catalytic, alpha subunit","1476","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1476"
"PRKACB","9381","protein kinase, cAMP-dependent, catalytic, beta subunit","1477","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1477"
"PRKACG","9382","protein kinase, cAMP-dependent, catalytic, gamma subunit","1478","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1478"
"PRKAG1","9385","protein kinase AMP-activated non-catalytic subunit gamma 1","1545","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1545"
"PRKAG2","9386","protein kinase AMP-activated non-catalytic subunit gamma 2","1546","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1546"
"PRKAG3","9387","protein kinase AMP-activated non-catalytic subunit gamma 3","1547","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1547"
"PRKAR1A","9388","protein kinase, cAMP-dependent, regulatory, type I, alpha subunit","1472","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1472"
"PRKAR1B","9390","protein kinase, cAMP-dependent, regulatory, type I, beta subunit","1473","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1473"
"PRKAR2A","9391","protein kinase, cAMP-dependent, regulatory, type II, alpha subunit","1474","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1474"
"PRKAR2B","9392","protein kinase, cAMP-dependent, regulatory, type II, beta subunit","1475","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1475"
"PRKCA","9393","protein kinase C alpha","1482","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1482"
"PRKCB","9395","protein kinase C beta","1483","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1483"
"PRKCD","9399","protein kinase C delta","1485","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1485"
"PRKCE","9401","protein kinase C epsilon","1486","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1486"
"PRKCG","9402","protein kinase C gamma","1484","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1484"
"PRKCH","9403","protein kinase C eta","1487","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1487"
"PRKCI","9404","protein kinase C iota","1490","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1490"
"PRKCQ","9410","protein kinase C theta","1488","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1488"
"PRKCZ","9412","protein kinase C zeta","1491","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1491"
"PRKD1","9407","protein kinase D1","1489","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1489"
"PRKD2","17293","protein kinase D2","2173","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2173"
"PRKD3","9408","protein kinase D3","2174","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2174"
"PRKDC","9413","protein kinase, DNA-activated, catalytic subunit","2800","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2800"
"PRKG1","9414","Protein kinase G (PKG) 1","1492","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1492"
"PRKG2","9416","Protein kinase G (PKG) 2","1493","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1493"
"PRKX","9441","protein kinase X-linked","2175","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2175"
"PRKY","9444","protein kinase Y-linked (pseudogene)","2176","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2176"
"PRL","9445","prolactin","5049","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5049"
"PRLH","17945","PrRP-31","1873","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1873"
"PRLHR","4464","PrRP receptor","337","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=337"
"PRLR","9446","Prolactin receptor","1721","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1721"
"PRMT1","5187","protein arginine methyltransferase 1 ","1252","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1252"
"PRMT2","5186","protein arginine methyltransferase 2 ","1253","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1253"
"PRMT3","30163","protein arginine methyltransferase 3","1254","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1254"
"PRMT5","10894","protein arginine methyltransferase 5 ","1256","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1256"
"PRMT6","18241","protein arginine methyltransferase 6","1257","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1257"
"PRMT7","25557","protein arginine methyltransferase 7 ","1258","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1258"
"PRMT8","5188","protein arginine methyltransferase 8","1259","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1259"
"PRMT9","25099","protein arginine methyltransferase 9","1261","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1261"
"PROC","9451","protein C, inactivator of coagulation factors Va and VIIIa","2396","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2396"
"PROK1","18454","prokineticin-1","1866","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1866"
"PROK2","18455","prokineticin-2","1867","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1867"
"PROKR1","4524","PKR<sub>1</sub>","335","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=335"
"PROKR2","15836","PKR<sub>2</sub>","336","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=336"
"PROS1","9456","protein S","5050","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5050"
"PRP4K","17346","pre-mRNA processing factor kinase PRP4K","2177","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2177"
"PRSS1","9475","serine protease 1","2397","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2397"
"PRSS2","9483","serine protease 2","2398","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2398"
"PRSS3","9486","serine protease 3","2399","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2399"
"PRSS8","9491","serine protease 8","2400","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2400"
"PRTN3","9495","proteinase 3","2401","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2401"
"PSAP","9498","prosaptide","6067","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6067"
"PSEN1","9508","presenilin 1","2402","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2402"
"PSEN2","9509","presenilin 2","2403","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2403"
"PSKH1","9529","protein serine kinase H1","2178","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2178"
"PSKH2","18997","protein serine kinase H2","2179","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2179"
"PSMB1","9537","proteasome 20S subunit beta 1","2404","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2404"
"PSMB2","9539","proteasome 20S subunit beta 2","2405","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2405"
"PSMB5","9542","proteasome 20S subunit beta 5","2406","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2406"
"PSMB6","9543","proteasome 20S subunit beta 6","2407","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2407"
"PSMB8","9545","proteasome 20S subunit beta 8","2408","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2408"
"PSMB9","9546","proteasome 20S subunit beta 9","2409","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2409"
"PSMD14","16889","proteasome 26S subunit, non-ATPase 14","2410","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2410"
"PSPN","9579","persephin","5045","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5045"
"PTAFR","9582","PAF receptor","334","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=334"
"PTEN","9588","phosphatase and tensin homolog","2497","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2497"
"PTGDR","9591","DP<sub>1</sub> receptor","338","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338"
"PTGDR2","4502","DP<sub>2</sub> receptor","339","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=339"
"PTGDS","9592","L-PGDS","1380","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1380"
"PTGER1","9593","EP<sub>1</sub> receptor","340","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340"
"PTGER2","9594","EP<sub>2</sub> receptor","341","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341"
"PTGER3","9595","EP<sub>3</sub> receptor","342","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342"
"PTGER4","9596","EP<sub>4</sub> receptor","343","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343"
"PTGES","9599","mPGES1","1377","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1377"
"PTGES2","17822","mPGES2","1378","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1378"
"PTGES3","16049","cPGES","1379","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1379"
"PTGFR","9600","FP receptor","344","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344"
"PTGIR","9602","IP receptor","345","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345"
"PTGIS","9603","CYP8A1","1356","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1356"
"PTGS1","9604","COX-1 ","1375","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1375"
"PTGS2","9605","COX-2 ","1376","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1376"
"PTH","9606","PTH","1785","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1785"
"PTH1R","9608","PTH1 receptor","331","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=331"
"PTH2","30828","TIP39","1815","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1815"
"PTH2R","9609","PTH2 receptor","332","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=332"
"PTHLH","9607","PTHrP","3738","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3738"
"PTK2","9611","protein tyrosine kinase 2","2180","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2180"
"PTK2B","9612","protein tyrosine kinase 2 beta","2181","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2181"
"PTK6","9617","protein tyrosine kinase 6","2182","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2182"
"PTK7","9618","protein tyrosine kinase 7 (inactive)","1848","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1848"
"PTN","9630","pleiotrophin","6618","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6618"
"PTP4A3","9636","protein tyrosine phosphatase 4A3","3224","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3224"
"PTPN1","9642","protein tyrosine phosphatase non-receptor type 1","2976","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2976"
"PTPN11","9644","protein tyrosine phosphatase non-receptor type 11","3203","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3203"
"PTPN2","9650","protein tyrosine phosphatase non-receptor type 2","3255","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3255"
"PTPN22","9652","protein tyrosine phosphatase non-receptor type 22","3084","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3084"
"PTPRA","9664","RTP Type A","1850","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1850"
"PTPRB","9665","RTP Type B","1851","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1851"
"PTPRC","9666","RTP Type C","1852","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1852"
"PTPRD","9668","RTP Type D","1853","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1853"
"PTPRE","9669","RTP Type E","1854","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1854"
"PTPRF","9670","RTP Type F","1855","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1855"
"PTPRG","9671","RTP Type G","1856","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1856"
"PTPRH","9672","RTP Type H","1857","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1857"
"PTPRJ","9673","RTP Type J","1858","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1858"
"PTPRK","9674","RTP Type K","1859","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1859"
"PTPRM","9675","RTP Type M","1860","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1860"
"PTPRN","9676","RTP Type N","1861","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1861"
"PTPRN2","9677","RTP Type N2","1862","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1862"
"PTPRO","9678","RTP Type O","1863","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1863"
"PTPRQ","9679","RTP Type Q","1864","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1864"
"PTPRR","9680","RTP Type R","1865","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1865"
"PTPRS","9681","RTP Type S","1866","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1866"
"PTPRT","9682","RTP Type T","1867","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1867"
"PTPRU","9683","RTP Type U","1868","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1868"
"PTPRZ1","9685","RTP Type Z1","1869","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1869"
"PVR","9705","PVR cell adhesion molecule","3095","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3095"
"PVRIG","32190","PVR related immunoglobulin domain containing","3080","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3080"
"PXK","23326","PX domain containing serine/threonine kinase like","2183","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2183"
"PYHIN1","28894","pyrin and HIN domain family member 1","2925","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2925"
"PYY","9748","peptide YY","1514","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1514"
"QPCT","9753","glutaminyl-peptide cyclotransferase","2411","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2411"
"QPCTL","25952","glutaminyl-peptide cyclotransferase like","3289","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3289"
"QRFP","29982","QRFP43 (43RFa)","3665","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3665"
"QRFPR","15565","QRFP receptor","333","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=333"
"RAB27A","9766","RAB27A, member RAS oncogene family","2916","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2916"
"RAB32","9772","RAB32, member RAS oncogene family","3292","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3292"
"RAC1","9801","Rac1","5250","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5250"
"RAC2","9802","Rac2","5251","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5251"
"RAC3","9803","Rac3","5252","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5252"
"RAF1","9829","Raf-1 proto-oncogene, serine/threonine kinase","2184","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2184"
"RAMP1","9843","RAMP1","51","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=51"
"RAMP2","9844","RAMP2","52","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=52"
"RAMP3","9845","RAMP3","53","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=53"
"RAPGEF3","16629","Rap guanine nucleotide exchange factor 3","1292","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1292"
"RAPGEF4","16626","Rap guanine nucleotide exchange factor 4","1293","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1293"
"RARA","9864","Retinoic acid receptor-&alpha;","590","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=590"
"RARB","9865","Retinoic acid receptor-&beta;","591","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=591"
"RARG","9866","Retinoic acid receptor-&gamma;","592","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=592"
"RARRES2","9868","chemerin","2945","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2945"
"RASGRP1","9878","RAS guanyl releasing protein 1","3016","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3016"
"RB1","9884","retinoblastoma-associated protein","5253","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5253"
"RBBP9","9892","RB binding protein 9, serine hydrolase","2874","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2874"
"RBP1","9919","retinol binding protein 1","2546","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2546"
"RBP2","9920","retinol binding protein 2","2547","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2547"
"RBP3","9921","retinol binding protein 3","2548","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2548"
"RBP4","9922","retinol binding protein 4","2549","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2549"
"RBP5","15847","retinol binding protein 5","2550","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2550"
"RBP7","30316","retinol binding protein 7","2551","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2551"
"RCE1","13721","Ras converting CAAX endopeptidase 1","2412","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2412"
"REL","9954","REL proto-oncogene, NF-kB subunit","3283","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3283"
"RELA","9955","RELA proto-oncogene, NF-kB subunit","3280","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3280"
"RELB","9956","RELB proto-oncogene, NF-kB subunit","3284","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3284"
"RELT","13764","RELT","1892","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1892"
"REN","9958","renin","2413","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2413"
"RET","9967","ret proto-oncogene","2185","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2185"
"RGMA","30308","repulsive guidance molecule BMP co-receptor a","2911","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2911"
"RGS1","9991","regulator of G-protein signaling 1","2804","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2804"
"RGS10","9992","regulator of G-protein signaling 10","2818","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2818"
"RGS11","9993","regulator of G-protein signaling 11","2814","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2814"
"RGS12","9994","regulator of G-protein signaling 12","2819","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2819"
"RGS13","9995","regulator of G-protein signaling 13","2805","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2805"
"RGS14","9996","regulator of G-protein signaling 14","2820","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2820"
"RGS16","9997","regulator of G-protein signaling 16","2806","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2806"
"RGS17","14088","regulator of G-protein signaling 17","2801","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2801"
"RGS18","14261","regulator of G-protein signaling 18","2807","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2807"
"RGS19","13735","regulator of G-protein signaling 19","2802","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2802"
"RGS2","9998","regulator of G-protein signaling 2","2808","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2808"
"RGS20","14600","regulator of G-protein signaling 20","2803","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2803"
"RGS21","26839","regulator of G-protein signaling 21","2809","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2809"
"RGS3","9999","regulator of G-protein signaling 3","2810","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2810"
"RGS4","10000","regulator of G-protein signaling 4","2811","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2811"
"RGS5","10001","regulator of G-protein signaling 5","2812","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2812"
"RGS6","10002","regulator of G-protein signaling 6","2815","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2815"
"RGS7","10003","regulator of G-protein signaling 7","2816","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2816"
"RGS8","16810","regulator of G-protein signaling 8","2813","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2813"
"RGS9","10004","regulator of G-protein signaling 9","2817","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2817"
"RHAG","10006","Ammonium transporter Rh type A","1198","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1198"
"RHBG","14572","Ammonium transporter Rh type B","1199","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1199"
"RHCG","18140","Ammonium transporter Rh type C","1200","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1200"
"RHO","10012","Rhodopsin","2963","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2963"
"RIGI","19102","DExD/H-box helicase 58","2920","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2920"
"RIOK1","18656","RIO kinase 1","2186","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2186"
"RIOK2","18999","RIO kinase 2","2187","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2187"
"RIOK3","11451","RIO kinase 3","2188","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2188"
"RIPK1","10019","receptor interacting serine/threonine kinase 1","2189","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2189"
"RIPK2","10020","receptor interacting serine/threonine kinase 2","2190","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2190"
"RIPK3","10021","receptor interacting serine/threonine kinase 3","2191","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2191"
"RIPK4","496","receptor interacting serine/threonine kinase 4","2192","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2192"
"RLBP1","10024","retinaldehyde binding protein 1","2545","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2545"
"RLN1","10026","relaxin-1 (B chain)","3743","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3743"
"RLN2","10027","relaxin (B chain)","3745","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3745"
"RLN3","17135","relaxin-3 (B chain)","1997","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1997"
"RNPEP","10078","Arginyl aminopeptidase","1564","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1564"
"RNPEPL1","10079","Arginyl aminopeptidase-like 1","1565","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1565"
"ROCK1","10251","Rho associated coiled-coil containing protein kinase 1","1503","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1503"
"ROCK2","10252","Rho associated coiled-coil containing protein kinase 2","1504","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1504"
"ROR1","10256","receptor tyrosine kinase like orphan receptor 1","1845","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1845"
"ROR2","10257","receptor tyrosine kinase like orphan receptor 2","1846","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1846"
"RORA","10258","RAR-related orphan receptor-&alpha;","598","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=598"
"RORB","10259","RAR-related orphan receptor-&beta;","599","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=599"
"RORC","10260","RAR-related orphan receptor-&gamma;","600","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=600"
"ROS1","10261","c-ros oncogene 1, receptor tyrosine kinase","1840","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1840"
"RPS19","10402","ribosomal protein S19","3728","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3728"
"RPS6","10429","ribosomal protein S6","5256","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5256"
"RPS6KA1","10430","ribosomal protein S6 kinase A1","1527","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1527"
"RPS6KA2","10431","ribosomal protein S6 kinase A2","1529","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1529"
"RPS6KA3","10432","ribosomal protein S6 kinase A3","1528","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1528"
"RPS6KA4","10433","ribosomal protein S6 kinase A4","1524","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1524"
"RPS6KA5","10434","ribosomal protein S6 kinase A5","1523","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1523"
"RPS6KA6","10435","ribosomal protein S6 kinase A6","1530","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1530"
"RPS6KB1","10436","ribosomal protein S6 kinase B1","1525","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1525"
"RPS6KB2","10437","ribosomal protein S6 kinase B2","1526","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1526"
"RPS6KC1","10439","ribosomal protein S6 kinase C1","1532","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1532"
"RPS6KL1","20222","ribosomal protein S6 kinase like 1","1533","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1533"
"RRM1","10451","ribonucleotide reductase catalytic subunit M1","2630","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2630"
"RRM2","10452","ribonucleotide reductase regulatory subunit M2","2631","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2631"
"RRM2B","17296","ribonucleotide reductase regulatory TP53 inducible subunit M2B","2754","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2754"
"RSKR","26314","SGK494","1531","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1531"
"RSPO1","21679","R-spondin-1","3697","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3697"
"RSPO2","28583","R-spondin-2","3698","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3698"
"RSPO3","20866","R-spondin-3","3699","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3699"
"RSPO4","16175","R-spondin-4","3700","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3700"
"RTN4","14085","reticulon 4","2838","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2838"
"RXFP1","19718","RXFP1","351","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=351"
"RXFP2","17318","RXFP2","352","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=352"
"RXFP3","24883","RXFP3","353","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=353"
"RXFP4","14666","RXFP4","354","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=354"
"RXRA","10477","Retinoid X receptor-&alpha;","610","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=610"
"RXRB","10478","Retinoid X receptor-&beta;","611","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=611"
"RXRG","10479","Retinoid X receptor-&gamma;","612","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=612"
"RYK","10481","receptor like tyrosine kinase","1849","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1849"
"RYR1","10483","RyR1","747","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=747"
"RYR2","10484","RyR2","748","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=748"
"RYR3","10485","RyR3","749","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=749"
"S100A11","10488","S100 calcium binding protein A11","3083","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3083"
"S1PR1","3165","S1P<sub>1</sub> receptor","275","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=275"
"S1PR2","3169","S1P<sub>2</sub> receptor","276","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=276"
"S1PR3","3167","S1P<sub>3</sub> receptor","277","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=277"
"S1PR4","3170","S1P<sub>4</sub> receptor","278","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=278"
"S1PR5","14299","S1P<sub>5</sub> receptor","279","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=279"
"SAA1","10513","serum amyloid A","6242","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6242"
"SAMD8","26320","sterile alpha motif domain containing 8","2525","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2525"
"SBK1","17699","SH3 domain binding kinase 1","2193","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2193"
"SBK2","34416","SH3 domain binding kinase family member 2","2194","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2194"
"SBK3","44121","sugen kinase 110","2290","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2290"
"SCN10A","10582","Na<sub>v</sub>1.8","585","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=585"
"SCN11A","10583","Na<sub>v</sub>1.9","586","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=586"
"SCN1A","10585","Na<sub>v</sub>1.1","578","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=578"
"SCN2A","10588","Na<sub>v</sub>1.2","579","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=579"
"SCN3A","10590","Na<sub>v</sub>1.3","580","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=580"
"SCN4A","10591","Na<sub>v</sub>1.4","581","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=581"
"SCN5A","10593","Na<sub>v</sub>1.5","582","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=582"
"SCN8A","10596","Na<sub>v</sub>1.6","583","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=583"
"SCN9A","10597","Na<sub>v</sub>1.7","584","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=584"
"SCNN1A","10599","ENaC &alpha;","738","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=738"
"SCNN1B","10600","ENaC &beta;","739","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=739"
"SCNN1D","10601","ENaC &delta;","740","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=740"
"SCNN1G","10602","ENaC &gamma;","741","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=741"
"SCPEP1","29507","Serine carboxypeptidase 1","1585","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1585"
"SCT","10607","secretin","3643","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3643"
"SCTR","10608","secretin receptor","252","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=252"
"SCYL1","14372","SCY1 like pseudokinase 1","2195","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2195"
"SCYL2","19286","SCY1 like pseudokinase 2","2196","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2196"
"SELE","10718","selectin E (CD62E)","3200","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3200"
"SELP","10721","selectin P (CD62)","3103","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3103"
"SELPLG","10722","selectin P ligand","10014","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10014"
"SEMA3A","10723","semaphorin 3A","9902","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9902"
"SEMA4D","10732","semaphorin 4D (CD100)","2883","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2883"
"SENP1","17927","SUMO specific peptidase 1","2414","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2414"
"SENP6","20944","SUMO specific peptidase 6","2415","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2415"
"SENP7","30402","SUMO specific peptidase 7","2416","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2416"
"SENP8","22992","SUMO peptidase family member, NEDD8 specific","2417","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2417"
"SERPINC1","775","serpin family C member 1","2632","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2632"
"SETD1A","29010","SET domain containing 1A, histone lysine methyltransferase","2700","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2700"
"SETD1B","29187","SET domain containing 1B, histone lysine methyltransferase","2701","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2701"
"SETD2","18420","SET domain containing 2, histone lysine methyltransferase","2702","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2702"
"SETD7","30412","SET domain containing 7, histone lysine methyltransferase","2703","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2703"
"SETDB1","10761","SET domain bifurcated histone lysine methyltransferase 1","2705","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2705"
"SETDB2","20263","SET domain bifurcated histone lysine methyltransferase 2","2706","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2706"
"SFRP1","10776","sFRP-1","3691","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3691"
"SFRP2","10777","sFRP-2","3692","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3692"
"SFRP4","10778","sFRP-4","3694","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3694"
"SFRP5","10779","sFRP-5","3695","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3695"
"SFXN1","16085","sideroflexin 1","3028","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3028"
"SFXN2","16086","sideroflexin 2","3029","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3029"
"SFXN3","16087","sideroflexin 3","3030","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3030"
"SFXN5","16073","sideroflexin 5","3032","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3032"
"SGK1","10810","serum/glucocorticoid regulated kinase 1","1534","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1534"
"SGK2","13900","serum/glucocorticoid regulated kinase 2","1535","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1535"
"SGK3","10812","serum/glucocorticoid regulated kinase family member 3","1536","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1536"
"SGMS1","29799","sphingomyelin synthase 1","2520","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2520"
"SGMS2","28395","sphingomyelin synthase 2","2521","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2521"
"SGPL1","10817","sphingosine-1-phosphate lyase 1","2522","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2522"
"SGPP1","17720","sphingosine-1-phosphate phosphatase 1","2523","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2523"
"SGPP2","19953","sphingosine-1-phosphate phosphatase 2","2524","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2524"
"SIGIRR","30575","single Ig and TIR domain containing","2969","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2969"
"SIGLEC10","15620","sialic acid binding Ig like lectin 10","3169","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3169"
"SIGLEC15","27596","sialic acid binding Ig like lectin 15","3265","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3265"
"SIGLEC8","10877","sialic acid binding Ig like lectin 8","3012","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3012"
"SIGMAR1","8157","sigma non-opioid intracellular receptor 1","2552","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2552"
"SIK1","11142","salt inducible kinase 1","2197","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2197"
"SIK2","21680","salt inducible kinase 2","2198","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2198"
"SIK3","29165","SIK family kinase 3","2199","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2199"
"SIRPA","9662","SIRPA (CD172a)","2942","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2942"
"SIRT1","14929","sirtuin 1","2707","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2707"
"SIRT2","10886","sirtuin 2","2708","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2708"
"SIRT3","14931","sirtuin 3","2709","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2709"
"SIRT4","14932","sirtuin 4","2710","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2710"
"SIRT5","14933","sirtuin 5","2711","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2711"
"SIRT6","14934","sirtuin 6","2712","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2712"
"SIRT7","14935","sirtuin 7","2713","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2713"
"SKP2","10901","S-phase kinase associated protein 2","3235","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3235"
"SLAMF7","21394","CS1 (CD319)","2850","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2850"
"SLC10A1","10905","Sodium/bile acid and sulphated solute cotransporter 1","959","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=959"
"SLC10A2","10906","Sodium/bile acid and sulphated solute cotransporter 2","960","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=960"
"SLC10A3","22979","Sodium/bile acid and sulphated solute cotransporter 3","962","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=962"
"SLC10A4","22980","Sodium/bile acid and sulphated solute cotransporter 4","963","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=963"
"SLC10A5","22981","Sodium/bile acid and sulphated solute cotransporter 5","964","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=964"
"SLC10A6","30603","Sodium/bile acid and sulphated solute cotransporter 6","961","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=961"
"SLC10A7","23088","Sodium/bile acid and sulphated solute cotransporter 7","965","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=965"
"SLC11A1","10907","NRAMP1","966","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=966"
"SLC11A2","10908","DMT1","967","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=967"
"SLC12A1","10910","Kidney-specific Na-K-Cl symporter","968","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=968"
"SLC12A2","10911","Basolateral Na-K-Cl symporter","969","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=969"
"SLC12A3","10912","Na-Cl symporter","970","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=970"
"SLC12A4","10913","K-Cl cotransporter 1","971","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=971"
"SLC12A5","13818","K-Cl cotransporter 2","972","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=972"
"SLC12A6","10914","K-Cl cotransporter 3","973","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=973"
"SLC12A7","10915","K-Cl cotransporter 4","974","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=974"
"SLC12A8","15595","Cation-chloride cotransporter 9","975","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=975"
"SLC12A9","17435","Cation-chloride cotransporter 6","976","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=976"
"SLC13A1","10916","Na<sup>+</sup>/sulfate cotransporter","977","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=977"
"SLC13A2","10917","Na<sup>+</sup>/dicarboxylate cotransporter 1","978","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=978"
"SLC13A3","14430","Na<sup>+</sup>/dicarboxylate cotransporter 3","979","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=979"
"SLC13A4","15827","Na<sup>+</sup>/sulfate cotransporter","980","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=980"
"SLC13A5","23089","Na<sup>+</sup>/citrate cotransporter","981","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=981"
"SLC14A1","10918","Erythrocyte urea transporter","982","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=982"
"SLC14A2","10919","Kidney urea transporter","983","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=983"
"SLC15A1","10920","Peptide transporter 1","984","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=984"
"SLC15A2","10921","Peptide transporter 2","985","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=985"
"SLC15A3","18068","Peptide transporter 3","986","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=986"
"SLC15A4","23090","Peptide transporter 4","987","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=987"
"SLC16A1","10922","Monocarboxylate transporter 1","988","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=988"
"SLC16A10","17027","Monocarboxylate transporter 10","993","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=993"
"SLC16A11","23093","Monocarboxylate transporter 11","998","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=998"
"SLC16A12","23094","Monocarboxylate transporter 12","999","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=999"
"SLC16A13","31037","Monocarboxylate transporter 13","1000","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1000"
"SLC16A14","26417","Monocarboxylate transporter 14","1001","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1001"
"SLC16A2","10923","Monocarboxylate transporter 8","992","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=992"
"SLC16A3","10924","Monocarboxylate transporter 4","989","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=989"
"SLC16A4","10925","Monocarboxylate transporter 5","994","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=994"
"SLC16A5","10926","Monocarboxylate transporter 6","995","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=995"
"SLC16A6","10927","Monocarboxylate transporter 7","996","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=996"
"SLC16A7","10928","Monocarboxylate transporter 2","990","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=990"
"SLC16A8","16270","Monocarboxylate transporter 3","991","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=991"
"SLC16A9","23520","Monocarboxylate transporter 9","997","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=997"
"SLC17A1","10929","Sodium/phosphate cotransporter 1","1002","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1002"
"SLC17A2","10930","Sodium/phosphate cotransporter 3","1003","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1003"
"SLC17A3","10931","Sodium/phosphate cotransporter 4","1004","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1004"
"SLC17A4","10932","Sodium/phosphate cotransporter homolog","1005","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1005"
"SLC17A5","10933","Sialin","1006","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1006"
"SLC17A6","16703","Vesicular glutamate transporter 2","1008","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1008"
"SLC17A7","16704","Vesicular glutamate transporter 1","1007","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1007"
"SLC17A8","20151","Vesicular glutamate transporter 3","1009","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1009"
"SLC17A9","16192","Vesicular nucleotide transporter","1010","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1010"
"SLC18A1","10934","Vesicular monoamine transporter 1","1011","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1011"
"SLC18A2","10935","Vesicular monoamine transporter 2","1012","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1012"
"SLC18A3","10936","Vesicular acetylcholine transporter","1013","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1013"
"SLC18B1","21573","Vesicular polyamine transporter","2556","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2556"
"SLC19A1","10937","Reduced folate transporter 1","1014","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1014"
"SLC19A2","10938","Thiamine transporter 1","1015","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1015"
"SLC19A3","16266","Thiamine transporter 2","1016","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1016"
"SLC1A1","10939","Excitatory amino acid transporter 3","870","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=870"
"SLC1A2","10940","Excitatory amino acid transporter 2","869","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=869"
"SLC1A3","10941","Excitatory amino acid transporter 1","868","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=868"
"SLC1A4","10942","Alanine/serine/cysteine transporter 1","873","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=873"
"SLC1A5","10943","Alanine/serine/cysteine transporter 2","874","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=874"
"SLC1A6","10944","Excitatory amino acid transporter 4","871","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=871"
"SLC1A7","10945","Excitatory amino acid transporter 5","872","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=872"
"SLC20A1","10946","Sodium-dependent phosphate transporter 1","1017","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1017"
"SLC20A2","10947","Sodium-dependent phosphate transporter 2","1018","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1018"
"SLC22A1","10963","Organic cation transporter 1","1019","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1019"
"SLC22A10","18057","Organic anion transporter 5","1029","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1029"
"SLC22A11","18120","Organic anion transporter 4","1030","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1030"
"SLC22A12","17989","Urate anion exchanger 1","1031","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1031"
"SLC22A13","8494","Organic anion transporter 10","1032","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1032"
"SLC22A14","8495","Organic cation transporter-like 2","1033","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1033"
"SLC22A15","20301","Fly-like putative transporter 1","1034","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1034"
"SLC22A16","20302","Carnitine transporter 2","1024","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1024"
"SLC22A17","23095","Brain-type organic cation transporter","1035","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1035"
"SLC22A18","10964","Organic cation transporter-like 2","1036","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1036"
"SLC22A2","10966","Organic cation transporter 2","1020","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1020"
"SLC22A20P","29867","OAT6","1037","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1037"
"SLC22A23","21106","SLC22A23","1038","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1038"
"SLC22A24","28542","SLC22A24","1039","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1039"
"SLC22A25","32935","UST6","1040","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1040"
"SLC22A3","10967","Organic cation transporter 3","1021","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1021"
"SLC22A31","27091","solute carrier family 22 member 31","2557","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2557"
"SLC22A4","10968","Organic cation/carnitine transporter 1","1022","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1022"
"SLC22A5","10969","Organic cation/carnitine transporter 2","1023","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1023"
"SLC22A6","10970","Organic anion transporter 1","1025","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1025"
"SLC22A7","10971","Organic anion transporter 2","1026","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1026"
"SLC22A8","10972","Organic anion transporter 3","1027","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1027"
"SLC22A9","16261","Organic anion transporter 7","1028","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1028"
"SLC23A1","10974","Sodium-dependent vitamin C transporter 1","1041","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1041"
"SLC23A2","10973","Sodium-dependent vitamin C transporter 2","1042","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1042"
"SLC23A3","20601","Sodium-dependent vitamin C transporter 3","1043","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1043"
"SLC23A4P","20602","Sodium-dependent nucleobase transporter","1044","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1044"
"SLC24A1","10975","Sodium/potassium/calcium exchanger 1","1045","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1045"
"SLC24A2","10976","Sodium/potassium/calcium exchanger 2","1046","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1046"
"SLC24A3","10977","Sodium/potassium/calcium exchanger 3","1047","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1047"
"SLC24A4","10978","Sodium/potassium/calcium exchanger 4","1048","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1048"
"SLC24A5","20611","Sodium/potassium/calcium exchanger 5","1049","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1049"
"SLC25A1","10979","Mitochondrial citrate transporter","1051","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1051"
"SLC25A10","10980","Mitochondrial dicarboxylate transporter","1052","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1052"
"SLC25A11","10981","Mitochondrial oxoglutarate carrier","1053","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1053"
"SLC25A12","10982","AGC1","1054","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1054"
"SLC25A13","10983","AGC2","1055","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1055"
"SLC25A14","10984","Uncoupling protein 5","1070","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1070"
"SLC25A15","10985","Mitochondrial ornithine transporter 1 ","1060","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1060"
"SLC25A16","10986","Graves disease carrier","1071","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1071"
"SLC25A17","10987","Peroxisomal membrane protein","1072","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1072"
"SLC25A18","10988","Mitochondrial glutamate carrier 2","1056","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1056"
"SLC25A19","14409","Deoxynucleotide carrier 1","1073","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1073"
"SLC25A2","22921","Mitochondrial ornithine transporter 2","1059","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1059"
"SLC25A20","1421","Carnitine/acylcarnitine carrier","1076","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1076"
"SLC25A21","14411","Mitochondrial oxodicarboxylate carrier","1057","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1057"
"SLC25A22","19954","Mitochondrial glutamate carrier 1","1058","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1058"
"SLC25A23","19375","Mitochondrial phosphate carrier 2","1078","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1078"
"SLC25A24","20662","Mitochondrial phosphate carrier 1","1077","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1077"
"SLC25A25","20663","Mitochondrial phosphate carrier 3","1079","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1079"
"SLC25A26","20661","S-Adenosylmethionine carrier","1074","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1074"
"SLC25A27","21065","Uncoupling protein 4","1069","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1069"
"SLC25A28","23472","Mitoferrin2","1080","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1080"
"SLC25A29","20116","ORNT3","1081","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1081"
"SLC25A3","10989","Mitochondrial phosphate carrier","1061","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1061"
"SLC25A30","27371","KMCP1","1082","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1082"
"SLC25A31","25319","Mitochondrial adenine nucleotide translocator 4","1065","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1065"
"SLC25A32","29683","MFT","1083","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1083"
"SLC25A33","29681","PNC1","1084","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1084"
"SLC25A34","27653","SLC25A34","1085","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1085"
"SLC25A35","31921","SLC25A35","1086","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1086"
"SLC25A36","25554","SLC25A36","1087","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1087"
"SLC25A37","29786","Mitoferrin1","1088","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1088"
"SLC25A38","26054","SLC25A38","1089","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1089"
"SLC25A39","24279","CGI-69","1090","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1090"
"SLC25A4","10990","Mitochondrial adenine nucleotide translocator 1","1062","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1062"
"SLC25A40","29680","MCFP","1091","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1091"
"SLC25A41","28533","SCaMC-3L","1092","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1092"
"SLC25A42","28380","SLC25A42","1075","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1075"
"SLC25A43","30557","SLC25A43","1093","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1093"
"SLC25A44","29036","SLC25A44","1094","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1094"
"SLC25A45","27442","SLC25A45","1095","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1095"
"SLC25A46","25198","SLC25A46","1096","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1096"
"SLC25A47","20115","solute carrier family 25 member 47","2558","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2558"
"SLC25A48","30451","solute carrier family 25 member 48","2559","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2559"
"SLC25A5","10991","Mitochondrial adenine nucleotide translocator 2","1063","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1063"
"SLC25A51","23323","solute carrier family 25 member 51","2560","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2560"
"SLC25A52","23324","solute carrier family 25 member 52","2561","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2561"
"SLC25A53","31894","solute carrier family 25 member 53","2562","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2562"
"SLC25A6","10992","Mitochondrial adenine nucleotide translocator 3","1064","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1064"
"SLC26A1","10993","Sat-1","1097","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1097"
"SLC26A10P","14470","SLC26A10","1106","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1106"
"SLC26A11","14471","KBAT","1107","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1107"
"SLC26A2","10994","DTDST","1098","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1098"
"SLC26A3","3018","DRA","1099","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1099"
"SLC26A4","8818","Pendrin","1100","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1100"
"SLC26A5","9359","Prestin","1104","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1104"
"SLC26A6","14472","PAT-1","1101","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1101"
"SLC26A7","14467","SLC26A7","1102","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1102"
"SLC26A8","14468","Tat1","1105","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1105"
"SLC26A9","14469","SLC26A9","1103","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1103"
"SLC27A1","10995","Fatty acid transport protein 1","1108","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1108"
"SLC27A2","10996","Fatty acid transport protein 2","1109","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1109"
"SLC27A3","10997","Fatty acid transport protein 3","1110","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1110"
"SLC27A4","10998","Fatty acid transport protein 4","1111","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1111"
"SLC27A5","10999","Fatty acid transport protein 5","1112","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1112"
"SLC27A6","11000","Fatty acid transport protein 6","1113","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1113"
"SLC28A1","11001","Sodium/nucleoside cotransporter 1","1114","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1114"
"SLC28A2","11002","Sodium/nucleoside cotransporter 2","1115","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1115"
"SLC28A3","16484","Solute carrier family 28 member 3","1116","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1116"
"SLC29A1","11003","Equilibrative nucleoside transporter 1","1117","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1117"
"SLC29A2","11004","Equilibrative nucleoside transporter 2","1118","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1118"
"SLC29A3","23096","Equilibrative nucleoside transporter 3","1119","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1119"
"SLC29A4","23097","Plasma membrane monoamine transporter","1120","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1120"
"SLC2A1","11005","Glucose transporter  1","875","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=875"
"SLC2A10","13444","Glucose transporter  10","886","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=886"
"SLC2A11","14239","Glucose transporter  11","883","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=883"
"SLC2A12","18067","Glucose transporter  12","887","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=887"
"SLC2A13","15956","Proton <i>myo</i>-inositol cotransporter","888","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=888"
"SLC2A14","18301","Glucose transporter  14","879","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=879"
"SLC2A2","11006","Glucose transporter  2","876","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=876"
"SLC2A3","11007","Glucose transporter  3","877","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=877"
"SLC2A4","11009","Glucose transporter  4","878","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=878"
"SLC2A5","11010","Glucose transporter  5","880","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=880"
"SLC2A6","11011","Glucose transporter  6","884","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=884"
"SLC2A7","13445","Glucose transporter  7","881","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=881"
"SLC2A8","13812","Glucose transporter  8","885","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=885"
"SLC2A9","13446","Glucose transporter  9","882","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=882"
"SLC30A1","11012","Zinc transporter 1","1121","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1121"
"SLC30A10","25355","Zinc transporter 10","1130","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1130"
"SLC30A2","11013","Zinc transporter 2","1122","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1122"
"SLC30A3","11014","Zinc transporter 3","1123","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1123"
"SLC30A4","11015","Zinc transporter 4","1124","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1124"
"SLC30A5","19089","Zinc transporter 5","1125","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1125"
"SLC30A6","19305","Zinc transporter 6","1126","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1126"
"SLC30A7","19306","Zinc transporter 7","1127","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1127"
"SLC30A8","20303","Zinc transporter 8","1128","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1128"
"SLC30A9","1329","Zinc transporter 9","1129","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1129"
"SLC31A1","11016","Copper transporter 1","1131","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1131"
"SLC31A2","11017","Copper transporter 2","1132","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1132"
"SLC32A1","11018","Vesicular inhibitory amino acid transporter","1133","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1133"
"SLC33A1","95","AcetylCoA transporter","1134","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1134"
"SLC34A1","11019","Sodium phosphate 1","1135","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1135"
"SLC34A2","11020","Sodium phosphate 2","1136","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1136"
"SLC34A3","20305","Sodium phosphate 3","1137","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1137"
"SLC35A1","11021","CMP-sialic acid transporter","1138","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1138"
"SLC35A2","11022","UDP-galactose transporter","1139","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1139"
"SLC35A3","11023","UDP-N-acetylglucosamine transporter","1140","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1140"
"SLC35A4","20753","MGC2541","1141","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1141"
"SLC35A5","20792","FLJ11130","1142","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1142"
"SLC35B1","20798","UGTREL1","1143","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1143"
"SLC35B2","16872","PAPS transporter 1","1144","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1144"
"SLC35B3","21601","PAPS transporter 2","1145","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1145"
"SLC35B4","20584","YEA","1146","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1146"
"SLC35C1","20197","GDP-Fucose transporter","1147","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1147"
"SLC35C2","17117","OVCOV1","1148","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1148"
"SLC35D1","20800","UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter","1149","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1149"
"SLC35D2","20799","HFRC1","1150","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1150"
"SLC35D3","15621","Fringe connection-like protein 1","1151","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1151"
"SLC35E1","20803","solute carrier family 35 member E1","1152","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1152"
"SLC35E2A","20863","solute carrier family 35 member E2A","1153","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1153"
"SLC35E2B","33941","solute carrier family 35 member E2B","2563","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2563"
"SLC35E3","20864","solute carrier family 35 member E3","1154","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1154"
"SLC35E4","17058","solute carrier family 35 member E4","1155","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1155"
"SLC35F1","21483","solute carrier family 35 member F1","1156","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1156"
"SLC35F2","23615","solute carrier family 35 member F2","1157","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1157"
"SLC35F3","23616","solute carrier family 35 member F3","1158","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1158"
"SLC35F4","19845","solute carrier family 35 member F4","1159","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1159"
"SLC35F5","23617","solute carrier family 35 member F5","1160","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1160"
"SLC35F6","26055","solute carrier family 35 member F6","2564","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2564"
"SLC35G1","26607","solute carrier family 35 member G1","2565","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2565"
"SLC35G2","28480","solute carrier family 35 member G2","2566","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2566"
"SLC35G3","26848","solute carrier family 35 member G3","2567","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2567"
"SLC35G4","31043","solute carrier family 35 member G4","2568","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2568"
"SLC35G5","15546","solute carrier family 35 member G5","2569","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2569"
"SLC35G6","31351","solute carrier family 35 member G6","2570","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2570"
"SLC36A1","18761","Proton-coupled Amino acid Transporter 1","1161","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1161"
"SLC36A2","18762","Proton-coupled Amino acid Transporter 2","1162","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1162"
"SLC36A3","19659","Proton-coupled Amino acid Transporter 3","1163","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1163"
"SLC36A4","19660","Proton-coupled Amino acid Transporter 4","1164","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1164"
"SLC37A1","11024","Glycerol-3-phosphate transporter","1165","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1165"
"SLC37A2","20644","Sugar phosphate exchanger 2","1166","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1166"
"SLC37A3","20651","Sugar phosphate exchanger 3","1167","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1167"
"SLC37A4","4061","Glucose-6-phosphate transporter","1168","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1168"
"SLC38A1","13447","sodium-coupled neutral amino acid transporter 1","1169","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1169"
"SLC38A10","28237","Putative sodium-coupled neutral amino acid transporter 10","1178","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1178"
"SLC38A11","26836","Putative sodium-coupled neutral amino acid transporter 11","1179","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1179"
"SLC38A2","13448","sodium-coupled neutral amino acid transporter 2","1170","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1170"
"SLC38A3","18044","Sodium-coupled neutral amino acid transporter 3","1172","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1172"
"SLC38A4","14679","sodium-coupled neutral amino acid transporter 4","1171","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1171"
"SLC38A5","18070","Sodium-coupled neutral amino acid transporter 5","1173","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1173"
"SLC38A6","19863","Probable sodium-coupled neutral amino acid transporter 6","1174","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1174"
"SLC38A7","25582","Putative sodium-coupled neutral amino acid transporter 7","1175","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1175"
"SLC38A8","32434","Putative sodium-coupled neutral amino acid transporter 8","1176","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1176"
"SLC38A9","26907","Putative sodium-coupled neutral amino acid transporter 9","1177","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1177"
"SLC39A1","12876","Zinc transporter 1","1180","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1180"
"SLC39A10","20861","Zinc transporter 10","1189","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1189"
"SLC39A11","14463","Zinc transporter 11","1190","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1190"
"SLC39A12","20860","Zinc transporter 12","1191","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1191"
"SLC39A13","20859","Zinc transporter 13","1192","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1192"
"SLC39A14","20858","Zinc transporter 14","1193","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1193"
"SLC39A2","17127","Zinc transporter 2","1181","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1181"
"SLC39A3","17128","Zinc transporter 3","1182","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1182"
"SLC39A4","17129","Zinc transporter 4","1183","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1183"
"SLC39A5","20502","Zinc transporter 5","1184","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1184"
"SLC39A6","18607","Zinc transporter 6","1185","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1185"
"SLC39A7","4927","Zinc transporter 7","1186","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1186"
"SLC39A8","20862","Zinc transporter 8","1187","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1187"
"SLC39A9","20182","Zinc transporter 9","1188","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1188"
"SLC3A1","11025","rBAT","889","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=889"
"SLC3A2","11026","4F2hc","890","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=890"
"SLC40A1","10909","Ferroportin","1194","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1194"
"SLC41A1","19429","Solute carrier family 41 member 1","1195","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1195"
"SLC41A2","31045","Solute carrier family 41 member 2","1196","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1196"
"SLC41A3","31046","Solute carrier family 41 member 3","1197","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1197"
"SLC43A1","9225","L-type amino acid transporter 3","1201","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1201"
"SLC43A2","23087","L-type amino acid transporter 4","1202","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1202"
"SLC43A3","17466","Solute carrier family 43 member 3","1203","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1203"
"SLC44A1","18798","Choline transporter-like 1","1204","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1204"
"SLC44A2","17292","Choline transporter-like 2","1205","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1205"
"SLC44A3","28689","Choline transporter-like 3","1206","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1206"
"SLC44A4","13941","Choline transporter-like 4","1207","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1207"
"SLC44A5","28524","Choline transporter-like 5","1208","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1208"
"SLC45A1","17939","Proton-associated sugar transporter A","1209","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1209"
"SLC45A2","16472","Membrane-associated transporter protein","1210","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1210"
"SLC45A3","8642","Solute carrier family 45 member 3","1211","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1211"
"SLC45A4","29196","Solute carrier family 45 member 4","1212","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1212"
"SLC46A1","30521","Proton-coupled folate transporter","1213","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1213"
"SLC46A2","16055","Thymic stromal co-transporter","1214","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1214"
"SLC46A3","27501","SLC46A3","1215","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1215"
"SLC47A1","25588","Multidrug and toxin extrusion","1216","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1216"
"SLC47A2","26439","MATE2","1217","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1217"
"SLC48A1","26035","Heme transporter","1218","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1218"
"SLC49A3","26177","Major facilitator superfamily domain containing 7","1912","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1912"
"SLC49A4","16628","Disrupted in renal carcinoma 2","1913","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1913"
"SLC4A1","11027","Anion exchange protein 1","904","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=904"
"SLC4A10","13811","Electroneutral sodium bicarbonate cotransporter 2","911","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=911"
"SLC4A11","16438","NaBC1","913","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=913"
"SLC4A2","11028","Anion exchange protein 2","905","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=905"
"SLC4A3","11029","Anion exchange protein 3","906","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=906"
"SLC4A4","11030","Electrogenic sodium bicarbonate cotransporter 1","908","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=908"
"SLC4A5","18168","Electrogenic sodium bicarbonate cotransporter 4","909","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=909"
"SLC4A7","11033","Electroneutral sodium bicarbonate cotransporter 1","910","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=910"
"SLC4A8","11034","NBCBE","912","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=912"
"SLC4A9","11035","Anion exchange protein 4","907","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=907"
"SLC50A1","30657","SLC50 sugar exporter","1914","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1914"
"SLC51A","29955","Organic solute transporter subunit &alpha;","1915","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1915"
"SLC51B","29956","Organic solute transporter subunit &beta;","1916","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1916"
"SLC52A1","30225","solute carrier family 52 member 1","2571","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2571"
"SLC52A2","30224","solute carrier family 52 member 2","2572","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2572"
"SLC52A3","16187","solute carrier family 52 member 3","2573","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2573"
"SLC5A1","11036","Sodium/glucose cotransporter 1","915","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=915"
"SLC5A10","23155","Sodium/glucose cotransporter 5","919","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=919"
"SLC5A11","23091","SGLT6","925","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=925"
"SLC5A12","28750","SMCT2","923","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=923"
"SLC5A2","11037","Sodium/glucose cotransporter 2","916","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916"
"SLC5A3","11038","SMIT","924","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=924"
"SLC5A4","11039","Low affinity sodium-glucose cotransporter","917","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=917"
"SLC5A5","11040","NIS","920","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=920"
"SLC5A6","11041","SMVT","921","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=921"
"SLC5A7","14025","CHT","914","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=914"
"SLC5A8","19119","SMCT1","922","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=922"
"SLC5A9","22146","Sodium/glucose cotransporter 4","918","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=918"
"SLC66A1","26001","solute carrier family 66 member 1","3160","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3160"
"SLC66A2","26188","solute carrier family 66 member 2","3161","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3161"
"SLC66A3","28503","solute carrier family 66 member 3","3162","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3162"
"SLC6A1","11042","GAT1","929","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=929"
"SLC6A11","11044","GAT3","931","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=931"
"SLC6A12","11045","BGT1","932","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=932"
"SLC6A13","11046","GAT2","930","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=930"
"SLC6A14","11047","ATB<sup>0,+</sup>","937","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=937"
"SLC6A15","13621","B<sup>0</sup>AT2","940","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=940"
"SLC6A16","13622","NTT5","942","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=942"
"SLC6A17","31399","NTT4","943","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=943"
"SLC6A18","26441","B<sup>0</sup>AT3","941","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=941"
"SLC6A19","27960","B<sup>0</sup>AT1","939","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=939"
"SLC6A2","11048","NET","926","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=926"
"SLC6A20","30927","SIT1","944","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=944"
"SLC6A3","11049","DAT","927","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=927"
"SLC6A4","11050","SERT","928","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=928"
"SLC6A5","11051","GlyT2","936","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=936"
"SLC6A6","11052","TauT","933","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=933"
"SLC6A7","11054","PROT","938","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=938"
"SLC6A8","11055","CT1","934","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=934"
"SLC6A9","11056","GlyT1","935","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=935"
"SLC7A1","11057","High affinity cationic amino acid transporter 1","891","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=891"
"SLC7A10","11058","Asc-type amino acid transporter 1","901","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=901"
"SLC7A11","11059","Cystine/glutamate transporter","902","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=902"
"SLC7A13","23092","AGT1","903","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=903"
"SLC7A14","29326","Probable cationic amino acid transporter","895","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=895"
"SLC7A2","11060","Low affinity cationic amino acid transporter 2","892","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=892"
"SLC7A3","11061","Cationic amino acid transporter 3","893","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=893"
"SLC7A4","11062","Cationic amino acid transporter 4","894","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=894"
"SLC7A5","11063","L-type amino acid transporter 1","896","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=896"
"SLC7A6","11064","y+L amino acid transporter 2","899","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=899"
"SLC7A7","11065","y+L amino acid transporter 1","898","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=898"
"SLC7A8","11066","L-type amino acid transporter 2","897","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=897"
"SLC7A9","11067","b<sup>0,+</sup>-type amino acid transporter 1","900","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=900"
"SLC8A1","11068","Sodium/calcium exchanger 1","945","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=945"
"SLC8A2","11069","Sodium/calcium exchanger 2","946","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=946"
"SLC8A3","11070","Sodium/calcium exchanger 3","947","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=947"
"SLC8B1","26175","Sodium/potassium/calcium exchanger 6","1050","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1050"
"SLC9A1","11071","Sodium/hydrogen exchanger 1","948","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=948"
"SLC9A2","11072","Sodium/hydrogen exchanger 2","949","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=949"
"SLC9A3","11073","Sodium/hydrogen exchanger 3","950","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=950"
"SLC9A4","11077","Sodium/hydrogen exchanger 4","951","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=951"
"SLC9A5","11078","Sodium/hydrogen exchanger 5","952","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=952"
"SLC9A6","11079","Sodium/hydrogen exchanger 6","953","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=953"
"SLC9A7","17123","Sodium/hydrogen exchanger 7","954","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=954"
"SLC9A8","20728","Sodium/hydrogen exchanger 8","955","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=955"
"SLC9A9","20653","Sodium/hydrogen exchanger 9","956","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=956"
"SLC9B1","24244","solute carrier family 9 member B1","2574","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2574"
"SLC9B2","25143","solute carrier family 9 member B2","2575","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2575"
"SLC9C1","31401","Sodium/hydrogen exchanger 10","957","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=957"
"SLC9C2","28664","Sodium/hydrogen exchanger 11","958","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=958"
"SLCO1A2","10956","OATP1A2","1219","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1219"
"SLCO1B1","10959","OATP1B1","1220","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1220"
"SLCO1B3","10961","OATP1B3","1221","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1221"
"SLCO1C1","13819","OATP1C1","1222","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1222"
"SLCO2A1","10955","OATP2A1","1223","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1223"
"SLCO2B1","10962","OATP2B1","1224","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1224"
"SLCO3A1","10952","OATP3A1","1225","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1225"
"SLCO4A1","10953","OATP4A1","1226","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1226"
"SLCO4C1","23612","OATP4C1","1227","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1227"
"SLCO5A1","19046","OATP5A1","1228","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1228"
"SLCO6A1","23613","OATP6A1","1229","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1229"
"SLK","11088","STE20 like kinase","2200","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2200"
"SMARCA2","11098","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2","2739","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2739"
"SMARCA4","11100","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4","2740","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2740"
"SMG1","30045","SMG1 nonsense mediated mRNA decay associated PI3K related kinase","2201","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2201"
"SMO","11119","SMO","239","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=239"
"SMPD1","11120","sphingomyelin phosphodiesterase 1","2514","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2514"
"SMPD2","11121","sphingomyelin phosphodiesterase 2","2515","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2515"
"SMPD3","14240","sphingomyelin phosphodiesterase 3","2516","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2516"
"SMPD4","32949","sphingomyelin phosphodiesterase 4","2517","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2517"
"SMPDL3A","17389","sphingomyelin phosphodiesterase acid-like 3A","2518","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2518"
"SMPDL3B","21416","sphingomyelin phosphodiesterase acid-like 3B","2519","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2519"
"SMYD2","20982","SET and MYND domain containing 2","2714","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2714"
"SNCA","11138","synuclein alpha","3285","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3285"
"SNCB","11140","synuclein beta","3286","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3286"
"SNCG","11141","synuclein gamma","3287","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3287"
"SNRK","30598","SNF related kinase","2202","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2202"
"SOS1","11187","SOS Ras/Rac guanine nucleotide exchange factor 1","3096","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3096"
"SOST","13771","sclerostin","3704","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3704"
"SP100","11206","SP100 nuclear antigen","2777","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2777"
"SP110","5401","SP110 nuclear body protein","2778","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2778"
"SP140","17133","SP140 nuclear body protein","2779","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2779"
"SP140L","25105","SP140 nuclear body protein like","2780","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2780"
"SPAG11B","14534","SPAG11B (61-103)","10542","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10542"
"SPEG","16901","striated muscle enriched protein kinase","2203","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2203"
"SPHK1","11240","sphingosine kinase 1","2204","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2204"
"SPHK2","18859","sphingosine kinase 2","2205","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2205"
"SPIN1","11243","spindlin 1","3274","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3274"
"SPINT1","11246","HGF-inhibitor 1","5315","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5315"
"SPNS1","30621","SPNS lysolipid transporter 1, lysophospholipid","3047","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3047"
"SPNS2","26992","SPNS lysolipid transporter 2, sphingosine-1-phosphate","3048","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3048"
"SPNS3","28433","SPNS lysolipid transporter 3, sphingosine-1-phosphate (putative)","3049","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3049"
"SPP1","11255","osteopontin","6753","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6753"
"SPR","11257","sepiapterin reductase","3020","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3020"
"SPTLC1","11277","serine palmitoyltransferase long chain base subunit 1","2509","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2509"
"SPTLC2","11278","serine palmitoyltransferase long chain base subunit 2","2510","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2510"
"SPTLC3","16253","serine palmitoyltransferase long chain base subunit 3","2511","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2511"
"SPTSSA","20361","serine palmitoyltransferase small subunit A","2512","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2512"
"SPTSSB","24045","serine palmitoyltransferase small subunit B","2513","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2513"
"SPX","28139","spexin-1","11417","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11417"
"SQLE","11279","squalene monooxygenase","2433","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2433"
"SQSTM1","11280","sequestosome 1","3213","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3213"
"SRC","11283","SRC proto-oncogene, non-receptor tyrosine kinase","2206","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2206"
"SRD5A2","11285","steroid 5 alpha-reductase 2","2633","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2633"
"SRMS","11298","src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites","2207","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2207"
"SRPK1","11305","SRSF protein kinase 1","2208","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2208"
"SRPK2","11306","SRSF protein kinase 2","2209","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2209"
"SRPK3","11402","SRSF protein kinase 3","2210","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2210"
"SST","11329","SRIF-28","2020","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2020"
"SSTR1","11330","SST<sub>1</sub> receptor","355","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=355"
"SSTR2","11331","SST<sub>2</sub> receptor","356","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=356"
"SSTR3","11332","SST<sub>3</sub> receptor","357","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=357"
"SSTR4","11333","SST<sub>4</sub> receptor","358","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=358"
"SSTR5","11334","SST<sub>5</sub> receptor","359","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=359"
"ST14","11344","ST14 transmembrane serine protease matriptase ","2418","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2418"
"STAB1","18628","stabilin 1","3247","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3247"
"STAT3","11364","signal transducer and activator of transcription 3","2994","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2994"
"STAT5A","11366","signal transducer and activator of transcription 5A","3221","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3221"
"STAT6","11368","signal transducer and activator of transcription 6","2993","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2993"
"STING1","27962","stimulator of interferon response cGAMP interactor 1","2902","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2902"
"STK10","11388","serine/threonine kinase 10","2211","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2211"
"STK11","11389","serine/threonine kinase 11","2212","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2212"
"STK16","11394","serine/threonine kinase 16","2213","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2213"
"STK17A","11395","serine/threonine kinase 17a","2214","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2214"
"STK17B","11396","serine/threonine kinase 17b","2215","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2215"
"STK19","11398","serine/threonine kinase 19","2216","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2216"
"STK24","11403","serine/threonine kinase 24","2217","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2217"
"STK25","11404","serine/threonine kinase 25","2218","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2218"
"STK26","18174","serine/threonine-protein kinase MST4","2287","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2287"
"STK3","11406","serine/threonine kinase 3","2219","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2219"
"STK31","11407","serine/threonine kinase 31","2220","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2220"
"STK32A","28317","serine/threonine kinase 32A","1537","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1537"
"STK32B","14217","serine/threonine kinase 32B","1538","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1538"
"STK32C","21332","serine/threonine kinase 32C","1539","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1539"
"STK33","14568","serine/threonine kinase 33","2221","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2221"
"STK35","16254","serine/threonine kinase 35","2222","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2222"
"STK36","17209","serine/threonine kinase 36","2223","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2223"
"STK38","17847","Serine/threonine kinase 38","1517","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1517"
"STK38L","17848","Serine/threonine kinase 38 like","1518","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1518"
"STK39","17717","serine/threonine kinase 39","2224","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2224"
"STK4","11408","serine/threonine kinase 4","2225","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2225"
"STK40","21373","serine/threonine kinase 40","2226","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2226"
"STKLD1","28669","serine/threonine kinase like domain containing 1","1951","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1951"
"STRADA","30172","STE20 related adaptor alpha","2227","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2227"
"STRADB","13205","STE20 related adaptor beta","2228","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2228"
"STUB1","11427","STIP1 homology and U-box containing protein 1","3202","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3202"
"STYK1","18889","serine/threonine/tyrosine kinase 1","2229","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2229"
"SUCNR1","4542","succinate receptor","166","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=166"
"SUV39H1","11479","SUV39H1 histone lysine methyltransferase","2715","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2715"
"SUV39H2","17287","SUV39H2 histone lysine methyltransferase","2716","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2716"
"SV2A","20566","synaptic vesicle glycoprotein 2A","2634","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2634"
"SVEP1","15985","SVEP1","12044","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12044"
"SYK","11491","spleen associated tyrosine kinase","2230","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2230"
"SYNJ1","11503","SYNJ1","1461","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1461"
"SYNJ2","11504","SYNJ2","1462","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1462"
"TAAR1","17734","TA<sub>1</sub> receptor","364","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364"
"TAAR2","4514","<i>TAAR2</i>","167","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=167"
"TAAR3P","4513","<i>TAAR3</i>","168","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=168"
"TAAR4P","31924","<i>TAAR4P </i>","169","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=169"
"TAAR5","30236","<i>TAAR5</i>","170","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=170"
"TAAR6","20978","<i>TAAR6</i>","171","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=171"
"TAAR8","14964","<i>TAAR8</i>","172","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=172"
"TAAR9","20977","<i>TAAR9</i>","173","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=173"
"TAC1","11517","neuropeptide K","2091","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2091"
"TAC3","11521","neurokinin B","2090","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2090"
"TACR1","11526","NK<sub>1</sub> receptor","360","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=360"
"TACR2","11527","NK<sub>2</sub> receptor","361","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=361"
"TACR3","11528","NK<sub>3</sub> receptor","362","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362"
"TACSTD2","11530","tumor associated calcium signal transducer 2","2837","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2837"
"TAF1","11535","TATA-box binding protein associated factor 1","2231","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2231"
"TAF1L","18056","TATA-box binding protein associated factor 1 like","2232","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2232"
"TAOK1","29259","TAO kinase 1","2233","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2233"
"TAOK2","16835","TAO kinase 2","2234","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2234"
"TAOK3","18133","TAO kinase 3","2235","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2235"
"TAP1","43","ABCB2","769","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=769"
"TAP2","44","ABCB3","770","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=770"
"TAS1R1","14448","<i>TAS1R1</i>","656","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=656"
"TAS1R2","14905","<i>TAS1R2</i>","657","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=657"
"TAS1R3","15661","<i>TAS1R3</i>","658","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=658"
"TAS2R1","14909","<i>TAS2R1</i>","659","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=659"
"TAS2R10","14918","<i>TAS2R10</i>","666","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=666"
"TAS2R13","14919","<i>TAS2R13</i>","667","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=667"
"TAS2R14","14920","<i>TAS2R14</i>","668","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=668"
"TAS2R16","14921","<i>TAS2R16</i>","669","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=669"
"TAS2R19","19108","<i>TAS2R19</i>","670","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=670"
"TAS2R20","19109","<i>TAS2R20</i>","671","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=671"
"TAS2R3","14910","<i>TAS2R3</i>","660","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=660"
"TAS2R30","19112","<i>TAS2R30</i>","673","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=673"
"TAS2R31","19113","<i>TAS2R31</i>","674","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=674"
"TAS2R38","9584","<i>TAS2R38</i>","682","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=682"
"TAS2R39","18886","<i>TAS2R39</i>","675","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=675"
"TAS2R4","14911","<i>TAS2R4</i>","661","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=661"
"TAS2R40","18885","<i>TAS2R40</i>","676","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=676"
"TAS2R41","18883","<i>TAS2R41</i>","680","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=680"
"TAS2R42","18888","<i>TAS2R42</i>","672","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=672"
"TAS2R43","18875","<i>TAS2R43</i>","678","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=678"
"TAS2R45","18876","<i>TAS2R45</i>","2828","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2828"
"TAS2R46","18877","<i>TAS2R46</i>","679","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=679"
"TAS2R5","14912","<i>TAS2R5</i>","662","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=662"
"TAS2R50","18882","<i>TAS2R50</i>","677","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=677"
"TAS2R60","20639","<i>TAS2R60</i>","681","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=681"
"TAS2R7","14913","<i>TAS2R7</i>","663","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=663"
"TAS2R8","14915","<i>TAS2R8</i>","664","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=664"
"TAS2R9","14917","<i>TAS2R9</i>","665","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=665"
"TASP1","15859","taspase 1","2419","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2419"
"TAT","11573","Tyrosine aminotransferase","2527","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2527"
"TBCK","28261","TBC1 domain containing kinase","2236","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2236"
"TBK1","11584","TANK binding kinase 1","2237","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2237"
"TBXA2R","11608","TP receptor","346","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346"
"TBXAS1","11609","CYP5A1","1353","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1353"
"TCIRG1","11647","V-type ATPase V<sub>0</sub> motor a3 subunit","825","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=825"
"TDO2","11708","tryptophan 2,3-dioxygenase","2887","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2887"
"TEAD1","11714","TEA domain transcription factor 1","3240","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3240"
"TEAD2","11715","TEA domain transcription factor 2","3241","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3241"
"TEAD3","11716","TEA domain transcription factor 3","3242","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3242"
"TEAD4","11717","TEA domain transcription factor 4","3243","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3243"
"TEC","11719","tec protein tyrosine kinase","2238","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2238"
"TEK","11724","TEK receptor tyrosine kinase","1842","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1842"
"TESK1","11731","testis associated actin remodelling kinase 1","2239","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2239"
"TESK2","11732","testis associated actin remodelling kinase 2","2240","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2240"
"TEX14","11737","testis expressed 14, intercellular bridge forming factor","2241","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2241"
"TFPI","11760","tissue factor pathway inhibitor","11181","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11181"
"TFRC","11763","transferrin receptor (CD71)","3196","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3196"
"TGFA","11765","TGF&alpha;","5059","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5059"
"TGFB1","11766","TGF&beta;1","5060","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5060"
"TGFB2","11768","TGF&beta;2","5061","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5061"
"TGFB3","11769","TGF&beta;3","5062","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5062"
"TGFBR1","11772","transforming growth factor beta receptor 1","1788","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1788"
"TGFBR2","11773","transforming growth factor beta receptor 2","1795","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1795"
"TGFBR3","11774","transforming growth factor beta receptor 3","1796","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1796"
"TGM2","11778","transglutaminase 2","3015","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3015"
"TH","11782","L-Tyrosine hydroxylase ","1243","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1243"
"THBS1","11785","thrombospondin 1","13047","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13047"
"THPO","11795","thrombopoietin","5063","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5063"
"THRA","11796","Thyroid hormone receptor-&alpha;","588","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=588"
"THRB","11799","Thyroid hormone receptor-&beta;","589","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=589"
"TIE1","11809","tyrosine kinase with immunoglobulin like and EGF like domains 1","1841","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1841"
"TIGIT","26838","TIGIT","2941","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2941"
"TIMP1","11820","TIMP1","5309","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5309"
"TIMP2","11821","TIMP2","5310","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5310"
"TIMP3","11822","TIMP3","5311","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5311"
"TIMP4","11823","TIMP4","5312","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5312"
"TIPARP","23696","TCDD inducible poly(ADP-ribose) polymerase","3266","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3266"
"TLK1","11841","tousled like kinase 1","2242","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2242"
"TLK2","11842","tousled like kinase 2","2243","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2243"
"TLR1","11847","TLR1","1751","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1751"
"TLR10","15634","TLR10","1760","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1760"
"TLR2","11848","TLR2","1752","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1752"
"TLR3","11849","TLR3","1753","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1753"
"TLR4","11850","TLR4","1754","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1754"
"TLR5","11851","TLR5","1755","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1755"
"TLR6","16711","TLR6","1756","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1756"
"TLR7","15631","TLR7","1757","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1757"
"TLR8","15632","TLR8","1758","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758"
"TLR9","15633","TLR9","1759","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1759"
"TMEM165","30760","transmembrane protein 165","3050","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3050"
"TMEM30A","16667","transmembrane protein 30A","3154","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3154"
"TMEM97","28106","&sigma;2","2553","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2553"
"TMPRSS11D","24059","transmembrane serine protease 11D","2420","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2420"
"TMPRSS15","9490","transmembrane serine protease 15","3189","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3189"
"TMPRSS2","11876","transmembrane serine protease 2","2421","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2421"
"TMPRSS6","16517","transmembrane serine protease 6","2422","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2422"
"TNF","11892","tumour necrosis factor membrane form","5073","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5073"
"TNFRSF10A","11904","death receptor 4","1879","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1879"
"TNFRSF10B","11905","death receptor 5","1880","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1880"
"TNFRSF10C","11906","decoy receptor 1","2323","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2323"
"TNFRSF10D","11907","decoy receptor 2","2324","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2324"
"TNFRSF11A","11908","receptor activator of NF-kappa B","1881","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1881"
"TNFRSF11B","11909","osteoprotegerin","1882","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1882"
"TNFRSF12A","18152","TWEAK receptor","1884","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1884"
"TNFRSF13B","18153","TACI","1885","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1885"
"TNFRSF13C","17755","BAFF receptor","1886","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1886"
"TNFRSF14","11912","herpes virus entry mediator","1887","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1887"
"TNFRSF17","11913","B cell maturation antigen","1889","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1889"
"TNFRSF18","11914","glucocorticoid-induced TNF receptor","1890","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1890"
"TNFRSF19","11915","toxicity and JNK inducer","1891","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1891"
"TNFRSF1A","11916","tumor necrosis factor receptor 1","1870","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1870"
"TNFRSF1B","11917","tumor necrosis factor receptor 2","1871","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1871"
"TNFRSF21","13469","death receptor 6","1893","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1893"
"TNFRSF25","11910","death receptor 3","1883","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1883"
"TNFRSF4","11918","OX40","1873","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1873"
"TNFRSF6B","11921","decoy receptor 3","2322","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2322"
"TNFRSF8","11923","CD30","1877","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1877"
"TNFRSF9","11924","4-1BB","1878","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1878"
"TNFSF10","11925","TRAIL","5065","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5065"
"TNFSF11","11926","RANK ligand","5066","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5066"
"TNFSF12","11927","TWEAK","5067","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5067"
"TNFSF13","11928","APRIL","5068","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5068"
"TNFSF13B","11929","BAFF","5069","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5069"
"TNFSF14","11930","LIGHT","5070","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5070"
"TNFSF15","11931","TL1A","5071","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5071"
"TNFSF18","11932","TL6","5072","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5072"
"TNFSF4","11934","OX-40 ligand","5076","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5076"
"TNFSF8","11938","CD30 ligand","5080","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5080"
"TNFSF9","11939","4-1BB ligand","5081","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5081"
"TNIK","30765","TRAF2 and NCK interacting kinase","2244","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2244"
"TNK1","11940","tyrosine kinase non receptor 1","2245","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2245"
"TNK2","19297","tyrosine kinase non receptor 2","2246","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2246"
"TNKS","11941","tankyrase","3108","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3108"
"TNKS2","15677","tankyrase 2","3109","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3109"
"TNNI3K","19661","TNNI3 interacting kinase","2247","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2247"
"TOP1","11986","DNA topoisomerase I","2636","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2636"
"TOP1MT","29787","topoisomerase (DNA) I mitochondrial","2759","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2759"
"TOP2A","11989","DNA topoisomerase II alpha","2637","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2637"
"TP53RK","16197","TP53 regulating kinase","2248","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2248"
"TPBG","12004","trophoblast glycoprotein","3009","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3009"
"TPCN1","18182","TPC1","392","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=392"
"TPCN2","20820","TPC2","393","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=393"
"TPH1","12008","L-Tryptophan hydroxylase 1","1241","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1241"
"TPH2","20692","L-Tryptophan hydroxylase 2","1242","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1242"
"TPO","12015","thyroid peroxidase","2526","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2526"
"TPP2","12016","tripeptidyl peptidase 2","2423","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2423"
"TPRA1","30413","<i>TPRA1</i>","655","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=655"
"TPSAB1","12019","tryptase alpha/beta 1","2424","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2424"
"TPSG1","14134","tryptase gamma 1","2425","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2425"
"TRAP1","16264","TNF receptor associated protein 1","2909","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2909"
"TRH","12298","TRH","2139","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2139"
"TRHDE","30748","TRH-specific aminopeptidase","1577","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1577"
"TRHR","12299","TRH<sub>1</sub> receptor","363","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=363"
"TRIB1","16891","tribbles pseudokinase 1","2249","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2249"
"TRIB2","30809","tribbles pseudokinase 2","2250","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2250"
"TRIB3","16228","tribbles pseudokinase 3","2251","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2251"
"TRIM21","11312","tripartite motif containing 21","2967","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2967"
"TRIM24","11812","tripartite motif containing 24","2252","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2252"
"TRIM28","16384","tripartite motif containing 28","2253","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2253"
"TRIM33","16290","tripartite motif containing 33","2254","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2254"
"TRIM38","10059","tripartite motif containing 38","2984","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2984"
"TRIM66","29005","tripartite motif containing 66","2783","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2783"
"TRIO","12303","trio Rho guanine nucleotide exchange factor","2255","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2255"
"TRPA1","497","TRPA1","485","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485"
"TRPC1","12333","TRPC1","486","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=486"
"TRPC2","12334","TRPC2","487","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=487"
"TRPC3","12335","TRPC3","488","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=488"
"TRPC4","12336","TRPC4","489","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=489"
"TRPC5","12337","TRPC5","490","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=490"
"TRPC6","12338","TRPC6","491","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=491"
"TRPC7","20754","TRPC7","492","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=492"
"TRPM1","7146","TRPM1","493","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=493"
"TRPM2","12339","TRPM2","494","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=494"
"TRPM3","17992","TRPM3","495","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=495"
"TRPM4","17993","TRPM4","496","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=496"
"TRPM5","14323","TRPM5","497","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=497"
"TRPM6","17995","TRPM6","498","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=498"
"TRPM7","17994","TRPM7","499","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=499"
"TRPM8","17961","TRPM8","500","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=500"
"TRPV1","12716","TRPV1","507","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507"
"TRPV2","18082","TRPV2","508","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=508"
"TRPV3","18084","TRPV3","509","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509"
"TRPV4","18083","TRPV4","510","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=510"
"TRPV5","3145","TRPV5","511","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=511"
"TRPV6","14006","TRPV6","512","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=512"
"TRRAP","12347","transformation/transcription domain associated protein","2256","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2256"
"TSHB","12372","TSH &beta; subunit","3734","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3734"
"TSHR","12373","TSH receptor","255","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=255"
"TSLP","30743","thymic stromal lymphopoietin","5083","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5083"
"TSPO","1158","Translocator protein","2879","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2879"
"TSSK1B","14968","testis specific serine kinase 1B","2257","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2257"
"TSSK2","11401","testis specific serine kinase 2","2258","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2258"
"TSSK3","15473","testis specific serine kinase 3","2259","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2259"
"TSSK4","19825","testis specific serine kinase 4","2260","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2260"
"TSSK6","30410","testis specific serine kinase 6","2261","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2261"
"TTBK1","19140","tau tubulin kinase 1","2262","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2262"
"TTBK2","19141","tau tubulin kinase 2","2263","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2263"
"TTK","12401","TTK protein kinase","2264","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2264"
"TTN","12403","titin","2265","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2265"
"TTR","12405","transthyretin","2851","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2851"
"TUBA1A","20766","tubulin alpha 1a","2638","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2638"
"TUBA4A","12407","tubulin alpha 4a","2639","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2639"
"TUBB","20778","tubulin beta class I","2640","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2640"
"TUBB3","20772","tubulin beta 3 class III","2752","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2752"
"TUBB4B","20771","tubulin beta 4B class IVb","2641","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2641"
"TUBB8","20773","tubulin beta 8 class VIII","2753","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2753"
"TUSC3","30242","tumor suppressor candidate 3","3040","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3040"
"TWF1","9620","twinfilin actin binding protein 1","2266","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2266"
"TWF2","9621","twinfilin actin binding protein 2","2267","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2267"
"TXK","12434","TXK tyrosine kinase","2268","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2268"
"TYK2","12440","tyrosine kinase 2","2269","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2269"
"TYMS","12441","thymidylate synthetase","2642","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2642"
"TYR","12442","tyrosinase","2643","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2643"
"TYRO3","12446","TYRO3 protein tyrosine kinase","1836","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1836"
"UBE2D1","12474","ubiquitin conjugating enzyme E2 D1","3228","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3228"
"UBE2D2","12475","ubiquitin conjugating enzyme E2 D2","3229","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3229"
"UCHL1","12513","ubiquitin C-terminal hydrolase L1","2426","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2426"
"UCHL3","12515","ubiquitin C-terminal hydrolase L3","2427","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2427"
"UCN","12516","urocortin 1","919","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=919"
"UCN2","18414","urocortin 2","921","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=921"
"UCN3","17781","urocortin 3","928","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=928"
"UCP1","12517","Uncoupling protein 1","1066","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1066"
"UCP2","12518","Uncoupling protein 2","1067","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1067"
"UCP3","12519","Uncoupling protein 3","1068","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1068"
"UGCG","12524","UDP-glucose ceramide glucosyltransferase","2528","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2528"
"UGT1A1","12530","UDP glucuronosyltransferase family 1 member A1","2990","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2990"
"UHMK1","19683","U2AF homology motif kinase 1","2270","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2270"
"ULK1","12558","unc-51 like autophagy activating kinase 1","2271","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2271"
"ULK2","13480","unc-51 like autophagy activating kinase 2","2272","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2272"
"ULK3","19703","unc-51 like kinase 3","2273","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2273"
"ULK4","15784","unc-51 like kinase 4","2274","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2274"
"UNC119","12565","unc-119 lipid binding chaperone","3011","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3011"
"USP1","12607","ubiquitin specific peptidase 1","2428","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2428"
"USP14","12612","ubiquitin specific peptidase 14","2429","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2429"
"USP2","12618","ubiquitin specific peptidase 2","2430","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2430"
"USP21","12620","ubiquitin specific peptidase 21","3223","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3223"
"USP5","12628","ubiquitin specific peptidase 5","2431","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2431"
"USP8","12631","ubiquitin specific peptidase 8","3209","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3209"
"UTS2","12636","urotensin-II","2153","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2153"
"UTS2B","30894","urotensin II-related peptide","2156","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2156"
"UTS2R","4468","UT receptor","365","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=365"
"VCAM1","12663","vascular cell adhesion protein 1","6758","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6758"
"VDR","12679","Vitamin D receptor","605","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=605"
"VEGFA","12680","VEGFA","5085","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5085"
"VEGFB","12681","VEGFB","5086","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5086"
"VEGFC","12682","VEGFC","5087","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5087"
"VEGFD","3708","VEGFD","5088","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5088"
"VGF","12684","TLQP-21","12220","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12220"
"VHL","12687","von Hippel-Lindau tumor suppressor","3204","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3204"
"VIP","12693","PHV","3706","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3706"
"VIPR1","12694","VPAC<sub>1</sub> receptor","371","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=371"
"VIPR2","12695","VPAC<sub>2</sub> receptor","372","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=372"
"VKORC1","23663","vitamin K epoxide reductase complex subunit 1","2645","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2645"
"VNN1","12705","vanin 1","3063","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3063"
"VRK1","12718","VRK serine/threonine kinase 1","2275","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2275"
"VRK2","12719","VRK serine/threonine kinase 2","2276","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2276"
"VRK3","18996","VRK serine/threonine kinase 3","2277","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2277"
"VSIR","30085","V-set immunoregulatory receptor","2956","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2956"
"VTN","12724","vitronectin","6746","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6746"
"VWF","12726","von Willebrand factor","6755","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6755"
"WDR5","12757","WD repeat domain 5","2831","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2831"
"WEE1","12761","WEE1 G2 checkpoint kinase","2278","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2278"
"WEE2","19684","WEE2 oocyte meiosis inhibiting kinase","2279","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2279"
"WIF1","18081","Wnt-inhibitory factor","5372","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5372"
"WNK1","14540","WNK lysine deficient protein kinase 1","2280","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2280"
"WNK2","14542","WNK lysine deficient protein kinase 2","2281","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2281"
"WNK3","14543","WNK lysine deficient protein kinase 3","2282","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2282"
"WNK4","14544","WNK lysine deficient protein kinase 4","2283","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2283"
"WNT1","12774","Wnt-1","3672","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3672"
"WNT10A","13829","Wnt-10a","3687","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3687"
"WNT10B","12775","Wnt-10b","3688","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3688"
"WNT11","12776","Wnt-11","3689","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3689"
"WNT16","16267","Wnt-16","3690","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3690"
"WNT2","12780","Wnt-2","3673","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3673"
"WNT2B","12781","Wnt-2b","3674","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3674"
"WNT3","12782","Wnt-3","3675","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3675"
"WNT3A","15983","Wnt-3a","3549","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3549"
"WNT4","12783","Wnt-4","3547","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3547"
"WNT5A","12784","Wnt-5a","3548","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3548"
"WNT5B","16265","Wnt-5b","3676","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3676"
"WNT6","12785","Wnt-6","3678","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3678"
"WNT7A","12786","Wnt-7a","3679","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3679"
"WNT7B","12787","Wnt-7b","3681","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3681"
"WNT8A","12788","Wnt-8a","3682","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3682"
"WNT8B","12789","Wnt-8b","3683","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3683"
"WNT9A","12778","Wnt-9a","3684","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3684"
"WNT9B","12779","Wnt-9b","3686","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3686"
"WRN","12791","WRN RecQ like helicase","3259","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3259"
"XCL1","10645","XCL1","3647","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3647"
"XCL2","10646","XCL2","4370","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4370"
"XCR1","1625","XCR1","75","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=75"
"XDH","12805","xanthine dehydrogenase","2646","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2646"
"XIAP","592","X-linked inhibitor of apoptosis","2790","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2790"
"XPNPEP1","12822","X-prolyl aminopeptidase 1","1578","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1578"
"XPNPEP2","12823","X-prolyl aminopeptidase 2","1579","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1579"
"XPNPEP3","28052","X-prolyl aminopeptidase 3","1580","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1580"
"XPO1","12825","exportin 1","3014","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3014"
"XPR1","12827","xenotropic and polytropic retrovirus receptor 1","3021","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3021"
"YARS1","12840","cytokine domain of tyrosyl tRNA synthetase","3729","https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3729"
"YES1","12841","YES proto-oncogene 1, Src family tyrosine kinase","2284","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2284"
"YTHDC1","30626","YTH N6-methyladenosine RNA binding protein C1","3288","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3288"
"ZACN","29504","ZAC ","587","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=587"
"ZAP70","12858","zeta chain of T cell receptor associated protein kinase 70","2285","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2285"
"ZBTB25","13112","zinc finger and BTB domain containing 25","3254","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3254"
"ZDHHC3","18470","zinc finger DHHC-type palmitoyltransferase 3","3271","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3271"
"ZDHHC6","19160","zinc finger DHHC-type palmitoyltransferase 6","3188","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3188"
"ZMYND11","16966","zinc finger MYND-type containing 11","2782","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2782"
"ZMYND8","9397","zinc finger MYND-type containing 8","2781","https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2781"
